Processing 00000000.tx.1: Effects of human pregnancy on fluid regulation responses to short-term exercise Aaron P. 

Phrase: "Effects of human pregnancy"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C1280500:effects [Qualitative Concept]
   737 E C2348382:Effect [Qualitative Concept]

Phrase: "on fluid regulation responses"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   827   C0871261:responses [Organism Attribute]
   793 E C1704632:Response [Finding]
   793 E C1706817:Response [Intellectual Product]
   793 E C2911692:Response [Mental Process]

Phrase: "to short-term exercise Aaron P."
Processing 00000000.tx.2: Heenan,1 Larry A. 

Phrase: "Heenan,"

Phrase: "1 Larry A."
Processing 00000000.tx.3: Wolfe,1,2 Gregory A. 

Phrase: "Wolfe,"

Phrase: "1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "2 Gregory A."
Processing 00000000.tx.4: L. 

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.5: Davies,1,3 and Michael J. 

Phrase: "Davies,"

Phrase: "1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "and"

Phrase: "Michael J."
Processing 00000000.tx.6: McGrath3 1School of Physical and Health Education, and Departments of 2Physiology, and 3Obstetrics and Gynaecology, Queen's University, Kingston, Ontario, Canada K7L 3N6 Submitted 24 October 2002 ; accepted in final form 8 August 2003  ABSTRACT TOP ABSTRACT METHODS RESULTS DISCUSSION DISCLOSURES REFERENCES  This study tested the hypothesis that human pregnancy alters fluid and electrolyte regulation responses to acute short-term exercise. 

Phrase: "McGrath3 1School of Physical"

Phrase: "and"

Phrase: "Health Education,"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0018701:Health education [Educational Activity]
   861   C0013621:Education [Educational Activity]
   861   C0013622:education [Classification]
   861   C0013658:Education, NOS [Finding]
   861   C0039401:Education [Educational Activity]
   789 E C1555905:Educational [Intellectual Product]

Phrase: "and"

Phrase: "Departments of 2Physiology,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C1704729:Department [Organization]

Phrase: "and"

Phrase: "3Obstetrics"

Phrase: "and"

Phrase: "Gynaecology,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0018417:Gynaecology [Biomedical Occupation or Discipline]
  1000   C0237419:Gynecology [Professional or Occupational Group]
   928 E C0205480:Gynaecologic [Spatial Concept]

Phrase: "Queen's University,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0041740:University [Manufactured Object,Organization]

Phrase: "Kingston,"

Phrase: "Ontario,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0029040:Ontario [Geographic Area]

Phrase: "Canada K7L 3N6"

Phrase: "Submitted"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1515023:Submitted [Functional Concept]

Phrase: "24 October 2002"

Phrase: ";"

Phrase: "accepted in final form 8 August 2003  ABSTRACT TOP ABSTRACT METHODS RESULTS DISCUSSION DISCLOSURES"
Meta Candidates (Total=22; Excluded=2; Pruned=0; Remaining=20)
   734   C0000857:Abstract [Occupational Activity]
   734   C0012625:disclosures [Individual Behavior]
   734   C0025663:Methods [Intellectual Product]
   734   C0025664:methods [Intellectual Product]
   734   C0205088:Final [Temporal Concept]
   734   C0348078:Form [Qualitative Concept]
   734   C0376315:Form [Manufactured Object]
   734   C0449851:Methods [Functional Concept]
   734   C0557061:Discussion [Therapeutic or Preventive Procedure]
   734   C0600678:Abstract [Intellectual Product]
   734   C1272684:Accepted [Qualitative Concept]
   734   C1522492:Form [Functional Concept]
   734   C1546485:Final [Idea or Concept]
   734   C1548435:Accepted [Idea or Concept]
   734   C1552863:Abstract [Idea or Concept]
   734   C1704458:Top [Spatial Concept]
   734   C2584313:Discussion [Social Behavior]
   701 E C0871511:METHOD [Intellectual Product]
   701   C1274040:Result [Functional Concept]
   701   C1546471:Result [Idea or Concept]
   701 E C1548601:Accept [Idea or Concept]
   701   C2825142:Result [Finding]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "This study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "tested"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392366:tested [Intellectual Product]
   966 E C0022885:Test [Laboratory Procedure]
   966 E C0039593:Test [Functional Concept]

Phrase: "the hypothesis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1512571:Hypothesis [Idea or Concept]

Phrase: "that human pregnancy"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
   861   C0032961:Pregnancy [Organism Function]
   861   C3484365:Pregnancy [Clinical Attribute]
   789 E C0549206:Pregnant [Finding]
   789 E C0553641:Pregnant [Functional Concept]
   789 E C0600457:PREGNANT [Finding]
   777 E C0552112:Pregnancies [Clinical Attribute]

Phrase: "alters"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   916   C0392747:Altered [Functional Concept]

Phrase: "fluid"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0005889:FLUID [Body Substance]
  1000   C0302908:fluid [Substance]
  1000   C0444611:Fluid [Qualitative Concept]
  1000   C1704353:Fluid [Substance]

Phrase: "and"

Phrase: "electrolyte regulation responses to acute short-term exercise."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   782   C2265833:response to exercise [Organism Function]
   744   C0871261:responses [Organism Attribute]
   711 E C1704632:Response [Finding]
   711 E C1706817:Response [Intellectual Product]
   711 E C2911692:Response [Mental Process]
Processing 00000000.tx.7: Responses of 22 healthy pregnant women (PG; gestational age, 37.0  0.2 wk) and 17 nonpregnant controls (CG) were compared at rest and during cycling at 70 and 110% of the ventilatory threshold (VT). 

Phrase: "Responses of 22 healthy pregnant women"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   753   C0871261:responses [Organism Attribute]
   719 E C1704632:Response [Finding]
   719 E C1706817:Response [Intellectual Product]
   719 E C2911692:Response [Mental Process]

Phrase: "(PG"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0441833:Group [Idea or Concept]
   861   C0687744:group [Population Group]
   861   C1257890:Group [Population Group]
   861   C1552516:Group [Health Care Related Organization]
   861   C1705428:Group [Conceptual Entity]
   861   C1705429:Group [Population Group]

Phrase: "; gestational age,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0017504:Gestational Age [Organism Attribute]
  1000   C1148461:Gestational age [Clinical Attribute]
   861   C0001779:Age [Organism Attribute]
   861   C0439671:Gestational [Temporal Concept]
   789 E C0032961:Gestation [Organism Function]

Phrase: "37.0  0.2 wk)"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0332174:/wk [Temporal Concept]
   804   C0439230:wk [Temporal Concept]

Phrase: "and"

Phrase: "17 nonpregnant controls"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   793   C0243148:control [Qualitative Concept]
   793   C1550141:Control [Substance]
   793   C1882979:Control [Conceptual Entity]
   793   C2587213:Control [Functional Concept]
   793   C3274648:Control [Qualitative Concept]

Phrase: "(CG"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
  1000   C0009932:Control Group [Group]
   861   C0243148:control [Qualitative Concept]
   861   C0441833:Group [Idea or Concept]
   861   C0687744:group [Population Group]
   861   C1257890:Group [Population Group]
   861   C1550141:Control [Substance]
   861   C1552516:Group [Health Care Related Organization]
   861   C1705428:Group [Conceptual Entity]
   861   C1705429:Group [Population Group]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]

Phrase: ")"

Phrase: "were"

Phrase: "compared at rest"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0035253:Rest [Daily or Recreational Activity]
   790   C1622890:ResT [Molecular Function]
   790   C1707455:Compared [Activity]

Phrase: "and during cycling"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1515981:And [Idea or Concept]
   756   C1511572:Cycle [Temporal Concept]

Phrase: "at 70"

Phrase: "and"

Phrase: "110% of the ventilatory threshold (VT)."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0449864:Threshold [Qualitative Concept]
Processing 00000000.tx.8: At rest, ANG II concentration was significantly (P < 0.05) higher in PG vs. 

Phrase: "At rest,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0035253:Rest [Daily or Recreational Activity]
  1000   C1622890:ResT [Molecular Function]

Phrase: "ANG II concentration"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0086045:Concentration [Mental Process]
   827   C1446561:Concentration [Quantitative Concept]
   755 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "was"

Phrase: "significantly"

Phrase: "(P < 0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "higher in PG"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   737   C0205250:High [Qualitative Concept]
   737   C1299351:High [Qualitative Concept]
   737   C2700149:HIGH [Intellectual Product]

Phrase: "vs."
Processing 00000000.tx.9: CG, whereas plasma osmolality and concentrations of AVP, sodium, and potasium were significantly lower. 

Phrase: "CG,"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
  1000   C0009932:Control Group [Group]
   861   C0243148:control [Qualitative Concept]
   861   C0441833:Group [Idea or Concept]
   861   C0687744:group [Population Group]
   861   C1257890:Group [Population Group]
   861   C1550141:Control [Substance]
   861   C1552516:Group [Health Care Related Organization]
   861   C1705428:Group [Conceptual Entity]
   861   C1705429:Group [Population Group]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]

Phrase: "whereas"

Phrase: "plasma osmolality"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0860721:Plasma osmolality [Organ or Tissue Function]
   861   C0032105:Plasma [Body Substance]
   861   C0086741:Osmolality [Clinical Attribute]
   861   C0201803:Osmolality [Laboratory Procedure]
   861   C1547034:*Osmolality [Quantitative Concept]
   861   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   761 E C0439186:osmol [Quantitative Concept]

Phrase: "and"

Phrase: "concentrations of AVP,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   790   C0086045:Concentrations [Mental Process]
   756 E C1446561:Concentration [Quantitative Concept]
   706 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "sodium,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0037473:Sodium [Biologically Active Substance,Element, Ion, or Isotope]
  1000   C0597484:Sodium+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "and"

Phrase: "potasium"

Phrase: "were"

Phrase: "significantly lower."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441994:Lower [Spatial Concept]
   861   C1548802:Lower [Body Location or Region]
   861   C2003888:Lower [Activity]
Processing 00000000.tx.10: Atrial natriuretic peptide concentration at rest was similar between groups. 

Phrase: "Atrial natriuretic peptide concentration at rest"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0086045:Concentration [Mental Process]
   753   C1446561:Concentration [Quantitative Concept]

Phrase: "was"

Phrase: "similar between groups."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C2348205:Similar [Qualitative Concept]
Processing 00000000.tx.11: ANG II and AVP concentrations increased significantly from rest to 110% VT in CG only, whereas increases in atrial natriuretic peptide concentration were similar between groups. 

Phrase: "ANG II"

Phrase: "and"

Phrase: "AVP concentrations"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0086045:Concentrations [Mental Process]
   827 E C1446561:Concentration [Quantitative Concept]
   777 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "significantly from rest"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0035253:Rest [Daily or Recreational Activity]
   790   C1622890:ResT [Molecular Function]

Phrase: "to 110% VT"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0449864:Threshold [Qualitative Concept]

Phrase: "in CG only,"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   901   C0009932:Control Group [Group]
   827   C0243148:control [Qualitative Concept]
   827   C0441833:Group [Idea or Concept]
   827   C0687744:group [Population Group]
   827   C1257890:Group [Population Group]
   827   C1550141:Control [Substance]
   827   C1552516:Group [Health Care Related Organization]
   827   C1705428:Group [Conceptual Entity]
   827   C1705429:Group [Population Group]
   827   C1882979:Control [Conceptual Entity]
   827   C2587213:Control [Functional Concept]
   827   C3274648:Control [Qualitative Concept]

Phrase: "whereas"

Phrase: "increases in atrial natriuretic peptide concentration"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0442805:increases [Functional Concept]

Phrase: "were"

Phrase: "similar between groups."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C2348205:Similar [Qualitative Concept]
Processing 00000000.tx.12: Increases in osmolality, and total protein and albumin concentrations from rest to both work rates were similar between the two groups. 

Phrase: "Increases in osmolality,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0442805:increases [Functional Concept]

Phrase: "and"

Phrase: "total protein"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0555903:Total protein [Laboratory Procedure]
  1000   C1261360:total protein [Laboratory or Test Result]
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0439175:% total [Quantitative Concept]
   861   C0439810:Total [Qualitative Concept]

Phrase: "and"

Phrase: "albumin concentrations from rest"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   833   C0486291:albumin concentrations [Laboratory or Test Result]
   770   C0086045:Concentrations [Mental Process]
   737 E C1446561:Concentration [Quantitative Concept]

Phrase: "to both work rates"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0043227:Work [Occupational Activity]
   827   C0871208:Rate [Activity]
   827   C1521828:Rate [Quantitative Concept]

Phrase: "were"

Phrase: "similar between the two groups."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C2348205:Similar [Qualitative Concept]
Processing 00000000.tx.13: PG and CG exhibited similar shifts in fluid during acute short-term exercise, but the increases in ANG II and AVP were absent and attenuated, respectively, during pregnancy. 

Phrase: "PG"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0441833:Group [Idea or Concept]
   861   C0687744:group [Population Group]
   861   C1257890:Group [Population Group]
   861   C1552516:Group [Health Care Related Organization]
   861   C1705428:Group [Conceptual Entity]
   861   C1705429:Group [Population Group]

Phrase: "and"

Phrase: "CG"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
  1000   C0009932:Control Group [Group]
   861   C0243148:control [Qualitative Concept]
   861   C0441833:Group [Idea or Concept]
   861   C0687744:group [Population Group]
   861   C1257890:Group [Population Group]
   861   C1550141:Control [Substance]
   861   C1552516:Group [Health Care Related Organization]
   861   C1705428:Group [Conceptual Entity]
   861   C1705429:Group [Population Group]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]

Phrase: "exhibited"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0015272:Exhibit [Intellectual Product]

Phrase: "similar shifts in fluid"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   819   C0242705:Fluid Shifts [Physiologic Function]
   770   C0333051:shifts [Functional Concept]
   737 E C2347509:Shift [Phenomenon or Process]

Phrase: "during acute short-term exercise,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0015259:Exercise [Daily or Recreational Activity]
   812   C1522704:Exercise [Therapeutic or Preventive Procedure]

Phrase: "but"

Phrase: "the increases in ANG II"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0442805:increases [Functional Concept]

Phrase: "and"

Phrase: "AVP"

Phrase: "were"

Phrase: "absent"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0332197:Absent [Quantitative Concept]
  1000   C2699517:ABSENT [Finding]
   928 E C0424530:Absences [Finding]
   928 E C1689985:Absence [Anatomical Abnormality]

Phrase: "and"

Phrase: "attenuated, respectively,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0332161:Attenuated [Qualitative Concept]
   861   C0599946:Attenuated [Activity]

Phrase: "during pregnancy."
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
  1000   C0032961:Pregnancy [Organism Function]
  1000   C3484365:Pregnancy [Clinical Attribute]
   928 E C0549206:Pregnant [Finding]
   928 E C0553641:Pregnant [Functional Concept]
   928 E C0600457:PREGNANT [Finding]
   916 E C0552112:Pregnancies [Clinical Attribute]
Processing 00000000.tx.14: This was attributed to the significantly augmented fluid volume state already present at rest in late gestation. angiotensin II; 

Phrase: "This"

Phrase: "was"

Phrase: "attributed to the significantly augmented fluid volume"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   778   C0449971:fluid volume [Quantitative Concept]
   748   C0005889:FLUID [Body Substance]
   748   C0205217:Augmented [Quantitative Concept]
   748   C0302908:fluid [Substance]
   748   C0444611:Fluid [Qualitative Concept]
   748   C0449468:*Volume [Quantitative Concept]
   748   C1690016:% volume [Qualitative Concept]
   748   C1704353:Fluid [Substance]
   748   C1705102:Volume [Intellectual Product]
   748   C2700258:Volume [Laboratory Procedure]
   714   C0449234:Attribute [Idea or Concept]
   714   C1704772:Attribute [Conceptual Entity]
   714   C1882133:Attribute [Qualitative Concept]

Phrase: "state"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1301808:State [Geographic Area]
  1000   C1442792:State [Functional Concept]
  1000   C3148680:State [Geographic Area]

Phrase: "already"

Phrase: "present at rest"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0035253:Rest [Daily or Recreational Activity]
   790   C0150312:Present [Quantitative Concept]
   790   C0449450:Present [Idea or Concept]
   790   C1622890:ResT [Molecular Function]

Phrase: "in late gestation. angiotensin II"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0003009:Angiotensin 2 [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   812   C0003018:Angiotensin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: ";"
Processing 00000000.tx.15: arginine vasopressin; 

Phrase: "arginine vasopressin"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0003779:Arginine Vasopressin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
           Vasopressin
  1000   C1527128:Arginine Vasopressin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0003765:Arginine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   861   C0042413:vasopressin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1705480:Vasopressin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: ";"
Processing 00000000.tx.16: atrial natriuretic peptide; 

Phrase: "atrial natriuretic peptide"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
  1000   C0027481:Atrial natriuretic peptide [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   913   C0051989:atrial peptide [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   901   C1144709:natriuretic peptide [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   901   C2709270:Natriuretic peptide [Amino Acid, Peptide, or Protein,Hormone]
   901   C3537020:Natriuretic Peptide [Pharmacologic Substance]
   827   C0018792:Atrial [Body Part, Organ, or Organ Component]
   827   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   827   C0597421:natriuretic [Pharmacologic Substance]
   755 E C0524422:atria [Body Part, Organ, or Organ Component]
   755 E C1280619:Atrium [Body Part, Organ, or Organ Component]

Phrase: ";"
Processing 00000000.tx.17: progesterone; 

Phrase: "progesterone"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
  1000   C0033308:Progesterone [Hormone,Pharmacologic Substance,Steroid]
  1000   C2757070:Progesterone [Pharmacologic Substance]
   944 E C0010094:Corpus luteum hormone [Hormone]
   944 E C0701112:Proluton [Hormone,Pharmacologic Substance,Steroid]
   944 E C0701115:Lutromone [Hormone,Pharmacologic Substance,Steroid]
   944 E C0701118:Lipo-Lutin [Hormone,Pharmacologic Substance,Steroid]

Phrase: ";"
Processing 00000000.tx.18: osmolality BOTH PREGNANCY AND STRENUOUS EXERCISE have striking effects on body fluid homeostasis, but, to our knowledge, their interactive effects have not been reported in any published study. 

Phrase: "osmolality"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0086741:Osmolality [Clinical Attribute]
  1000   C0201803:Osmolality [Laboratory Procedure]
  1000   C1547034:*Osmolality [Quantitative Concept]
   900 E C0439186:osmol [Quantitative Concept]

Phrase: "BOTH PREGNANCY"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
  1000   C0032961:Pregnancy [Organism Function]
  1000   C3484365:Pregnancy [Clinical Attribute]
   928 E C0549206:Pregnant [Finding]
   928 E C0553641:Pregnant [Functional Concept]
   928 E C0600457:PREGNANT [Finding]
   916 E C0552112:Pregnancies [Clinical Attribute]

Phrase: "AND"

Phrase: "STRENUOUS EXERCISE"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1514989:Strenuous Exercise [Daily or Recreational Activity]
   861   C0015259:Exercise [Daily or Recreational Activity]
   861   C1522704:Exercise [Therapeutic or Preventive Procedure]

Phrase: "have"

Phrase: "striking effects on body fluid homeostasis,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C1280500:effects [Qualitative Concept]
   719 E C2348382:Effect [Qualitative Concept]

Phrase: "but"

Phrase: ","

Phrase: "to our knowledge,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0376554:Knowledge [Intellectual Product]

Phrase: "their interactive effects"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1280500:effects [Qualitative Concept]
   827 E C2348382:Effect [Qualitative Concept]

Phrase: "have"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "been"

Phrase: "reported in any published study."
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   781   C1317750:Study report [Intellectual Product]
   781   C1831145:Study report [Clinical Attribute]
   760   C0034037:Published [Occupational Activity]
   760   C0557651:Study [Manufactured Object]
   760   C0684224:Reported [Intellectual Product]
   760   C0700287:Reported [Health Care Activity]
   760   C1704324:Published [Intellectual Product]
   760   C2603343:Study [Research Activity]
   760   C3496591:Reported [Clinical Attribute]
   726 E C3273238:Report [Intellectual Product]
Processing 00000000.tx.19: Therefore, this study was conducted to examine the effects of human pregnancy on plasma electrolytes, osmolality, and circulating fluid balance hormone responses to short-term exercise above and below the ventilatory anaerobic threshold. 

Phrase: "Therefore,"

Phrase: "this study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "was"

Phrase: "conducted"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0004927:Conduct [Individual Behavior]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "examine"

Phrase: "the effects of human pregnancy"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C1280500:effects [Qualitative Concept]
   726 E C2348382:Effect [Qualitative Concept]

Phrase: "on plasma electrolytes,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0858120:plasma electrolytes nos [Laboratory Procedure]
   861   C0013832:Electrolytes [Inorganic Chemical,Pharmacologic Substance]
   861   C3536863:Electrolytes [Pharmacologic Substance]

Phrase: "osmolality,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0086741:Osmolality [Clinical Attribute]
  1000   C0201803:Osmolality [Laboratory Procedure]
  1000   C1547034:*Osmolality [Quantitative Concept]
   900 E C0439186:osmol [Quantitative Concept]

Phrase: "and"

Phrase: "circulating fluid balance hormone responses to short-term exercise"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   773   C2265833:response to exercise [Organism Function]
   742   C0871261:responses [Organism Attribute]
   708 E C1704632:Response [Finding]
   708 E C1706817:Response [Intellectual Product]
   708 E C2911692:Response [Mental Process]

Phrase: "above"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1282910:Above [Spatial Concept]
  1000   C1552828:above [Idea or Concept]

Phrase: "and below the ventilatory anaerobic threshold."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0002749:Anaerobic Threshold [Quantitative Concept]
   753   C0449864:Threshold [Qualitative Concept]
   753   C1515981:And [Idea or Concept]
   753   C3641081:Anaerobic [Qualitative Concept]
Processing 00000000.tx.20: In early pregnancy, a reduction in systemic vascular tone attributed to gestational hormones activates "volume-restoring mechanisms," an increase in blood volume, and a reduction in plasma osmolality (9, 23). 

Phrase: "In early pregnancy,"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
  1000   C0747845:early pregnancy [Disease or Syndrome]
   861   C0032961:Pregnancy [Organism Function]
   861   C3484365:Pregnancy [Clinical Attribute]
   789 E C0549206:Pregnant [Finding]
   789 E C0553641:Pregnant [Functional Concept]
   789 E C0600457:PREGNANT [Finding]
   777 E C0552112:Pregnancies [Clinical Attribute]

Phrase: "a reduction in systemic vascular tone"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0301630:Reduction [Natural Phenomenon or Process]
   753   C0392756:Reduction [Qualitative Concept]
   753   C0441610:Reduction [Therapeutic or Preventive Procedure]

Phrase: "attributed to gestational hormones"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0019932:Hormones [Hormone]
   770   C0439671:Gestational [Temporal Concept]
   737   C0449234:Attribute [Idea or Concept]
   737   C1704772:Attribute [Conceptual Entity]
   737   C1882133:Attribute [Qualitative Concept]

Phrase: "activates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515877:Activate [Functional Concept]
  1000   C1879547:Activate [Activity]

Phrase: """volume-restoring mechanisms,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0441712:Mechanisms [Functional Concept]
   793 E C1706376:Mechanism [Manufactured Object]

Phrase: """"

Phrase: "an increase in blood volume,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0442805:Increase [Functional Concept]

Phrase: "and"

Phrase: "a reduction in plasma osmolality"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0301630:Reduction [Natural Phenomenon or Process]
   760   C0392756:Reduction [Qualitative Concept]
   760   C0441610:Reduction [Therapeutic or Preventive Procedure]

Phrase: "(9,"

Phrase: "23"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.21: The reduction in mean arterial pressure caused by the decrease in vascular tone activates the renin-ANG-aldosterone (Aldo) system (RAAS) (9, 21, 32), causing sodium retention. 

Phrase: "The reduction in mean arterial pressure"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0301630:Reduction [Natural Phenomenon or Process]
   753   C0392756:Reduction [Qualitative Concept]
   753   C0441610:Reduction [Therapeutic or Preventive Procedure]

Phrase: "caused by the decrease"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0392756:Decrease [Qualitative Concept]
   770   C0547047:Decrease [Quantitative Concept]
   737   C0015127:cause [Functional Concept]
   737   C1524003:Cause [Conceptual Entity]

Phrase: "in vascular tone"

Phrase: "activates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515877:Activate [Functional Concept]
  1000   C1879547:Activate [Activity]

Phrase: "the renin-ANG-aldosterone (Aldo) system"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   812   C0449913:System [Functional Concept]
   812   C1553451:System [Manufactured Object]
   812   C1704459:System [Medical Device]
   741 E C0205373:Systemic [Functional Concept]
   708   C1115104:renin aldosterone [Laboratory Procedure]

Phrase: "(RAAS) (9,"

Phrase: "21,"

Phrase: "32"

Phrase: ")"

Phrase: ","

Phrase: "causing"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0678227:Causing [Functional Concept]
   966 E C0015127:cause [Functional Concept]
   966 E C1524003:Cause [Conceptual Entity]

Phrase: "sodium retention."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0020488:Sodium retention [Disease or Syndrome]
   861   C0035280:Retention [Mental Process]
   861   C0333117:Retention [Functional Concept]
   861   C1753315:retention [Cell Function]
Processing 00000000.tx.22: Plasma renin concentration and plasma renin activity (PRA) remain elevated throughout pregnancy (9, 32). 

Phrase: "Plasma renin concentration"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   913   C0683150:plasma concentration [Quantitative Concept]
   827   C0032105:Plasma [Body Substance]
   827   C0035094:Renin [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0035100:Rennin [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   827   C0086045:Concentration [Mental Process]
   827   C1419338:RENIN [Gene or Genome]
   827   C1446561:Concentration [Quantitative Concept]
   827   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   771 E C0022877:Lab [Manufactured Object,Organization]
   771 E C0587081:Labs [Finding]
   755 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "and"

Phrase: "plasma renin activity (PRA)"
Meta Candidates (Total=13; Excluded=3; Pruned=0; Remaining=10)
   901   C1150120:renin activity [Molecular Function]
   873 E C1150116:chymosin activity [Molecular Function]
   827   C0032105:Plasma [Body Substance]
   827   C0035094:Renin [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0035100:Rennin [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1419338:RENIN [Gene or Genome]
   827   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   827   C1561536:*Activity [Idea or Concept]
   771 E C0022877:Lab [Manufactured Object,Organization]
   771 E C0587081:Labs [Finding]

Phrase: "remain"

Phrase: "elevated throughout pregnancy"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   790   C0032961:Pregnancy [Organism Function]
   790   C0205250:Elevated [Qualitative Concept]
   790   C3163633:Elevated [Qualitative Concept]
   790   C3484365:Pregnancy [Clinical Attribute]
   718 E C0549206:Pregnant [Finding]
   718 E C0553641:Pregnant [Functional Concept]
   718 E C0600457:PREGNANT [Finding]
   706 E C0552112:Pregnancies [Clinical Attribute]

Phrase: "(9,"

Phrase: "32"

Phrase: ")."
Processing 00000000.tx.23: The elevated circulating ANG II concentration ([ANG II]) also stimulates AVP release, leading to water retention (5). 

Phrase: "The elevated circulating ANG II concentration"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   804   C0086045:Concentration [Mental Process]
   804   C1446561:Concentration [Quantitative Concept]
   733 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "("

Phrase: "[ANG II"

Phrase: "]"

Phrase: ")"

Phrase: "also"

Phrase: "stimulates"

Phrase: "AVP release,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0030685:Release [Health Care Activity]
   861   C0391871:Release [Functional Concept]
   861   C0439180:% release [Quantitative Concept]
   861   C0680255:release [Health Care Activity]
   861   C1283071:Release [Functional Concept]
   861   C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "leading to water retention"
Meta Candidates (Total=14; Excluded=4; Pruned=0; Remaining=10)
   833   C0542203:water retention [Finding]
   833   C2584327:Water retention [Organism Function]
   770   C0035280:Retention [Mental Process]
   770   C0043047:Water [Inorganic Chemical,Pharmacologic Substance]
   770   C0332152:Leading [Temporal Concept]
   770   C0333117:Retention [Functional Concept]
   770   C0599638:WATER [Substance]
   770   C1522538:Leading [Functional Concept]
   770   C1550678:Water [Inorganic Chemical]
   770   C1753315:retention [Cell Function]
   737 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   737 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   737 E C2348269:Lead [Element, Ion, or Isotope]
   737 E C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "(5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.24: The osmotic threshold for AVP release is also lowered in pregnancy along with the threshold for thirst (17). 

Phrase: "The osmotic threshold for AVP release"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0449864:Threshold [Qualitative Concept]

Phrase: "is"

Phrase: "also"

Phrase: "lowered in pregnancy"
Meta Candidates (Total=10; Excluded=5; Pruned=0; Remaining=5)
   790   C0032961:Pregnancy [Organism Function]
   790   C0441994:lowered [Spatial Concept]
   790   C1272755:Lowered [Quantitative Concept]
   790   C2003888:Lowered [Activity]
   790   C3484365:Pregnancy [Clinical Attribute]
   756 E C1548802:Lower [Body Location or Region]
   718 E C0549206:Pregnant [Finding]
   718 E C0553641:Pregnant [Functional Concept]
   718 E C0600457:PREGNANT [Finding]
   706 E C0552112:Pregnancies [Clinical Attribute]

Phrase: "along with the threshold"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449864:Threshold [Qualitative Concept]

Phrase: "for thirst"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0039971:Thirst [Physiologic Function]
   928 E C0232471:Thirsty [Sign or Symptom]

Phrase: "(17"

Phrase: ")."
Processing 00000000.tx.25: The most important purpose of atrial natriuretic peptide (ANP) is to protect against excessive increases in central blood volume, and ANP is secreted in response to increased venous return and the resulting atrial distention. 

Phrase: "The most important purpose of atrial natriuretic peptide (ANP)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1285529:Purpose [Functional Concept]

Phrase: "is"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "protect against excessive increases"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0442802:Excessive [Qualitative Concept]
   770   C0442805:increases [Functional Concept]

Phrase: "in central blood volume,"
Meta Candidates (Total=15; Excluded=7; Pruned=0; Remaining=8)
   901   C0005850:Blood Volume [Organism Attribute]
   827   C0005767:Blood [Tissue]
   827   C0005768:blood [Body Substance]
   827   C0229664:Blood [Body Substance]
   827   C0449468:*Volume [Quantitative Concept]
   827   C1690016:% volume [Qualitative Concept]
   827   C1705102:Volume [Intellectual Product]
   827   C2700258:Volume [Laboratory Procedure]
   755 E C0333275:Bloody [Qualitative Concept]
   743 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   743 E C0392895:Bloods [Population Group]
   743 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   743 E C1511228:VESSEL, BLOOD [Tissue]
   727 E C1558950:VASCULAR [Finding]
   727 E C1801960:Vascular [Qualitative Concept]

Phrase: "and"

Phrase: "ANP"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
  1000   C0027481:Atrial natriuretic peptide [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   913   C0051989:atrial peptide [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   901   C1144709:natriuretic peptide [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   901   C2709270:Natriuretic peptide [Amino Acid, Peptide, or Protein,Hormone]
   901   C3537020:Natriuretic Peptide [Pharmacologic Substance]
   827   C0018792:Atrial [Body Part, Organ, or Organ Component]
   827   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   827   C0597421:natriuretic [Pharmacologic Substance]
   755 E C0524422:atria [Body Part, Organ, or Organ Component]
   755 E C1280619:Atrium [Body Part, Organ, or Organ Component]

Phrase: "is"

Phrase: "secreted in response"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0871261:Response [Organism Attribute]
   790   C1327616:Secreted [Cell Function]
   790   C1704632:Response [Finding]
   790   C1706817:Response [Intellectual Product]
   790   C2911692:Response [Mental Process]

Phrase: "to increased venous return"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0042449:Venous [Body Part, Organ, or Organ Component]
   827   C0332156:Return [Qualitative Concept]
   827   C0348013:Venous [Spatial Concept]

Phrase: "and"

Phrase: "the resulting atrial distention."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0012359:Distension [Pathologic Function]
Processing 00000000.tx.26: In human pregnancy, circulating plasma ANP concentrations ([ANP]) have been variously reported to decrease (29), increase (25), or remain unchanged (9) during pregnancy. 

Phrase: "In human pregnancy,"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
   861   C0032961:Pregnancy [Organism Function]
   861   C3484365:Pregnancy [Clinical Attribute]
   789 E C0549206:Pregnant [Finding]
   789 E C0553641:Pregnant [Functional Concept]
   789 E C0600457:PREGNANT [Finding]
   777 E C0552112:Pregnancies [Clinical Attribute]

Phrase: "circulating"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0175630:Circulating [Functional Concept]

Phrase: "plasma ANP concentrations"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   881   C0683150:plasma concentration [Quantitative Concept]
   804   C0086045:Concentrations [Mental Process]
   771 E C1446561:Concentration [Quantitative Concept]
   721 E C1880165:Concentrated [Biomedical or Dental Material]
   717   C0027481:Atrial natriuretic peptide [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "("

Phrase: "[ANP"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
  1000   C0027481:Atrial natriuretic peptide [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   913   C0051989:atrial peptide [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   901   C1144709:natriuretic peptide [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   901   C2709270:Natriuretic peptide [Amino Acid, Peptide, or Protein,Hormone]
   901   C3537020:Natriuretic Peptide [Pharmacologic Substance]
   827   C0018792:Atrial [Body Part, Organ, or Organ Component]
   827   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   827   C0597421:natriuretic [Pharmacologic Substance]
   755 E C0524422:atria [Body Part, Organ, or Organ Component]
   755 E C1280619:Atrium [Body Part, Organ, or Organ Component]

Phrase: "]"

Phrase: ")"

Phrase: "have"

Phrase: "been"

Phrase: "variously"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "decrease"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0392756:Decrease [Qualitative Concept]
  1000   C0547047:Decrease [Quantitative Concept]

Phrase: "(29"

Phrase: ")"

Phrase: ","

Phrase: "increase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]

Phrase: "(25"

Phrase: ")"

Phrase: ","

Phrase: "or"

Phrase: "remain"

Phrase: "unchanged"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0442739:Unchanged [Finding]
  1000   C2346711:Unchanged [Qualitative Concept]

Phrase: "(9"

Phrase: ")"

Phrase: "during pregnancy."
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
  1000   C0032961:Pregnancy [Organism Function]
  1000   C3484365:Pregnancy [Clinical Attribute]
   928 E C0549206:Pregnant [Finding]
   928 E C0553641:Pregnant [Functional Concept]
   928 E C0600457:PREGNANT [Finding]
   916 E C0552112:Pregnancies [Clinical Attribute]
Processing 00000000.tx.27: Although blood volume and venous return are increased substantially by late gestation (20, 22, 23), this is also accommodated by the cardiac dilation mediated by gestational hormones that occurs in early pregnancy (20, 33). 

Phrase: "Although"

Phrase: "blood volume"
Meta Candidates (Total=15; Excluded=7; Pruned=0; Remaining=8)
  1000   C0005850:Blood Volume [Organism Attribute]
   861   C0005767:Blood [Tissue]
   861   C0005768:blood [Body Substance]
   861   C0229664:Blood [Body Substance]
   861   C0449468:*Volume [Quantitative Concept]
   861   C1690016:% volume [Qualitative Concept]
   861   C1705102:Volume [Intellectual Product]
   861   C2700258:Volume [Laboratory Procedure]
   789 E C0333275:Bloody [Qualitative Concept]
   777 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   777 E C0392895:Bloods [Population Group]
   777 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   777 E C1511228:VESSEL, BLOOD [Tissue]
   761 E C1558950:VASCULAR [Finding]
   761 E C1801960:Vascular [Qualitative Concept]

Phrase: "and"

Phrase: "venous return"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0042449:Venous [Body Part, Organ, or Organ Component]
   861   C0332156:Return [Qualitative Concept]
   861   C0348013:Venous [Spatial Concept]

Phrase: "are"

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "substantially by late gestation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0032961:Gestation [Organism Function]
   770   C0205087:Late [Temporal Concept]

Phrase: "(20,"

Phrase: "22,"

Phrase: "23"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "this"

Phrase: "is"

Phrase: "also"

Phrase: "accommodated by the cardiac dilation"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0012359:Dilation [Pathologic Function]
   760   C0018787:Cardiac [Body Part, Organ, or Organ Component]
   760   C0393293:Dilation [Therapeutic or Preventive Procedure]
   760   C0700124:Dilation [Functional Concept]
   760   C1522601:Cardiac [Spatial Concept]

Phrase: "mediated by gestational hormones"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0019932:Hormones [Hormone]
   770   C0086597:mediated [Social Behavior]
   770   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
   770   C0439671:Gestational [Temporal Concept]

Phrase: "that"

Phrase: "occurs in early pregnancy"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   833   C0747845:early pregnancy [Disease or Syndrome]
   770   C0032961:Pregnancy [Organism Function]
   770   C1279919:Early [Temporal Concept]
   770   C1709305:Occur [Activity]
   770   C2745955:OCCUR [Temporal Concept]
   770   C3484365:Pregnancy [Clinical Attribute]

Phrase: "(20,"

Phrase: "33"

Phrase: ")."
Processing 00000000.tx.28: This may prevent an increase in resting left ventricular enddiastolic pressure (20) and presumably atrial stretch so that the stimulus to increase ANP release is not significantly affected. 

Phrase: "This"

Phrase: "may"

Phrase: "prevent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0309872:PREVENT [Pharmacologic Substance]

Phrase: "an increase in resting left ventricular enddiastolic pressure"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   793   C0677038:Increase in pressure [Phenomenon or Process]
           increase pressure
   793   C1881187:INCREASE IN PRESSURE [Phenomenon or Process]
   744   C0442805:Increase [Functional Concept]

Phrase: "(20"

Phrase: ")"

Phrase: "and"

Phrase: "presumably atrial stretch"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0600080:stretch [Therapeutic or Preventive Procedure]

Phrase: "so"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0037640:SO [Geographic Area]

Phrase: "that"

Phrase: "the stimulus to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0234402:Stimulus [Phenomenon or Process]

Phrase: "increase"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "ANP release"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   812   C0030685:Release [Health Care Activity]
   812   C0391871:Release [Functional Concept]
   812   C0439180:% release [Quantitative Concept]
   812   C0680255:release [Health Care Activity]
   812   C1283071:Release [Functional Concept]
   812   C1963578:Release [Therapeutic or Preventive Procedure]
   756   C0027481:Atrial natriuretic peptide [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   708   C0051989:atrial peptide [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "is"

Phrase: "not significantly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1518422:Not [Functional Concept]

Phrase: "affected."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0392760:Affected [Functional Concept]
  1000   C1314939:Affected [Functional Concept]
   966 E C0001721:Affect [Mental Process]
Processing 00000000.tx.29: In response to exercise, plasma osmolality, PRA, AVP concentration ([AVP]), [ANP], and Aldo concentration ([Aldo]) increase in healthy men (6, 7, 10, 11) and nonpregnant women (8, 12, 15, 28). 

Phrase: "In response to"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0871261:Response [Organism Attribute]
   861   C1704632:Response [Finding]
   861   C1706817:Response [Intellectual Product]
   861   C2911692:Response [Mental Process]

Phrase: "exercise"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0015259:Exercise [Daily or Recreational Activity]
  1000   C1522704:Exercise [Therapeutic or Preventive Procedure]

Phrase: ","

Phrase: "plasma osmolality,"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0860721:Plasma osmolality [Organ or Tissue Function]
   861   C0032105:Plasma [Body Substance]
   861   C0086741:Osmolality [Clinical Attribute]
   861   C0201803:Osmolality [Laboratory Procedure]
   861   C1547034:*Osmolality [Quantitative Concept]
   861   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   761 E C0439186:osmol [Quantitative Concept]

Phrase: "PRA,"
Meta Candidates (Total=13; Excluded=3; Pruned=0; Remaining=10)
   901   C1150120:renin activity [Molecular Function]
   873 E C1150116:chymosin activity [Molecular Function]
   827   C0032105:Plasma [Body Substance]
   827   C0035094:Renin [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0035100:Rennin [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1419338:RENIN [Gene or Genome]
   827   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   827   C1561536:*Activity [Idea or Concept]
   771 E C0022877:Lab [Manufactured Object,Organization]
   771 E C0587081:Labs [Finding]

Phrase: "AVP concentration"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0086045:Concentration [Mental Process]
   861   C1446561:Concentration [Quantitative Concept]
   789 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "("

Phrase: "[AVP]"

Phrase: ")"

Phrase: ","

Phrase: "[ANP"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
  1000   C0027481:Atrial natriuretic peptide [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   913   C0051989:atrial peptide [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   901   C1144709:natriuretic peptide [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   901   C2709270:Natriuretic peptide [Amino Acid, Peptide, or Protein,Hormone]
   901   C3537020:Natriuretic Peptide [Pharmacologic Substance]
   827   C0018792:Atrial [Body Part, Organ, or Organ Component]
   827   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   827   C0597421:natriuretic [Pharmacologic Substance]
   755 E C0524422:atria [Body Part, Organ, or Organ Component]
   755 E C1280619:Atrium [Body Part, Organ, or Organ Component]

Phrase: "],"

Phrase: "and"

Phrase: "Aldo concentration"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0086045:Concentration [Mental Process]
   861   C1446561:Concentration [Quantitative Concept]
   789 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "("

Phrase: "[Aldo"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0002006:Aldosterone [Hormone,Pharmacologic Substance,Steroid]

Phrase: "]"

Phrase: ")"

Phrase: "increase in healthy men (6,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   762   C1456606:Men's Health [Group Attribute]
   760   C0025266:Men [Population Group]
   760   C0442805:Increase [Functional Concept]
   726 E C0024554:MAN [Finding]
   726 E C0086418:Man [Human]
   704 E C1517378:Gain [Quantitative Concept]

Phrase: "7,"

Phrase: "10,"

Phrase: "11"

Phrase: ")"

Phrase: "and"

Phrase: "nonpregnant women"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0043210:Women [Population Group]

Phrase: "(8,"

Phrase: "12,"

Phrase: "15,"

Phrase: "28"

Phrase: ")."
Processing 00000000.tx.30: Stimulation of the RAAS and AVP release is intensity-dependent, requiring an exercise intensity of 5060% of maximal oxygen uptake (O2 max) (7, 11), although others have reported a significant rise in PRA (6) and plasma [Aldo] (11) at 40% O2 max. 

Phrase: "Stimulation of the RAAS"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1292856:Stimulation [Therapeutic or Preventive Procedure]
   770   C1948023:Stimulation [Natural Phenomenon or Process]

Phrase: "and"

Phrase: "AVP release"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0030685:Release [Health Care Activity]
   861   C0391871:Release [Functional Concept]
   861   C0439180:% release [Quantitative Concept]
   861   C0680255:release [Health Care Activity]
   861   C1283071:Release [Functional Concept]
   861   C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "is"

Phrase: "intensity-dependent,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0851827:Dependent [Qualitative Concept]
   861   C1701901:Dependent [Qualitative Concept]
   861   C3244310:dependent [Functional Concept]

Phrase: "requiring"

Phrase: "an exercise intensity of 5060% of maximal oxygen uptake"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0522510:Intensity [Qualitative Concept]

Phrase: "(O2 max) (7,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0030054:O2 [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "11"

Phrase: ")"

Phrase: ","

Phrase: "although"

Phrase: "others"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1955473:Others [Finding]
   966 E C0205394:Other [Qualitative Concept]

Phrase: "have"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "a significant rise in PRA"

Phrase: "(6"

Phrase: ")"

Phrase: "and"

Phrase: "plasma [Aldo"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0002006:Aldosterone [Hormone,Pharmacologic Substance,Steroid]
   861   C0032105:Plasma [Body Substance]
   861   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]

Phrase: "]"

Phrase: "(11"

Phrase: ")"

Phrase: "at 40% O2 max."
Processing 00000000.tx.31: Plasma [ANP] increases significantly at exercise intensities as low as 25% O2 max (11). 

Phrase: "Plasma"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032105:Plasma [Body Substance]
  1000   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]

Phrase: "[ANP"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
  1000   C0027481:Atrial natriuretic peptide [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   913   C0051989:atrial peptide [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   901   C1144709:natriuretic peptide [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   901   C2709270:Natriuretic peptide [Amino Acid, Peptide, or Protein,Hormone]
   901   C3537020:Natriuretic Peptide [Pharmacologic Substance]
   827   C0018792:Atrial [Body Part, Organ, or Organ Component]
   827   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   827   C0597421:natriuretic [Pharmacologic Substance]
   755 E C0524422:atria [Body Part, Organ, or Organ Component]
   755 E C1280619:Atrium [Body Part, Organ, or Organ Component]

Phrase: "]"

Phrase: "increases"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "significantly at exercise intensities"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0015259:Exercise [Daily or Recreational Activity]
   770   C0522510:intensities [Qualitative Concept]
   770   C1522704:Exercise [Therapeutic or Preventive Procedure]

Phrase: "as low"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205251:low [Qualitative Concept]
  1000   C1299352:Low [Qualitative Concept]
  1000   C1550472:low [Idea or Concept]

Phrase: "as 25% O2 max (11"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0030054:O2 [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: ")."
Processing 00000000.tx.32: Activation of the RAAS during exercise is attributed to sympathetic stimulation of juxtaglomerular cells and reduced renal blood flow (6). 

Phrase: "Activation of the RAAS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1879547:Activation [Activity]

Phrase: "during exercise"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0015259:Exercise [Daily or Recreational Activity]
  1000   C1522704:Exercise [Therapeutic or Preventive Procedure]

Phrase: "is"

Phrase: "attributed to sympathetic stimulation of juxtaglomerular cells"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   748   C0007634:Cells [Cell]
   748   C1292856:Stimulation [Therapeutic or Preventive Procedure]
   748   C1948023:Stimulation [Natural Phenomenon or Process]
   748   C3282337:Cells [Cell]
   745   C0227650:Juxtaglomerular cell [Cell]
   714   C0449234:Attribute [Idea or Concept]
   714 E C1269647:Cell [Cell]
   714 E C1704653:Cell [Medical Device]
   714   C1704772:Attribute [Conceptual Entity]
   714   C1882133:Attribute [Qualitative Concept]
   714 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "reduced renal blood flow"
Meta Candidates (Total=15; Excluded=7; Pruned=0; Remaining=8)
   923   C0035070:renal blood flow [Organ or Tissue Function]
   923   C1527409:Renal blood flow [Organ or Tissue Function]
   861   C0232338:Blood flow [Organism Function]
   812   C0005767:Blood [Tissue]
   812   C0005768:blood [Body Substance]
   812   C0022646:Renal [Body Part, Organ, or Organ Component]
   812   C0229664:Blood [Body Substance]
   812   C0806140:Flow [Natural Phenomenon or Process]
   741 E C0333275:Bloody [Qualitative Concept]
   729 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   729 E C0392895:Bloods [Population Group]
   729 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   729 E C1511228:VESSEL, BLOOD [Tissue]
   712 E C1558950:VASCULAR [Finding]
   712 E C1801960:Vascular [Qualitative Concept]

Phrase: "(6"

Phrase: ")."
Processing 00000000.tx.33: An increase in plasma osmolality, due to the shifting of water out of the vasculature, stimulates AVP release from the neurohypophysis and promotes water retention. 

Phrase: "An increase in plasma osmolality,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0442805:Increase [Functional Concept]

Phrase: "due to the shifting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0333051:shifting [Functional Concept]

Phrase: "of water"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0043047:Water [Inorganic Chemical,Pharmacologic Substance]
  1000   C0599638:WATER [Substance]
  1000   C1550678:Water [Inorganic Chemical]
   928 E C0443350:Watery [Qualitative Concept]

Phrase: "out of the vasculature,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0005839:vasculature [Body Part, Organ, or Organ Component]

Phrase: "stimulates"

Phrase: "AVP release from the neurohypophysis"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0030685:Release [Health Care Activity]
   760   C0391871:Release [Functional Concept]
   760   C0439180:% release [Quantitative Concept]
   760   C0680255:release [Health Care Activity]
   760   C1283071:Release [Functional Concept]
   760   C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "promotes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033414:Promote [Activity]

Phrase: "water retention."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0542203:water retention [Finding]
  1000   C2584327:Water retention [Organism Function]
   861   C0035280:Retention [Mental Process]
   861   C0333117:Retention [Functional Concept]
   861   C1753315:retention [Cell Function]
Processing 00000000.tx.34: Increased circulating [ANG II] also stimulates AVP secretion via type 1 (AT1) angiotensin receptors located outside the blood-brain barrier (5). 

Phrase: "Increased circulating"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0175630:Circulating [Functional Concept]

Phrase: "[ANG II"

Phrase: "] also"

Phrase: "stimulates"

Phrase: "AVP secretion via type 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0036536:secretion [Biologic Function]
   760   C0036537:Secretion [Body Substance]

Phrase: "(AT1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1412113:AT-1 [Gene or Genome]

Phrase: ")"

Phrase: "angiotensin receptors"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0034787:Receptors, Angiotensin [Amino Acid, Peptide, or Protein,Receptor]
   983 E C0072471:Angiotensin Receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "located"

Phrase: "outside"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205101:Outside [Spatial Concept]

Phrase: "the blood-brain barrier"
Meta Candidates (Total=15; Excluded=7; Pruned=0; Remaining=8)
  1000   C0005854:Blood-Brain Barrier [Body Part, Organ, or Organ Component]
  1000   C1305865:Blood-brain barrier [Organ or Tissue Function]
   827   C0005767:Blood [Tissue]
   827   C0005768:blood [Body Substance]
   827   C0006104:Brain [Body Part, Organ, or Organ Component]
   827   C0229664:Blood [Body Substance]
   827   C1269537:Brain [Body Part, Organ, or Organ Component]
   827   C1706912:BARRIER [Medical Device]
   755 E C0333275:Bloody [Qualitative Concept]
   743 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   743 E C0392895:Bloods [Population Group]
   743 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   743 E C1511228:VESSEL, BLOOD [Tissue]
   727 E C1558950:VASCULAR [Finding]
   727 E C1801960:Vascular [Qualitative Concept]

Phrase: "(5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.35: Stimulation of these fluid retention mechanisms during exercise helps to preserve plasma volume to maintain cardiovascular function and thermoregulation. 

Phrase: "Stimulation of these fluid retention mechanisms"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1292856:Stimulation [Therapeutic or Preventive Procedure]
   753   C1948023:Stimulation [Natural Phenomenon or Process]

Phrase: "during exercise"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0015259:Exercise [Daily or Recreational Activity]
  1000   C1522704:Exercise [Therapeutic or Preventive Procedure]

Phrase: "helps"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0018896:Help [Social Behavior]
  1000   C1552861:help [Idea or Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "preserve"

Phrase: "plasma volume to"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   901   C0032127:Plasma Volume [Clinical Attribute]
   827   C0032105:Plasma [Body Substance]
   827   C0449468:*Volume [Quantitative Concept]
   827   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   827   C1690016:% volume [Qualitative Concept]
   827   C1705102:Volume [Intellectual Product]
   827   C2700258:Volume [Laboratory Procedure]

Phrase: "maintain"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0024501:Maintain [Activity]

Phrase: "cardiovascular function"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C0007227:Cardiovascular function [Organ or Tissue Function]
   861   C0007226:Cardiovascular [Body System]
   861   C0031843:function [Physiologic Function]
   861   C0542341:Function [Functional Concept]
   861   C0700205:FUNCTION [Classification]
   861   C1705273:Function [Intellectual Product]
   789 E C0205245:Functional [Functional Concept]
   789 E C2700217:Functional [Conceptual Entity]

Phrase: "and"

Phrase: "thermoregulation."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0005905:Thermoregulation [Organism Function]
  1000   C0262758:thermoregulation [Therapeutic or Preventive Procedure]
Processing 00000000.tx.36: Also during dynamic exercise, enhanced venous return and atrial stretch result in augmented ANP secretion. 

Phrase: "Also during dynamic exercise,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0015259:Exercise [Daily or Recreational Activity]
   770   C0729333:Dynamic [Functional Concept]
   770   C1522704:Exercise [Therapeutic or Preventive Procedure]

Phrase: "enhanced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2349975:Enhanced [Activity]

Phrase: "venous return"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0042449:Venous [Body Part, Organ, or Organ Component]
   861   C0332156:Return [Qualitative Concept]
   861   C0348013:Venous [Spatial Concept]

Phrase: "and"

Phrase: "atrial stretch result in augmented ANP secretion."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   742   C1274040:Result [Functional Concept]
   742   C1546471:Result [Idea or Concept]
   742   C2825142:Result [Finding]
Processing 00000000.tx.37: However, because strenuous exercise is associated with antidiuresis and antinatriuresis, there is a dissociation between changes in plasma ANP levels and the normal effect of ANP to excrete sodium and promote fluid loss (11). 

Phrase: "However,"

Phrase: "because"

Phrase: "strenuous exercise"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1514989:Strenuous Exercise [Daily or Recreational Activity]
   861   C0015259:Exercise [Daily or Recreational Activity]
   861   C1522704:Exercise [Therapeutic or Preventive Procedure]

Phrase: "is"

Phrase: "associated with antidiuresis"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   882   C0332281:Associated with [Qualitative Concept]
           Associated
   790   C0232826:ANTIDIURESIS [Disease or Syndrome]
   790   C3159008:antidiuresis [Physiologic Function]
   756 E C0750490:Associate [Idea or Concept]
   756 E C1706221:Associate [Professional or Occupational Group]
   718 E C0596110:antidiuretic [Pharmacologic Substance]

Phrase: "and"

Phrase: "antinatriuresis,"

Phrase: "there"

Phrase: "is"

Phrase: "a dissociation between changes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0086168:Dissociation [Mental or Behavioral Dysfunction]

Phrase: "in plasma ANP levels"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   804   C0441889:Levels [Qualitative Concept]
   771 E C0456079:Level [Classification]
   771 E C1547707:Level [Geographic Area]
   771 E C2946261:Level [Pharmacologic Substance]
   717   C0027481:Atrial natriuretic peptide [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "the normal effect of ANP"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   774   C3179308:Natriuretic Effect [Physiologic Function]
   748   C1280500:Effect [Qualitative Concept]
   748   C2348382:Effect [Qualitative Concept]

Phrase: "to"

Phrase: "excrete"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0221102:excrete [Physiologic Function]

Phrase: "sodium"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0037473:Sodium [Biologically Active Substance,Element, Ion, or Isotope]
  1000   C0597484:Sodium+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "and"

Phrase: "promote"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033414:Promote [Activity]

Phrase: "fluid loss"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0235395:Fluid loss [Pathologic Function]
   861   C1517945:Loss [Quantitative Concept]

Phrase: "(11"

Phrase: ")."
Processing 00000000.tx.38: Acute expansion of plasma volume in men results in a blunted PRA (24), Aldo (13, 24), and AVP response to exercise (24). 

Phrase: "Acute expansion of plasma volume"

Phrase: "in men"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0025266:Men [Population Group]
   966 E C0024554:MAN [Finding]
   966 E C0086418:Man [Human]

Phrase: "results in a blunted PRA"
Meta Candidates (Total=16; Excluded=1; Pruned=0; Remaining=15)
   778   C1150120:renin activity [Molecular Function]
   751 E C1150116:chymosin activity [Molecular Function]
   748   C0032105:Plasma [Body Substance]
   748   C0035094:Renin [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0035100:Rennin [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   748   C0205177:Activity [Functional Concept]
   748   C0439167:% activity [Quantitative Concept]
   748   C0441655:Activity [Activity]
   748   C1274040:Result [Functional Concept]
   748   C1419338:RENIN [Gene or Genome]
   748   C1546471:Result [Idea or Concept]
   748   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   748   C1561536:*Activity [Idea or Concept]
   748   C1997138:Blunted [Qualitative Concept]
   748   C2825142:Result [Finding]
   746   C3244125:lab results [Intellectual Product]

Phrase: "(24"

Phrase: ")"

Phrase: ","

Phrase: "Aldo"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0002006:Aldosterone [Hormone,Pharmacologic Substance,Steroid]

Phrase: "(13,"

Phrase: "24"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "AVP response to"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0871261:Response [Organism Attribute]
   827   C1704632:Response [Finding]
   827   C1706817:Response [Intellectual Product]
   827   C2911692:Response [Mental Process]

Phrase: "exercise"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0015259:Exercise [Daily or Recreational Activity]
  1000   C1522704:Exercise [Therapeutic or Preventive Procedure]

Phrase: "(24"

Phrase: ")."
Processing 00000000.tx.39: The greater the plasma volume expansion, the less pronounced the Aldo response (13). 

Phrase: "The greater"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0443228:greater [Quantitative Concept]
  1000   C1704243:Greater [Quantitative Concept]
   966 E C0549177:Great [Quantitative Concept]

Phrase: "the plasma volume expansion,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   901   C0032127:Plasma Volume [Clinical Attribute]
   827   C0032105:Plasma [Body Substance]
   827   C0449468:*Volume [Quantitative Concept]
   827   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   827   C1690016:% volume [Qualitative Concept]
   827   C1705102:Volume [Intellectual Product]
   827   C2700258:Volume [Laboratory Procedure]

Phrase: "the less"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439092:less [Intellectual Product]
  1000   C0547044:Less [Qualitative Concept]

Phrase: "pronounced"

Phrase: "the Aldo response"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0871261:Response [Organism Attribute]
   861   C1704632:Response [Finding]
   861   C1706817:Response [Intellectual Product]
   861   C2911692:Response [Mental Process]

Phrase: "(13"

Phrase: ")."
Processing 00000000.tx.40: Plasma volume expansion also has been observed to result in lower plasma [AVP] (13) and higher [ANP] (13, 24) during exercise as a result of changes in resting levels of these hormones (13, 24). 

Phrase: "Plasma volume expansion also"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   861   C0032127:Plasma Volume [Clinical Attribute]
   812   C0032105:Plasma [Body Substance]
   812   C0449468:*Volume [Quantitative Concept]
   812   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   812   C1690016:% volume [Qualitative Concept]
   812   C1705102:Volume [Intellectual Product]
   812   C2700258:Volume [Laboratory Procedure]

Phrase: "has"

Phrase: "been"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "result in lower plasma"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   770   C0032105:Plasma [Body Substance]
   770   C0441994:Lower [Spatial Concept]
   770   C1274040:Result [Functional Concept]
   770   C1546471:Result [Idea or Concept]
   770   C1548802:Lower [Body Location or Region]
   770   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   770   C2003888:Lower [Activity]
   770   C2825142:Result [Finding]

Phrase: "[AVP] (13"

Phrase: ")"

Phrase: "and"

Phrase: "higher"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   966   C0205250:High [Qualitative Concept]
   966   C1299351:High [Qualitative Concept]
   966   C2700149:HIGH [Intellectual Product]
   916 E C0489786:Height [Organism Attribute]

Phrase: "[ANP"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
  1000   C0027481:Atrial natriuretic peptide [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   913   C0051989:atrial peptide [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   901   C1144709:natriuretic peptide [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   901   C2709270:Natriuretic peptide [Amino Acid, Peptide, or Protein,Hormone]
   901   C3537020:Natriuretic Peptide [Pharmacologic Substance]
   827   C0018792:Atrial [Body Part, Organ, or Organ Component]
   827   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   827   C0597421:natriuretic [Pharmacologic Substance]
   755 E C0524422:atria [Body Part, Organ, or Organ Component]
   755 E C1280619:Atrium [Body Part, Organ, or Organ Component]

Phrase: "]"

Phrase: "(13,"

Phrase: "24"

Phrase: ")"

Phrase: "during exercise"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0015259:Exercise [Daily or Recreational Activity]
  1000   C1522704:Exercise [Therapeutic or Preventive Procedure]

Phrase: "as a result"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1274040:Result [Functional Concept]
  1000   C1546471:Result [Idea or Concept]
  1000   C2825142:Result [Finding]

Phrase: "of changes"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0392747:changes [Functional Concept]
  1000   C0443172:changes [Quantitative Concept]
   966 E C1705241:Change [Quantitative Concept]

Phrase: "in resting levels"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   861   C0035253:Resting [Daily or Recreational Activity]
   861   C0441889:Levels [Qualitative Concept]
   861   C1512899:resting [Cell]
   827 E C0456079:Level [Classification]
   827 E C1547707:Level [Geographic Area]
   827 E C1622890:ResT [Molecular Function]
   827 E C2946261:Level [Pharmacologic Substance]

Phrase: "of these hormones"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0019932:Hormones [Hormone]
   916 E C0458083:Hormonal [Qualitative Concept]

Phrase: "(13,"

Phrase: "24"

Phrase: ")."
Processing 00000000.tx.41: This study compared the fluid regulation responses of pregnant and nonpregnant women to short-term (7 min) exercise at intensities corresponding to 70 and 110% of the ventilatory threshold (VT). 

Phrase: "This study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "compared"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707455:Compared [Activity]

Phrase: "the fluid regulation responses of pregnant"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   753   C0871261:responses [Organism Attribute]
   719 E C1704632:Response [Finding]
   719 E C1706817:Response [Intellectual Product]
   719 E C2911692:Response [Mental Process]

Phrase: "and"

Phrase: "nonpregnant women to short-term"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0043210:Women [Population Group]

Phrase: "(7 min)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0702093:/min [Temporal Concept]

Phrase: "exercise at intensities"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0015259:Exercise [Daily or Recreational Activity]
   790   C0522510:intensities [Qualitative Concept]
   790   C1522704:Exercise [Therapeutic or Preventive Procedure]

Phrase: "corresponding to 70"

Phrase: "and"

Phrase: "110% of the ventilatory threshold"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0449864:Threshold [Qualitative Concept]

Phrase: "(VT"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0449864:Threshold [Qualitative Concept]

Phrase: ")."
Processing 00000000.tx.42: Based on the findings of Grant et al. 

Phrase: "Based on the findings of Grant et al."
Meta Candidates (Total=13; Excluded=6; Pruned=0; Remaining=7)
   744   C0018173:Grant [Quantitative Concept]
   744   C1527178:Based [Functional Concept]
   744   C1548284:Grant [Idea or Concept]
   744   C1705938:Based [Idea or Concept]
   744   C2607943:findings [Functional Concept]
   744   C2926606:Findings [Clinical Attribute]
   744   C3539655:Findings [Intellectual Product]
   711 E C0002055:base [Inorganic Chemical]
   711 E C0037088:Finding [Sign or Symptom]
   711 E C0178499:Base [Chemical Viewed Functionally]
   711 E C0243095:Finding [Finding]
   711 E C1880279:Base [Biomedical or Dental Material]
   711 E C2825141:Finding [Finding]
Processing 00000000.tx.43: (13) and Roy et al. 

Phrase: "(13"

Phrase: ")"

Phrase: "and"

Phrase: "Roy et al."
Processing 00000000.tx.44: (24) on the effects of acute plasma volume expansion in men, we hypothesized that the plasma volume expansion of pregnancy would attenuate the normal response for ANG II and AVP to exercise.  

Phrase: "(24"

Phrase: ")"

Phrase: "on the effects"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1280500:effects [Qualitative Concept]
   966 E C2348382:Effect [Qualitative Concept]

Phrase: "of acute plasma volume expansion"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   861   C0032127:Plasma Volume [Clinical Attribute]
   812   C0032105:Plasma [Body Substance]
   812   C0449468:*Volume [Quantitative Concept]
   812   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   812   C1690016:% volume [Qualitative Concept]
   812   C1705102:Volume [Intellectual Product]
   812   C2700258:Volume [Laboratory Procedure]

Phrase: "in men,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0025266:Men [Population Group]
   966 E C0024554:MAN [Finding]
   966 E C0086418:Man [Human]

Phrase: "we"

Phrase: "hypothesized"

Phrase: "that"

Phrase: "the plasma volume expansion of pregnancy"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   814   C0365304:Volume of Plasma [Clinical Attribute]
   790   C0032127:Plasma Volume [Clinical Attribute]
   753   C0032105:Plasma [Body Substance]
   753   C0449468:*Volume [Quantitative Concept]
   753   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   753   C1690016:% volume [Qualitative Concept]
   753   C1705102:Volume [Intellectual Product]
   753   C2700258:Volume [Laboratory Procedure]

Phrase: "would"

Phrase: "attenuate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0599946:Attenuate [Activity]

Phrase: "the normal response for ANG II"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0871261:Response [Organism Attribute]
   753   C1704632:Response [Finding]
   753   C1706817:Response [Intellectual Product]
   753   C2911692:Response [Mental Process]

Phrase: "and"

Phrase: "AVP to"

Phrase: "exercise."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0015259:Exercise [Daily or Recreational Activity]
  1000   C1522704:Exercise [Therapeutic or Preventive Procedure]
Processing 00000000.tx.45: METHODS TOP ABSTRACT METHODS RESULTS DISCUSSION DISCLOSURES REFERENCES  Subjects. 

Phrase: "METHODS TOP ABSTRACT METHODS RESULTS DISCUSSION DISCLOSURES"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   795   C0012625:disclosures [Individual Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Subjects."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0681850:Subject [Group]
   966   C1550501:{Subject} [Idea or Concept]
   966   C1706203:Subject [Idea or Concept]
   966   C2349001:Subject [Human]
   966   C2697811:Subject [Functional Concept]
Processing 00000000.tx.46: Subjects were 22 healthy, nonsmoking, physically active pregnant women [pregnant group (PG); aged 30.0  0.8 yr, mean gestational age 37.0  0.2 wk] and 17 healthy nonpregnant women [control group (CG); aged 27.1  1.4 yr] with similar physical and demographic characteristics. 

Phrase: "Subjects"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0681850:Subject [Group]
   966   C1550501:{Subject} [Idea or Concept]
   966   C1706203:Subject [Idea or Concept]
   966   C2349001:Subject [Human]
   966   C2697811:Subject [Functional Concept]

Phrase: "were"

Phrase: "22 healthy, nonsmoking, physically active pregnant women"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   818   C0033011:Pregnant Women [Population Group]
   795   C0043210:Women [Population Group]

Phrase: "[pregnant group (PG)"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0441833:Group [Idea or Concept]
   861   C0687744:group [Population Group]
   861   C1257890:Group [Population Group]
   861   C1552516:Group [Health Care Related Organization]
   861   C1705428:Group [Conceptual Entity]
   861   C1705429:Group [Population Group]

Phrase: "; aged 30.0  0.8 yr,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0439234:yr [Temporal Concept]

Phrase: "mean gestational age 37.0  0.2 wk]"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C0332174:/wk [Temporal Concept]
   793   C0439230:wk [Temporal Concept]

Phrase: "and"

Phrase: "17 healthy nonpregnant women"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0043210:Women [Population Group]

Phrase: "[control group (CG)"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
  1000   C0009932:Control Group [Group]
   861   C0243148:control [Qualitative Concept]
   861   C0441833:Group [Idea or Concept]
   861   C0687744:group [Population Group]
   861   C1257890:Group [Population Group]
   861   C1550141:Control [Substance]
   861   C1552516:Group [Health Care Related Organization]
   861   C1705428:Group [Conceptual Entity]
   861   C1705429:Group [Population Group]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]

Phrase: "; aged 27.1  1.4 yr] with similar physical"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0439234:yr [Temporal Concept]

Phrase: "and"

Phrase: "demographic characteristics."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0683970:demographic characteristics [Group Attribute]
   861   C1521970:Characteristics [Qualitative Concept]
Processing 00000000.tx.47: Prospective subjects were recruited from local prenatal fitness classes and from the general population via media advertisements, posters, flyers, and contact with local obstetricians. 

Phrase: "Prospective subjects"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0681850:Subject [Group]
   827   C1550501:{Subject} [Idea or Concept]
   827   C1706203:Subject [Idea or Concept]
   827   C2349001:Subject [Human]
   827   C2697811:Subject [Functional Concept]

Phrase: "were"

Phrase: "recruited from local prenatal fitness classes"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0205276:Local [Spatial Concept]
   753   C0456387:Class [Intellectual Product]
   753   C0678804:prenatal [Age Group]
   753   C1456706:Fitness [Daily or Recreational Activity]
   753   C1705943:Class [Classification]
   753   C2828394:Prenatal [Temporal Concept]

Phrase: "and from the general population"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C0683971:General Population [Population Group]
   760   C0032659:Population [Quantitative Concept]
   760   C0205246:General [Spatial Concept]
   760   C1257890:Population [Population Group]
   760   C1515981:And [Idea or Concept]
   760   C1553889:General [Idea or Concept]

Phrase: "via media advertisements,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0949214:Advertisements [Intellectual Product]

Phrase: "posters,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0376675:Posters [Intellectual Product]

Phrase: "flyers,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683877:flyers [Intellectual Product]

Phrase: "and"

Phrase: "contact with local obstetricians."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0332158:Contact with [Functional Concept]
           contact
   770   C0337611:Contact [Population Group]
   770   C1705415:Contact [Idea or Concept]
Processing 00000000.tx.48: Medical clearance for pregnant subjects was obtained from the physician or midwife monitoring their pregnancy with the Physical Activity Readiness Medical Examination for Pregnancy. 

Phrase: "Medical clearance for pregnant subjects"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0449297:Clearance [Qualitative Concept]
   760   C1382187:Clearance [Clinical Attribute]
   760   C2825073:Clearance [Natural Phenomenon or Process]

Phrase: "was"

Phrase: "obtained from the physician"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0031831:Physician [Professional or Occupational Group]
   770   C0804815:Physician [Clinical Attribute]
   770   C1301820:Obtained [Functional Concept]
   737 E C1706701:Obtain [Activity]

Phrase: "or"

Phrase: "midwife monitoring"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0150369:Monitoring [Health Care Activity]
   861   C1516647:monitoring [Research Activity]

Phrase: "their pregnancy with the Physical Activity Readiness Medical Examination"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   762   C0849979:examination pregnancy [Health Care Activity]
   742   C0032961:Pregnancy [Organism Function]
   742   C3484365:Pregnancy [Clinical Attribute]

Phrase: "for Pregnancy."
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
  1000   C0032961:Pregnancy [Organism Function]
  1000   C3484365:Pregnancy [Clinical Attribute]
   928 E C0549206:Pregnant [Finding]
   928 E C0553641:Pregnant [Functional Concept]
   928 E C0600457:PREGNANT [Finding]
   916 E C0552112:Pregnancies [Clinical Attribute]
Processing 00000000.tx.49: Nonpregnant subjects completed the Revised Physical Activity Readiness Questionnaire. 

Phrase: "Nonpregnant subjects"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0681850:Subject [Group]
   827   C1550501:{Subject} [Idea or Concept]
   827   C1706203:Subject [Idea or Concept]
   827   C2349001:Subject [Human]
   827   C2697811:Subject [Functional Concept]

Phrase: "completed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205197:COMPLETED [Qualitative Concept]

Phrase: "the Revised Physical Activity Readiness Questionnaire."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0034394:Questionnaire [Intellectual Product]
Processing 00000000.tx.50: Both forms are available online from the Canadian Society for Exercise Physiology (www.csep.ca/forms.asp). 

Phrase: "Both forms"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0348078:forms [Qualitative Concept]
  1000   C0376315:Forms [Manufactured Object]
   966 E C1522492:Form [Functional Concept]

Phrase: "are"

Phrase: "available online from the Canadian Society"

Phrase: "for Exercise Physiology"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C1516990:Exercise Physiology [Biomedical Occupation or Discipline]
   861   C0031842:Physiology [Biomedical Occupation or Discipline]
   861   C0031843:physiology [Physiologic Function]
   789 E C0205463:Physiologic [Functional Concept]

Phrase: "(www.csep.ca/forms.asp"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0206293:Asp [Reptile]
   804   C3541260:ASP [Gene or Genome]

Phrase: ")."
Processing 00000000.tx.51: Written, informed consent was obtained from all subjects before entry into the study. 

Phrase: "Written"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0043266:write [Occupation or Discipline]
   966   C1576875:Write [Finding]
   966   C2584304:Write [Mental Process]

Phrase: ","

Phrase: "informed consent"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C0021430:Informed Consent [Regulation or Law]
   861   C1511481:Consent [Functional Concept]
   861   C1522154:Informed [Qualitative Concept]
   861   C1554192:consent [Idea or Concept]
   827 E C0537670:Inform [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   827 E C0700287:inform [Health Care Activity]
   827 E C1552002:inform [Idea or Concept]

Phrase: "was"

Phrase: "obtained from all"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   790   C1301820:Obtained [Functional Concept]
   756 E C1706701:Obtain [Activity]
   718 E C1517378:Gain [Quantitative Concept]

Phrase: "subjects before entry"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0681850:Subject [Group]
   790   C1550501:{Subject} [Idea or Concept]
   790   C1705654:Entry [Intellectual Product]
   790   C1706203:Subject [Idea or Concept]
   790   C2349001:Subject [Human]
   790   C2697811:Subject [Functional Concept]

Phrase: "into the study."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]
Processing 00000000.tx.52: The study protocol and consent form were approved by the Research Ethics Board, Faculty of Medicine, Queen's University and the US Army Medical Research and Materiel Command, Human Subjects Protection Branch. 

Phrase: "The study protocol"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C1507394:Study Protocol [Intellectual Product]
           Protocol
  1000   C2348563:Study Protocol [Intellectual Product]
           Protocol
   861   C0442711:Protocol [Intellectual Product]
   861   C0557651:Study [Manufactured Object]
   861   C1522729:Protocol [Intellectual Product]
   861   C2603343:Study [Research Activity]

Phrase: "and"

Phrase: "consent form"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0009797:Consent Form [Intellectual Product]
   861   C0348078:Form [Qualitative Concept]
   861   C0376315:Form [Manufactured Object]
   861   C1522492:Form [Functional Concept]

Phrase: "were"

Phrase: "approved by the Research Ethics Board,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   790   C0814851:Ethics, Research [Idea or Concept]
   753   C0015000:Ethics [Idea or Concept]
   753   C0035168:research [Research Activity]
   753   C0205540:Approved [Qualitative Concept]
   753   C0242481:Research [Research Activity]
   753   C0972401:board [Medical Device]
   753   C1527243:ethics [Idea or Concept]
   753   C1948070:Board [Organization]

Phrase: "Faculty of Medicine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0015535:Faculty [Professional or Occupational Group]

Phrase: "Queen's University"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0041740:University [Manufactured Object,Organization]

Phrase: "and"

Phrase: "the US Army Medical Research"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0079816:Medical Research [Research Activity]
   901   C1556038:Medical Research [Professional or Occupational Group]
   827   C0035168:research [Research Activity]
   827   C0242481:Research [Research Activity]

Phrase: "and"

Phrase: "Materiel Command,"

Phrase: "Human"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086418:Human [Human]

Phrase: "Subjects"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0681850:Subject [Group]
  1000   C1550501:{Subject} [Idea or Concept]
  1000   C1706203:Subject [Idea or Concept]
  1000   C2349001:Subject [Human]
  1000   C2697811:Subject [Functional Concept]

Phrase: "Protection Branch."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C1253959:Branch [Body Part, Organ, or Organ Component]
   861   C1881507:Branch [Chemical Viewed Structurally]
   861   C2700383:Branch [Plant]
   861   C2826234:BRANCH [Intellectual Product]
Processing 00000000.tx.53: Basic physical measurements included body height, body mass, and resting blood pressure. 

Phrase: "Basic physical measurements"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0242485:measurements [Functional Concept]

Phrase: "included"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0332257:included [Functional Concept]
  1000   C3538986:INCLUDED [Gene or Genome]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "body height,"
Meta Candidates (Total=11; Excluded=5; Pruned=0; Remaining=6)
  1000   C0005890:Body Height [Organism Attribute]
  1000   C0487985:Body height [Clinical Attribute]
   861   C0242821:body [Human]
   861   C0460148:Body [Anatomical Structure]
   861   C0489786:Height [Organism Attribute]
   861   C1268086:Body [Anatomical Structure]
   789 E C0205250:High [Qualitative Concept]
   789 E C1299351:High [Qualitative Concept]
   789 E C1522410:Highest [Qualitative Concept]
   789 E C2700149:HIGH [Intellectual Product]
   777 E C1995017:Bodies [Cell Component]

Phrase: "body mass,"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
  1000   C0518010:body mass [Finding]
   861   C0242821:body [Human]
   861   C0460148:Body [Anatomical Structure]
   861   C0577559:Mass [Finding]
   861   C1268086:Body [Anatomical Structure]
   861   C1306372:*Mass [Quantitative Concept]
   861   C3152252:Mass [Quantitative Concept]
   777 E C1995017:Bodies [Cell Component]

Phrase: "and"

Phrase: "resting blood pressure."
Meta Candidates (Total=16; Excluded=7; Pruned=0; Remaining=9)
   901   C0005823:Blood Pressure [Organism Function]
   901   C1271104:Blood Pressure [Finding]
   901   C1272641:Blood pressure [Finding]
   827   C0005767:Blood [Tissue]
   827   C0005768:blood [Body Substance]
   827   C0033095:Pressure [Phenomenon or Process]
   827   C0229664:Blood [Body Substance]
   827   C0460139:Pressure [Finding]
   827   C1306345:Pressure [Functional Concept]
   755 E C0333275:Bloody [Qualitative Concept]
   743 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   743 E C0392895:Bloods [Population Group]
   743 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   743 E C1511228:VESSEL, BLOOD [Tissue]
   727 E C1558950:VASCULAR [Finding]
   727 E C1801960:Vascular [Qualitative Concept]
Processing 00000000.tx.54: Body mass index was calculated as body mass/body height2 (kg/m2). 

Phrase: "Body mass index"
Meta Candidates (Total=13; Excluded=1; Pruned=0; Remaining=12)
  1000   C0005893:Body Mass Index [Diagnostic Procedure]
  1000   C1305855:Body mass index [Clinical Attribute]
   901   C0518010:body mass [Finding]
   827   C0242821:body [Human]
   827   C0460148:Body [Anatomical Structure]
   827   C0577559:Mass [Finding]
   827   C0918012:Index [Intellectual Product]
   827   C1268086:Body [Anatomical Structure]
   827   C1306372:*Mass [Quantitative Concept]
   827   C1552854:index [Idea or Concept]
   827   C1637833:% index [Quantitative Concept]
   827   C3152252:Mass [Quantitative Concept]
   743 E C1995017:Bodies [Cell Component]

Phrase: "was"

Phrase: "calculated as body mass/body height2"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   790   C0518010:body mass [Finding]
   753   C0242821:body [Human]
   753   C0444686:Calculated [Functional Concept]
   753   C0460148:Body [Anatomical Structure]
   753   C0577559:Mass [Finding]
   753   C1268086:Body [Anatomical Structure]
   753   C1306372:*Mass [Quantitative Concept]
   753   C1441506:Calculated [Activity]
   753   C1443182:Calculated [Laboratory Procedure]
   753   C3152252:Mass [Quantitative Concept]

Phrase: "(kg/m2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0456689:kg/m2 [Quantitative Concept]
   861   C0457242:m2 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.55: PG and CG values were equated for mean age, body height, prepregnant body mass (as reported by subject), parity, and aerobic fitness. 

Phrase: "PG"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0441833:Group [Idea or Concept]
   861   C0687744:group [Population Group]
   861   C1257890:Group [Population Group]
   861   C1552516:Group [Health Care Related Organization]
   861   C1705428:Group [Conceptual Entity]
   861   C1705429:Group [Population Group]

Phrase: "and"

Phrase: "CG values"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0042295:Values [Qualitative Concept]
   793 E C1522609:Value [Quantitative Concept]
   734   C0009932:Control Group [Group]

Phrase: "were"

Phrase: "equated for mean age,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0001779:Age [Organism Attribute]
   770   C0444504:Mean [Quantitative Concept]
   770   C2347634:Mean [Quantitative Concept]
   770   C2348143:Mean [Quantitative Concept]

Phrase: "body height,"
Meta Candidates (Total=11; Excluded=5; Pruned=0; Remaining=6)
  1000   C0005890:Body Height [Organism Attribute]
  1000   C0487985:Body height [Clinical Attribute]
   861   C0242821:body [Human]
   861   C0460148:Body [Anatomical Structure]
   861   C0489786:Height [Organism Attribute]
   861   C1268086:Body [Anatomical Structure]
   789 E C0205250:High [Qualitative Concept]
   789 E C1299351:High [Qualitative Concept]
   789 E C1522410:Highest [Qualitative Concept]
   789 E C2700149:HIGH [Intellectual Product]
   777 E C1995017:Bodies [Cell Component]

Phrase: "prepregnant body mass"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   901   C0518010:body mass [Finding]
   827   C0242821:body [Human]
   827   C0460148:Body [Anatomical Structure]
   827   C0577559:Mass [Finding]
   827   C1268086:Body [Anatomical Structure]
   827   C1306372:*Mass [Quantitative Concept]
   827   C3152252:Mass [Quantitative Concept]
   743 E C1995017:Bodies [Cell Component]

Phrase: "("

Phrase: "as"

Phrase: "reported by subject"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   882   C1709908:Reported By [Group]
   790   C0681850:Subject [Group]
   790   C0684224:Reported [Intellectual Product]
   790   C0700287:Reported [Health Care Activity]
   790   C1550501:{Subject} [Idea or Concept]
   790   C1706203:Subject [Idea or Concept]
   790   C2349001:Subject [Human]
   790   C2697811:Subject [Functional Concept]
   790   C3496591:Reported [Clinical Attribute]
   756 E C3273238:Report [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "parity,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0030563:Parity [Finding]
  1000   C0595999:Parity [Clinical Attribute]

Phrase: "and"

Phrase: "aerobic fitness."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C1456706:Fitness [Daily or Recreational Activity]
   789 E C0036572:Fit [Sign or Symptom]
   789 E C0424576:Fit [Finding]
   789 E C2349186:Fit [Activity]
Processing 00000000.tx.56: Members of PG performed the two exercise tests for the study between 34 and 38 wk of gestation. 

Phrase: "Members of PG"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0680022:members [Population Group]
   737 E C2698041:Member [Professional or Occupational Group]

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "the two exercise tests for the study"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   778   C0015260:Exercise tests [Diagnostic Procedure]
   748   C0015259:Exercise [Daily or Recreational Activity]
   748   C0022885:Tests [Laboratory Procedure]
   748   C0392366:Tests [Intellectual Product]
   748   C1522704:Exercise [Therapeutic or Preventive Procedure]
   714 E C0039593:Test [Functional Concept]

Phrase: "between 34"

Phrase: "and"

Phrase: "38 wk of gestation."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0332174:/wk [Temporal Concept]
   770   C0439230:wk [Temporal Concept]
Processing 00000000.tx.57: Subjects in CG were not using oral contraceptives. 

Phrase: "Subjects in CG"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   737   C0681850:Subject [Group]
   737   C1550501:{Subject} [Idea or Concept]
   737   C1706203:Subject [Idea or Concept]
   737   C2349001:Subject [Human]
   737   C2697811:Subject [Functional Concept]

Phrase: "were"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "oral contraceptives."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0009905:Contraceptives, Oral [Pharmacologic Substance]
   966 E C0029151:Oral contraceptive [Therapeutic or Preventive Procedure]
   861   C0009871:Contraceptives [Pharmacologic Substance]
   861   C0442027:Oral [Spatial Concept]
   827 E C0009886:Contraceptive [Medical Device]
   827 E C2364326:Contraceptive [Functional Concept]
Processing 00000000.tx.58: Exercise testing protocols. 

Phrase: "Exercise testing protocols."
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   901   C0681908:testing protocols [Research Activity]
   867 E C0449876:test protocol [Research Activity]
   827   C0442711:Protocols [Intellectual Product]
   793 E C1507394:Protocol [Intellectual Product]
   793 E C1522729:Protocol [Intellectual Product]
   793 E C2348563:Protocol [Intellectual Product]
   734   C0015260:exercise testing [Diagnostic Procedure]
Processing 00000000.tx.59: Subjects performed two exercise tests on a Sensor Medics (model 800S; Sensor Medics, Yorba Linda, CA) constant work rate cycle ergometer on separate days, at least 1 day apart. 

Phrase: "Subjects"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0681850:Subject [Group]
  1000   C1550501:{Subject} [Idea or Concept]
  1000   C1706203:Subject [Idea or Concept]
  1000   C2349001:Subject [Human]
  1000   C2697811:Subject [Functional Concept]

Phrase: "performed two exercise tests on a Sensor Medics"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   770   C0015260:Exercise tests [Diagnostic Procedure]
   744   C0015259:Exercise [Daily or Recreational Activity]
   744   C0022885:Tests [Laboratory Procedure]
   744   C0392366:Tests [Intellectual Product]
   744   C1522704:Exercise [Therapeutic or Preventive Procedure]
   711 E C0039593:Test [Functional Concept]

Phrase: "(model 800S"

Phrase: "; Sensor Medics,"

Phrase: "Yorba Linda,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3570325:Linda [Eukaryote]

Phrase: "CA) constant work rate cycle ergometer on separate days,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   745   C1955120:Cycle day [Temporal Concept]
   742   C0180748:ergometer [Medical Device]
   742   C1511572:Cycle [Temporal Concept]

Phrase: "at least 1 day apart."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0332173:/day [Temporal Concept]
   812   C0439228:day [Temporal Concept]
   812   C0439505:/day [Temporal Concept]
Processing 00000000.tx.60: To help standardize nutritional status and to ensure normal hydration, subjects consumed a standard meal (350 kcal, 40% carbohydrate, 40% fat, 20% protein) 12 h before both tests and avoided strenuous physical activity and caffeine on the day of testing. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "help"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0018896:Help [Social Behavior]
  1000   C1552861:help [Idea or Concept]

Phrase: "standardize"

Phrase: "nutritional status"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0392209:Nutritional status [Organism Attribute]
   861   C0449438:Status [Qualitative Concept]
   861   C1521739:Nutritional [Qualitative Concept]
   861   C2707262:Nutritional [Clinical Attribute]

Phrase: "and"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "ensure"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0218063:Ensure [Food]

Phrase: "normal hydration,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1321013:Hydration [Finding]

Phrase: "subjects"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0681850:Subject [Group]
   966   C1550501:{Subject} [Idea or Concept]
   966   C1706203:Subject [Idea or Concept]
   966   C2349001:Subject [Human]
   966   C2697811:Subject [Functional Concept]

Phrase: "consumed"

Phrase: "a standard meal"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0444664:Standard meal [Finding]
   861   C1998602:Meal [Daily or Recreational Activity]

Phrase: "(350 kcal,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439259:kcal [Quantitative Concept]
   861   C1556156:kcal [Quantitative Concept]

Phrase: "40% carbohydrate,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0007004:Carbohydrate [Carbohydrate]

Phrase: "40% fat,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0424612:FAT [Organism Attribute]

Phrase: "20% protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ")"

Phrase: "12 h before both tests"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0033727:H+ [Element, Ion, or Isotope]
   760   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0441932:H+ [Classification]
   760   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "avoided strenuous physical activity"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   875   C1514989:Strenuous Activity [Daily or Recreational Activity]
   861   C0026606:Physical activity [Daily or Recreational Activity]
   812   C0031809:Physical [Health Care Activity]
   812   C0205177:Activity [Functional Concept]
   812   C0205485:Physical [Functional Concept]
   812   C0439167:% activity [Quantitative Concept]
   812   C0441655:Activity [Activity]
   812   C1509143:Physical [Finding]
   812   C1561536:*Activity [Idea or Concept]

Phrase: "and"

Phrase: "caffeine on the day of testing."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0006644:Caffeine [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.61: The first test was used to determine VT and to assess aerobic working capacity (14). 

Phrase: "The first test"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0022885:Test [Laboratory Procedure]
   861   C0039593:Test [Functional Concept]
   861   C0392366:test [Intellectual Product]

Phrase: "was"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "determine"

Phrase: "VT"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0449864:Threshold [Qualitative Concept]

Phrase: "and"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "assess"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1516048:Assess [Activity]

Phrase: "aerobic working capacity"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   913   C2371107:Aerobic capacity [Clinical Attribute]
   827   C1516240:Capacity [Quantitative Concept]

Phrase: "(14"

Phrase: ")."
Processing 00000000.tx.62: The protocol involved 5 min of resting data collection and a 4-min warm-up at 20 W, followed by an increase in work rate of 20 W/min until a heart rate (HR) of 170 beats/min was reached (14). 

Phrase: "The protocol"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0442711:Protocol [Intellectual Product]
  1000   C1507394:Protocol [Intellectual Product]
  1000   C1522729:Protocol [Intellectual Product]
  1000   C2348563:Protocol [Intellectual Product]

Phrase: "involved"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1314939:Involved [Functional Concept]

Phrase: "5 min of resting data collection"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0702093:/min [Temporal Concept]

Phrase: "and"

Phrase: "a 4-min warm-up at 20 W,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0687712:warm [Natural Phenomenon or Process]

Phrase: "followed by an increase"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   833   C0332283:Followed by [Temporal Concept]
           followed
   770   C0442805:Increase [Functional Concept]
   737 E C1719822:Follow [Intellectual Product]

Phrase: "in work rate"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0043227:Work [Occupational Activity]
   861   C0871208:Rate [Activity]
   861   C1521828:Rate [Quantitative Concept]

Phrase: "of 20 W/min"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0702093:/min [Temporal Concept]

Phrase: "until a heart rate (HR)"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0018810:heart rate [Clinical Attribute]
   861   C0018787:Heart [Body Part, Organ, or Organ Component]
   861   C0871208:Rate [Activity]
   861   C1281570:Heart [Body Part, Organ, or Organ Component]
   861   C1521828:Rate [Quantitative Concept]

Phrase: "of 170 beats/min"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0439385:beats/min [Quantitative Concept]
   827   C0702093:/min [Temporal Concept]

Phrase: "was"

Phrase: "reached"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2584321:Reach [Organism Function]

Phrase: "(14"

Phrase: ")."
Processing 00000000.tx.63: Respiratory responses and oxygen uptake (O2) were measured on a breath-by-breath basis by using a computerized system (First Breath, St. Agatha, Ontario, Canada) that incorporates a respiratory mass spectrometer (MGA 1100; Marquette Electronics, Milwaukee, WI) with a volume turbine (VMM-2; Interface Associates, Aliso Viejo, CA) as described previously (14). 

Phrase: "Respiratory responses"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0871261:responses [Organism Attribute]
   827 E C1704632:Response [Finding]
   827 E C1706817:Response [Intellectual Product]
   827 E C2911692:Response [Mental Process]

Phrase: "and"

Phrase: "oxygen uptake"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0429627:Oxygen uptake [Finding]
   861   C0030054:Oxygen [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C0243144:Uptake [Physiologic Function]
   861   C0347980:% uptake [Quantitative Concept]

Phrase: "(O2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030054:O2 [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: ")"

Phrase: "were"

Phrase: "measured on a breath-"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   770   C0225386:Breath [Body Substance]
   770   C0444706:Measured [Qualitative Concept]
   770   C3541902:MEASURED [Diagnostic Procedure]
   737 E C0079809:Measure [Quantitative Concept]
   737 E C0242485:Measure [Functional Concept]

Phrase: "by-breath basis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1527178:Basis [Functional Concept]
   861   C1874451:Basis [Pharmacologic Substance]

Phrase: "by"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a computerized system"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0449913:System [Functional Concept]
   861   C1553451:System [Manufactured Object]
   861   C1704459:System [Medical Device]
   789 E C0205373:Systemic [Functional Concept]

Phrase: "(First Breath,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0225386:Breath [Body Substance]
   761 E C0559307:Breathiness [Sign or Symptom]

Phrase: "St. Agatha,"

Phrase: "Ontario,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0029040:Ontario [Geographic Area]

Phrase: "Canada"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0006823:Canada [Geographic Area]

Phrase: ")"

Phrase: "that"

Phrase: "incorporates"

Phrase: "a respiratory mass spectrometer"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   901   C0183396:Mass Spectrometer [Medical Device]
   827   C0183395:Spectrometer [Medical Device]
   827   C0577559:Mass [Finding]
   827   C1306372:*Mass [Quantitative Concept]
   827   C1710143:Spectrometer [Manufactured Object]
   827   C3152252:Mass [Quantitative Concept]

Phrase: "(MGA 1100"

Phrase: "; Marquette Electronics,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0013850:Electronics [Manufactured Object]

Phrase: "Milwaukee,"

Phrase: "WI) with a volume turbine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0043193:WI [Geographic Area]

Phrase: "(VMM-2"

Phrase: "; Interface"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1708533:Interface [Manufactured Object]
  1000   C2698172:Interface [Intellectual Product]

Phrase: "Associates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0750490:Associate [Idea or Concept]
  1000   C1706221:Associate [Professional or Occupational Group]

Phrase: ","

Phrase: "Aliso Viejo,"

Phrase: "CA)"

Phrase: "as"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "previously"

Phrase: "(14"

Phrase: ")."
Processing 00000000.tx.64: The V-slope method (2) was used to identify VT. 

Phrase: "The V-slope method"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0025663:Method [Intellectual Product]
   827   C0449851:Method [Functional Concept]
   827   C0871511:METHOD [Intellectual Product]

Phrase: "(2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: ")"

Phrase: "was"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "identify"

Phrase: "VT."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0449864:Threshold [Qualitative Concept]
Processing 00000000.tx.65: Heart rate (HR) was monitored with both a Polar Vantage monitor (Polar Electro, Woodbury, NY) and Marquette Max-1 electrocardiograph (Marquette Electronics). 

Phrase: "Heart rate"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0018810:heart rate [Clinical Attribute]
   861   C0018787:Heart [Body Part, Organ, or Organ Component]
   861   C0871208:Rate [Activity]
   861   C1281570:Heart [Body Part, Organ, or Organ Component]
   861   C1521828:Rate [Quantitative Concept]

Phrase: "(HR"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0018810:heart rate [Clinical Attribute]
   861   C0018787:Heart [Body Part, Organ, or Organ Component]
   861   C0871208:Rate [Activity]
   861   C1281570:Heart [Body Part, Organ, or Organ Component]
   861   C1521828:Rate [Quantitative Concept]

Phrase: ")"

Phrase: "was"

Phrase: "monitored with both"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   756   C0030695:monitor [Health Care Activity]
   756   C0150369:monitor [Health Care Activity]
   756   C0181904:Monitor [Medical Device]
   756   C0596972:Monitor [Medical Device]
   756   C1521743:Monitor [Professional or Occupational Group]
   756   C1704646:Monitor [Manufactured Object]

Phrase: "a Polar Vantage monitor"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   827   C0030695:monitor [Health Care Activity]
   827   C0150369:monitor [Health Care Activity]
   827   C0181904:Monitor [Medical Device]
   827   C0596972:Monitor [Medical Device]
   827   C1521743:Monitor [Professional or Occupational Group]
   827   C1704646:Monitor [Manufactured Object]

Phrase: "(Polar Electro,"

Phrase: "Woodbury,"

Phrase: "NY"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027976:NY [Geographic Area]
  1000   C1879958:NY [Intellectual Product]

Phrase: ")"

Phrase: "and"

Phrase: "Marquette Max-1 electrocardiograph"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0013798:electrocardiograph [Finding]
   812   C0180600:Electrocardiograph [Medical Device]
   812   C1623258:Electrocardiograph [Diagnostic Procedure]

Phrase: "(Marquette Electronics"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0013850:Electronics [Manufactured Object]

Phrase: ")."
Processing 00000000.tx.66: Oxygen pulse (O2/HR) at a HR of 170 beats/min was calculated as an index of aerobic working capacity (14). 

Phrase: "Oxygen pulse"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0232117:PULSE [Clinical Attribute]
   861   C0391850:Pulse [Physiologic Function]
   861   C1947910:Pulse [Phenomenon or Process]
   777 E C0034107:Pulses [Health Care Activity]

Phrase: "(O2/HR"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0018810:heart rate [Clinical Attribute]
   827   C0018787:Heart [Body Part, Organ, or Organ Component]
   827   C0871208:Rate [Activity]
   827   C1281570:Heart [Body Part, Organ, or Organ Component]
   827   C1521828:Rate [Quantitative Concept]

Phrase: ")"

Phrase: "at a HR"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0018810:heart rate [Clinical Attribute]
   861   C0018787:Heart [Body Part, Organ, or Organ Component]
   861   C0871208:Rate [Activity]
   861   C1281570:Heart [Body Part, Organ, or Organ Component]
   861   C1521828:Rate [Quantitative Concept]

Phrase: "of 170 beats/min"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0439385:beats/min [Quantitative Concept]
   827   C0702093:/min [Temporal Concept]

Phrase: "was"

Phrase: "calculated as an index of aerobic working capacity"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   767   C2371107:Aerobic capacity [Clinical Attribute]
   744   C0043227:Working [Occupational Activity]
   744   C0444686:Calculated [Functional Concept]
   744   C0918012:Index [Intellectual Product]
   744   C1441506:Calculated [Activity]
   744   C1443182:Calculated [Laboratory Procedure]
   744   C1510824:Aerobic [Qualitative Concept]
   744   C1516240:Capacity [Quantitative Concept]
   744   C1552854:index [Idea or Concept]
   744   C1637833:% index [Quantitative Concept]

Phrase: "(14"

Phrase: ")."
Processing 00000000.tx.67: The second exercise test involved a 10-min resting data collection period, followed by a 3-min warm-up at 0 W and a ramp increase in work rate, over a 30-s time period, to a work rate corresponding to 70 or 110% VT (14). 

Phrase: "The second exercise test"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   901   C0015260:Exercise Test [Diagnostic Procedure]
   827   C0015259:Exercise [Daily or Recreational Activity]
   827   C0022885:Test [Laboratory Procedure]
   827   C0039593:Test [Functional Concept]
   827   C0392366:test [Intellectual Product]
   827   C1522704:Exercise [Therapeutic or Preventive Procedure]

Phrase: "involved"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1314939:Involved [Functional Concept]

Phrase: "a 10-min resting data collection period,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   818   C0449239:collection period [Temporal Concept]
   795   C0439531:/period [Temporal Concept]
   795   C1948053:Period [Temporal Concept]
   724 E C0332182:Periodic [Temporal Concept]
   724 E C1706381:PERIODIC [Intellectual Product]

Phrase: "followed by a 3-min warm-up"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   778   C0332283:Followed by [Temporal Concept]
           followed
   757   C0589120:Follow-up [Finding]
   757   C1522577:follow-up [Health Care Activity]
   757   C1704685:FOLLOW-UP [Intellectual Product]
   757   C3274571:FOLLOW-UP [Health Care Activity]
   748   C0687712:warm [Natural Phenomenon or Process]
   748   C0702093:/min [Temporal Concept]
   714 E C1719822:Follow [Intellectual Product]

Phrase: "at 0 W"

Phrase: "and"

Phrase: "a ramp increase in work rate,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0442805:Increase [Functional Concept]

Phrase: "over a 30-s time period,"
Meta Candidates (Total=11; Excluded=6; Pruned=0; Remaining=5)
   861   C0439582:Time period [Temporal Concept]
   812   C0040223:Time [Temporal Concept]
   812   C0439531:/period [Temporal Concept]
   812   C1948053:Period [Temporal Concept]
   812   C3541383:Time [Temporal Concept]
   756 E C0442043:Temporal [Spatial Concept]
   756 E C2362314:Temporal [Temporal Concept]
   741 E C0332182:Periodic [Temporal Concept]
   741 E C1706381:PERIODIC [Intellectual Product]
   729 E C1632851:Times [Quantitative Concept]
   712 E C0031084:Periodicities [Temporal Concept]

Phrase: "to a work rate"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0043227:Work [Occupational Activity]
   861   C0871208:Rate [Activity]
   861   C1521828:Rate [Quantitative Concept]

Phrase: "corresponding to 70"

Phrase: "or"

Phrase: "110% VT"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0449864:Threshold [Qualitative Concept]

Phrase: "(14"

Phrase: ")."
Processing 00000000.tx.68: Both work rates were continued for 7 min after achievement of the prescribed work rate. 

Phrase: "Both work rates"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0043227:Work [Occupational Activity]
   827   C0871208:Rate [Activity]
   827   C1521828:Rate [Quantitative Concept]

Phrase: "were"

Phrase: "continued for 7 min"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0549178:Continued [Idea or Concept]
   770   C0702093:/min [Temporal Concept]

Phrase: "after achievement"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001072:Achievement [Behavior]

Phrase: "of the prescribed work rate."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0043227:Work [Occupational Activity]
   827   C0871208:Rate [Activity]
   827   C1521828:Rate [Quantitative Concept]
Processing 00000000.tx.69: Subjects rested for 20 min between levels. 

Phrase: "Subjects"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0681850:Subject [Group]
   966   C1550501:{Subject} [Idea or Concept]
   966   C1706203:Subject [Idea or Concept]
   966   C2349001:Subject [Human]
   966   C2697811:Subject [Functional Concept]

Phrase: "rested for 20 min"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0035253:rested [Daily or Recreational Activity]
   770   C0702093:/min [Temporal Concept]
   737 E C1622890:ResT [Molecular Function]

Phrase: "between levels."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0441889:Levels [Qualitative Concept]
   966 E C0456079:Level [Classification]
   966 E C1547707:Level [Geographic Area]
   966 E C2946261:Level [Pharmacologic Substance]
Processing 00000000.tx.70: Before this test, an indwelling catheter was inserted into a dorsal hand vein situated as far from the thumb as possible. 

Phrase: "Before this test,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0022885:Test [Laboratory Procedure]
  1000   C0039593:Test [Functional Concept]
  1000   C0392366:test [Intellectual Product]

Phrase: "an indwelling catheter"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0007439:In-Dwelling Catheter [Medical Device]
  1000   C0177049:Indwelling catheter [Therapeutic or Preventive Procedure]
   861   C0085590:Catheter [Medical Device]
   861   C0439848:Indwelling [Functional Concept]
   861   C1704454:Catheter [Medical Device]

Phrase: "was"

Phrase: "inserted into a dorsal hand vein"
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
   790   C0230372:Hand, dorsal [Body Location or Region]
   790   C1285501:hand vein [Body Part, Organ, or Organ Component]
   783   C1185737:Dorsal vein [Body Part, Organ, or Organ Component]
   753   C0018563:Hand [Body Part, Organ, or Organ Component]
   753   C0042449:Vein [Body Part, Organ, or Organ Component]
   753   C0205095:Dorsal [Spatial Concept]
   753   C0441587:Inserted [Health Care Activity]
   753   C1278960:Vein [Body Part, Organ, or Organ Component]
   753   C1281583:Hand [Body Part, Organ, or Organ Component]
   753   C1552914:hand [Quantitative Concept]
   719 E C1743766:Insert [Medical Device]
   719 E C1883719:Insert [Functional Concept]

Phrase: "situated as far"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0205108:far [Spatial Concept]

Phrase: "from the thumb"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0040067:Thumb [Body Part, Organ, or Organ Component]
  1000   C1269613:Thumb [Body Part, Organ, or Organ Component]

Phrase: "as possible."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332149:Possible [Qualitative Concept]
  1000   C1705910:Possible [Qualitative Concept]
  1000   C2362652:Possible [Qualitative Concept]
Processing 00000000.tx.71: The hand and lower arm were soaked in a warm water bath before insertion of the catheter and then placed in a Plexiglas heating box (45C) to promote vasodilation. 

Phrase: "The hand"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0018563:Hand [Body Part, Organ, or Organ Component]
  1000   C1281583:Hand [Body Part, Organ, or Organ Component]
  1000   C1552914:hand [Quantitative Concept]
   944 E C0024763:Manual [Intellectual Product,Manufactured Object]
   944 E C0175674:Manual [Functional Concept]

Phrase: "and"

Phrase: "lower arm"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   861   C0446516:Arm [Body Location or Region]
   861   C1269078:Arm [Body Part, Organ, or Organ Component]
   861   C1269612:Arm [Body Location or Region]
   805 E C0445456:Brachial [Spatial Concept]
   777 E C0206655:ARMS [Neoplastic Process]
   777 E C2681631:ARMS [Gene or Genome]

Phrase: "were"

Phrase: "soaked in a warm water bath"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   783   C0179245:bath water [Medical Device]
   753   C0043047:Water [Inorganic Chemical,Pharmacologic Substance]
   753   C0150141:Bath [Therapeutic or Preventive Procedure]
   753   C0204774:soaked [Therapeutic or Preventive Procedure]
   753   C0599638:WATER [Substance]
   753   C0687712:warm [Natural Phenomenon or Process]
   753   C1550678:Water [Inorganic Chemical]
   719 E C1549544:Soak [Functional Concept]

Phrase: "before insertion"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021107:Insertion [Therapeutic or Preventive Procedure]
  1000   C0441587:Insertion [Health Care Activity]
  1000   C1512796:Insertion [Genetic Function]
  1000   C1883719:Insertion [Functional Concept]

Phrase: "of the catheter"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0085590:Catheter [Medical Device]
  1000   C1704454:Catheter [Medical Device]

Phrase: "and"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "placed in a Plexiglas"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0600424:Plexiglass [Biomedical or Dental Material,Organic Chemical]
   770   C0701415:Plexiglas [Biomedical or Dental Material,Organic Chemical]
   737   C0442504:Place [Spatial Concept]
   737   C1704765:Place [Functional Concept]
   737   C1882509:Place [Activity]
   737   C3496241:place [Disease or Syndrome]

Phrase: "heating"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0018851:Heating [Environmental Effect of Humans]
   966 E C0018837:Heat [Natural Phenomenon or Process]

Phrase: "box"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0179400:Box [Manufactured Object]
  1000   C1533124:Box [Medical Device]

Phrase: "(45C"

Phrase: ")"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "promote"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033414:Promote [Activity]

Phrase: "vasodilation."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0042401:Vasodilation [Physiologic Function]
  1000   C0595862:VASODILATION [Pathologic Function]
  1000   C3537065:Vasodilation [Physiologic Function]
Processing 00000000.tx.72: Arterialized blood samples were then collected at rest and during the minute 6 of exercise at 70 or 110% VT. 

Phrase: "Arterialized blood samples"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0178913:blood samples [Body Substance]
   793   C0370003:Sample [Substance]
   793   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "collected at rest"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0035253:Rest [Daily or Recreational Activity]
   790   C1516695:Collected [Idea or Concept]
   790   C1516698:Collected [Functional Concept]
   790   C1622890:ResT [Molecular Function]

Phrase: "and during the minute 6 of exercise"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   748   C0015259:Exercise [Daily or Recreational Activity]
   748   C0439232:minute [Temporal Concept]
   748   C0700321:minute [Quantitative Concept]
   748   C0702093:/minute [Temporal Concept]
   748   C1282918:Minute [Quantitative Concept]
   748   C1515981:And [Idea or Concept]
   748   C1522704:Exercise [Therapeutic or Preventive Procedure]
   748   C2347166:Minute [Quantitative Concept]

Phrase: "at 70"

Phrase: "or"

Phrase: "110% VT."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0449864:Threshold [Qualitative Concept]
Processing 00000000.tx.73: Blood samples for the determination of oxygen tension, arterial PCO2 and H+ concentration were collected in a syringe containing lyophilized heparin and analyzed immediately by using a Radiometer ABL 30 acid-base analyzer at a standard temperature of 37C. 

Phrase: "Blood samples for the determination of oxygen tension,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0178913:blood samples [Body Substance]
   711   C0370003:Sample [Substance]
   711   C2347026:Sample [Conceptual Entity]

Phrase: "arterial PCO2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0428190:arterial pCO2 [Laboratory Procedure]
   861   C0201931:PCO2 [Laboratory Procedure]
   861   C0391839:pco2 [Laboratory or Test Result]

Phrase: "and"

Phrase: "H+ concentration"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0020283:H+ concentration [Quantitative Concept]
   861   C0086045:Concentration [Mental Process]
   861   C1446561:Concentration [Quantitative Concept]
   789 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "were"

Phrase: "collected in a syringe"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0039142:Syringe [Medical Device]
   770   C1516695:Collected [Idea or Concept]
   770   C1516698:Collected [Functional Concept]
   770   C1706072:Syringe [Manufactured Object]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "lyophilized heparin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0019134:Heparin [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   861   C0770546:HEPARIN [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "and"

Phrase: "analyzed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0936012:Analyzed [Research Activity]

Phrase: "immediately by"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C0205548:Immediately [Temporal Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a Radiometer ABL 30 acid-base analyzer at a standard temperature"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   738   C0179038:Analyzer [Medical Device]
   738   C1706246:Analyzer [Manufactured Object]

Phrase: "of 37C."
Processing 00000000.tx.74: Tympanic temperature measurements confirmed no significant deviation from 37C with pregnancy or exercise with the use of the present protocol (14). 

Phrase: "Tympanic temperature measurements"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0242485:measurements [Functional Concept]
   734   C1532039:Tympanic temperature [Finding]

Phrase: "confirmed"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0521093:confirmed [Qualitative Concept]
  1000   C0750484:Confirmed [Idea or Concept]
   966 E C1456348:Confirm [Qualitative Concept]

Phrase: "no significant deviation from 37C"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0012727:Deviation [Spatial Concept]
   760   C0205419:Deviation [Qualitative Concept]
   760   C1705236:Deviation [Finding]

Phrase: "with pregnancy"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
  1000   C0032961:Pregnancy [Organism Function]
  1000   C3484365:Pregnancy [Clinical Attribute]
   928 E C0549206:Pregnant [Finding]
   928 E C0553641:Pregnant [Functional Concept]
   928 E C0600457:PREGNANT [Finding]
   916 E C0552112:Pregnancies [Clinical Attribute]

Phrase: "or"

Phrase: "exercise with the use of the present protocol"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0015259:Exercise [Daily or Recreational Activity]
   744   C1522704:Exercise [Therapeutic or Preventive Procedure]

Phrase: "(14"

Phrase: ")."
Processing 00000000.tx.75: Quality control checks using four control liquids were done on all testing days. 

Phrase: "Quality control checks"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   793   C1283174:Check [Activity]
   734   C0034378:quality control [Functional Concept]
   734   C1561524:Quality Control [Intellectual Product]
   734   C1610034:Quality Control [Intellectual Product]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "four control liquids"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   827   C0302908:liquids [Substance]
   793 E C1304698:Liquid [Finding]
   793 E C1546699:Liquid NOS [Intellectual Product]
   793 E C1561501:Liquid NOS [Substance]

Phrase: "were"

Phrase: "done on all testing days."
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   760   C0039593:Testing [Functional Concept]
   760   C0392366:testing [Intellectual Product]
   760   C0439228:days [Temporal Concept]
   760   C1272695:Done [Qualitative Concept]
   760   C2746065:Done [Temporal Concept]
   726 E C0022885:Test [Laboratory Procedure]
   726 E C0332173:/day [Temporal Concept]
   726 E C0439505:/day [Temporal Concept]
Processing 00000000.tx.76: The remaining blood was used for plasma electrolyte, total protein (TP), and albumin analysis. 

Phrase: "The remaining blood"
Meta Candidates (Total=10; Excluded=7; Pruned=0; Remaining=3)
   861   C0005767:Blood [Tissue]
   861   C0005768:blood [Body Substance]
   861   C0229664:Blood [Body Substance]
   789 E C0333275:Bloody [Qualitative Concept]
   777 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   777 E C0392895:Bloods [Population Group]
   777 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   777 E C1511228:VESSEL, BLOOD [Tissue]
   761 E C1558950:VASCULAR [Finding]
   761 E C1801960:Vascular [Qualitative Concept]

Phrase: "was"

Phrase: "used for plasma electrolyte,"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   833   C0858120:plasma electrolyte [Laboratory Procedure]
   770   C0013832:Electrolyte [Inorganic Chemical,Pharmacologic Substance]
   770   C0032105:Plasma [Body Substance]
   770   C1273517:used [Finding]
   770   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   770   C3536863:Electrolyte [Pharmacologic Substance]
   737 E C0042153:use [Functional Concept]
   737 E C0457083:Use [Functional Concept]
   737 E C1947944:Use [Intellectual Product]

Phrase: "total protein (TP),"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0555903:Total protein [Laboratory Procedure]
  1000   C1261360:total protein [Laboratory or Test Result]
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0439175:% total [Quantitative Concept]
   861   C0439810:Total [Qualitative Concept]

Phrase: "and"

Phrase: "albumin analysis."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0002778:Analysis [Laboratory Procedure]
   861   C0936012:Analysis [Research Activity]
   861   C1524024:analysis [Functional Concept]
Processing 00000000.tx.77: Blood for plasma osmolality determination was collected in a 4.5-ml syringe containing lithium heparin (Monovette, Sarstedt). 

Phrase: "Blood for plasma osmolality determination"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   797   C0032105:Blood Plasma [Body Substance]
   797   C0373690:blood osmolality [Laboratory Procedure]
   760   C0005767:Blood [Tissue]
   760   C0005768:blood [Body Substance]
   760   C0229664:Blood [Body Substance]

Phrase: "was"

Phrase: "collected in a 4.5-ml syringe containing lithium heparin"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   739   C0019134:Heparin [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   739   C0023870:Lithium [Element, Ion, or Isotope,Pharmacologic Substance]
   739   C0039142:Syringe [Medical Device]
   739   C0332256:Containing [Functional Concept]
   739   C0439526:/mL [Quantitative Concept]
   739   C0770546:HEPARIN [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   739   C1516695:Collected [Idea or Concept]
   739   C1516698:Collected [Functional Concept]
   739   C1706072:Syringe [Manufactured Object]
   739   C2700400:Containing [Activity]

Phrase: "(Monovette,"

Phrase: "Sarstedt"

Phrase: ")."
Processing 00000000.tx.78: Blood samples for plasma analysis of [ANG II], [AVP], and [ANP] were collected in 10-ml chilled vacutainers containing EDTA (Becton-Dickinson) to which aprotinin (100 l of 100,000 KIU/ml solution) was immediately added to the whole blood and pepstatin A (20 l of 1 mg/ml solution) and O-phenanthroline (20 l of 50 mM solution) added to 2 ml of fresh plasma for AII determination. 

Phrase: "Blood samples for plasma analysis of [ANG II"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0178913:blood samples [Body Substance]
   750   C0444263:Plasma sample [Body Substance]
   750   C1303103:Sample analysis [Laboratory Procedure]
   711   C0370003:Sample [Substance]
   711   C2347026:Sample [Conceptual Entity]

Phrase: "],"

Phrase: "[AVP"

Phrase: "],"

Phrase: "and ["

Phrase: "ANP"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
  1000   C0027481:Atrial natriuretic peptide [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   913   C0051989:atrial peptide [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   901   C1144709:natriuretic peptide [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   901   C2709270:Natriuretic peptide [Amino Acid, Peptide, or Protein,Hormone]
   901   C3537020:Natriuretic Peptide [Pharmacologic Substance]
   827   C0018792:Atrial [Body Part, Organ, or Organ Component]
   827   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   827   C0597421:natriuretic [Pharmacologic Substance]
   755 E C0524422:atria [Body Part, Organ, or Organ Component]
   755 E C1280619:Atrium [Body Part, Organ, or Organ Component]

Phrase: "]"

Phrase: "were"

Phrase: "collected in 10-ml chilled vacutainers"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0439526:/mL [Quantitative Concept]
   753   C1516695:Collected [Idea or Concept]
   753   C1516698:Collected [Functional Concept]
   719   C0085593:Chill [Sign or Symptom]
   719   C1883522:Vacutainer [Medical Device]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "EDTA (Becton-Dickinson"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   901   C0331782:Becton Dickinson [Health Care Related Organization]

Phrase: ")"

Phrase: "to which aprotinin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0003641:Aprotinin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "(100 l of 100,000 KIU/ml solution"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   767   C0439458:kIU/L [Quantitative Concept]
   767   C1635169:mL/L [Quantitative Concept]

Phrase: ")"

Phrase: "was"

Phrase: "immediately"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205548:Immediately [Temporal Concept]

Phrase: "added to the whole blood"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   806   C0370231:whole blood [Body Substance]
   806   C1546552:Blood, Whole [Intellectual Product]
   806   C1608383:Whole Blood [Body Substance]
   806   C1608936:Blood, Whole [Intellectual Product]
   760   C0005767:Blood [Tissue]
   760   C0005768:blood [Body Substance]
   760   C0229664:Blood [Body Substance]
   760   C0444667:Whole [Quantitative Concept]
   760   C1524062:Added [Functional Concept]
   726 E C1883712:Add [Functional Concept]

Phrase: "and"

Phrase: "pepstatin A (20 l of 1 mg/ml solution"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   762   C0439268:mg/L [Quantitative Concept]
   762   C1635169:mL/L [Quantitative Concept]

Phrase: ")"

Phrase: "and"

Phrase: "O-phenanthroline"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0087870:o-phenanthroline [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]
   861   C0031370:phenanthroline [Organic Chemical]

Phrase: "(20 l of 50 mM solution"

Phrase: ")"

Phrase: "added to 2 ml of fresh plasma"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   757   C0947272:Add 2 [Quantitative Concept]
   748   C0032105:Plasma [Body Substance]
   748   C0439526:/mL [Quantitative Concept]
   748   C0443224:Fresh [Qualitative Concept]
   748   C1524062:Added [Functional Concept]
   748   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   748   C2827486:Fresh [Body Substance]
   714 E C1883712:Add [Functional Concept]

Phrase: "for AII determination."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1148554:determination [Laboratory Procedure]
Processing 00000000.tx.79: Blood for serum determination of progesterone concentration was collected in a vacutainer containing no additive and placed in ice for 0.51 h to allow time to clot. 

Phrase: "Blood for serum determination of progesterone concentration"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   774   C0229671:Blood Serum [Body Substance]
   774   C0427728:Blood concentration [Laboratory or Test Result]
   774   C0699870:blood concentration [Quantitative Concept]
   774   C1313904:Blood concentration [Laboratory Procedure]
   748   C0005767:Blood [Tissue]
   748   C0005768:blood [Body Substance]
   748   C0229664:Blood [Body Substance]

Phrase: "was"

Phrase: "collected in a vacutainer"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C1516695:Collected [Idea or Concept]
   770   C1516698:Collected [Functional Concept]
   770   C1883522:Vacutainer [Medical Device]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "no additive"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0442796:Additive [Qualitative Concept]
  1000   C1550602:Additive [Substance]

Phrase: "and"

Phrase: "placed in ice"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0020746:Ice [Inorganic Chemical]
   756   C0442504:Place [Spatial Concept]
   756   C1704765:Place [Functional Concept]
   756   C1882509:Place [Activity]
   756   C3496241:place [Disease or Syndrome]

Phrase: "for 0.51 h to"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0033727:H+ [Element, Ion, or Isotope]
   812   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   812   C0441932:H+ [Classification]
   812   C0564385:/h [Quantitative Concept]

Phrase: "allow"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683607:allow [Social Behavior]

Phrase: "time to"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0040223:Time [Temporal Concept]
   861   C3541383:Time [Temporal Concept]
   805 E C0442043:Temporal [Spatial Concept]
   805 E C2362314:Temporal [Temporal Concept]
   777 E C1632851:Times [Quantitative Concept]

Phrase: "clot."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0009074:CLOT [Organic Chemical,Pharmacologic Substance]
  1000   C0302148:Clot [Acquired Abnormality]
Processing 00000000.tx.80: All blood collected for plasma and serum analysis was centrifuged for 10 min at 2,500 rpm (532 g), and the plasma or serum was frozen at 80C for later analysis, as described below. 

Phrase: "All blood"
Meta Candidates (Total=10; Excluded=7; Pruned=0; Remaining=3)
  1000   C0005767:Blood [Tissue]
  1000   C0005768:blood [Body Substance]
  1000   C0229664:Blood [Body Substance]
   928 E C0333275:Bloody [Qualitative Concept]
   916 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   916 E C0392895:Bloods [Population Group]
   916 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   916 E C1511228:VESSEL, BLOOD [Tissue]
   900 E C1558950:VASCULAR [Finding]
   900 E C1801960:Vascular [Qualitative Concept]

Phrase: "collected for plasma"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0032105:Plasma [Body Substance]
   790   C1516695:Collected [Idea or Concept]
   790   C1516698:Collected [Functional Concept]
   790   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]

Phrase: "and"

Phrase: "serum analysis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0002778:Analysis [Laboratory Procedure]
   861   C0936012:Analysis [Research Activity]
   861   C1524024:analysis [Functional Concept]

Phrase: "was"

Phrase: "centrifuged for 10 min at 2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0456692:/10 min [Temporal Concept]
   753   C0702093:/min [Temporal Concept]
   719   C0179834:centrifuge [Medical Device]

Phrase: "500 rpm (532 g"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0439267:g% [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "the plasma"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032105:Plasma [Body Substance]
  1000   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]

Phrase: "or"

Phrase: "serum"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0229671:Serum [Body Substance]
  1000   C1546774:Serum [Intellectual Product]
  1000   C1550100:Serum [Body Substance]

Phrase: "was"

Phrase: "frozen at 80C"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0016701:Frozen [Natural Phenomenon or Process]
   790   C0677542:Frozen [Functional Concept]

Phrase: "for later analysis,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0002778:Analysis [Laboratory Procedure]
   861   C0936012:Analysis [Research Activity]
   861   C1524024:analysis [Functional Concept]

Phrase: "as"

Phrase: "described below."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C1552738:described [Idea or Concept]
Processing 00000000.tx.81: Plasma concentrations of sodium ([Na+]), potassium ([K+]) and chloride ([Cl]) were analyzed by using ion-selective electrodes. 

Phrase: "Plasma concentrations of sodium"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   819   C0683150:concentrations plasma [Quantitative Concept]
   770   C0086045:Concentrations [Mental Process]
   737 E C1446561:Concentration [Quantitative Concept]

Phrase: "("

Phrase: "[Na+]"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597484:Na+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1272460:{NA} [Qualitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "potassium"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032821:Potassium [Element, Ion, or Isotope]
  1000   C0597277:Potassium+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "("

Phrase: "[K+])"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "chloride ([Cl])"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0008203:Chloride, NOS [Inorganic Chemical]
  1000   C0596019:Chloride [Element, Ion, or Isotope]

Phrase: "were"

Phrase: "analyzed by"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C0936012:Analyzed [Research Activity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "ion-selective electrodes."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0206189:Ion-Selective Electrodes [Medical Device,Research Device]
   827   C0013812:Electrodes [Medical Device]
   827   C0022023:Ion [Element, Ion, or Isotope]
   827   C1700702:ION [Functional Concept]
   793 E C1705652:Electrode [Medical Device]
Processing 00000000.tx.82: Total calcium concentration was measured using a dye-binding assay. 

Phrase: "Total calcium concentration"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0086045:Concentration [Mental Process]
   827   C1446561:Concentration [Quantitative Concept]
   755 E C1880165:Concentrated [Biomedical or Dental Material]
   734   C0600069:Total calcium [Element, Ion, or Isotope]

Phrase: "was"

Phrase: "measured"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0444706:Measured [Qualitative Concept]
  1000   C3541902:MEASURED [Diagnostic Procedure]
   966 E C0079809:Measure [Quantitative Concept]
   966 E C0242485:Measure [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a dye-binding assay."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0005507:Assay [Laboratory Procedure]
   827   C0243073:assay [Qualitative Concept]
   827   C1510438:Assay [Laboratory Procedure]
Processing 00000000.tx.83: Ionized calcium concentration ([Ca2+]) was calculated from total calcium concentration. 

Phrase: "Ionized calcium concentration"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   827   C0086045:Concentration [Mental Process]
   827   C1446561:Concentration [Quantitative Concept]
   755 E C1880165:Concentrated [Biomedical or Dental Material]
   734   C0201927:Calcium, Ionized [Laboratory Procedure]
   734   C0373561:Ionised calcium [Biologically Active Substance,Element, Ion, or Isotope]
   734   C0596235:Ionized Calcium [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "("

Phrase: "[Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "]"

Phrase: ")"

Phrase: "was"

Phrase: "calculated from total calcium concentration."
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   806   C0600069:Total calcium [Element, Ion, or Isotope]
   760   C0006675:Calcium [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   760   C0006726:Calcium [Inorganic Chemical]
   760   C0086045:Concentration [Mental Process]
   760   C0439175:% total [Quantitative Concept]
   760   C0439810:Total [Qualitative Concept]
   760   C0444686:Calculated [Functional Concept]
   760   C1441506:Calculated [Activity]
   760   C1443182:Calculated [Laboratory Procedure]
   760   C1446561:Concentration [Quantitative Concept]
   760   C2936886:Calcium [Pharmacologic Substance]
Processing 00000000.tx.84: Plasma osmolality was determined by using the freezing-point depression technique (Osmette A, model 5002, Precision Systems, Natick, MA). 

Phrase: "Plasma osmolality"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0860721:Plasma osmolality [Organ or Tissue Function]
   861   C0032105:Plasma [Body Substance]
   861   C0086741:Osmolality [Clinical Attribute]
   861   C0201803:Osmolality [Laboratory Procedure]
   861   C1547034:*Osmolality [Quantitative Concept]
   861   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   761 E C0439186:osmol [Quantitative Concept]

Phrase: "was"

Phrase: "determined by"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the freezing-point depression technique"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   886   C0016701:Freeze Technique [Natural Phenomenon or Process]
   812   C0449851:Technique [Functional Concept]
   756   C0444700:Freezing point depression [Therapeutic or Preventive Procedure]
   729 E C0025664:techniques [Intellectual Product]

Phrase: "(Osmette A,"

Phrase: "model 5002,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3161035:Model [Intellectual Product]

Phrase: "Precision Systems,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0449913:System [Functional Concept]
   827   C1553451:System [Manufactured Object]
   827   C1704459:System [Medical Device]
   777 E C0205373:Systemic [Functional Concept]

Phrase: "Natick,"

Phrase: "MA"

Phrase: ")."
Processing 00000000.tx.85: TP concentration ([TP]) was measured by using the direct Biuret method. 

Phrase: "TP concentration"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   901   C0427716:Protein concentration [Laboratory Procedure]
   901   C0555903:Total protein [Laboratory Procedure]
   901   C1261360:total protein [Laboratory or Test Result]
   901   C1304757:Protein concentration [Laboratory or Test Result]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0086045:Concentration [Mental Process]
   827   C0439175:% total [Quantitative Concept]
   827   C0439810:Total [Qualitative Concept]
   827   C1446561:Concentration [Quantitative Concept]
   755 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "("

Phrase: "[TP"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0555903:Total protein [Laboratory Procedure]
  1000   C1261360:total protein [Laboratory or Test Result]
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0439175:% total [Quantitative Concept]
   861   C0439810:Total [Qualitative Concept]

Phrase: "]"

Phrase: ")"

Phrase: "was"

Phrase: "measured by"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   833   C0444706:Measured [Qualitative Concept]
   833   C3541902:MEASURED [Diagnostic Procedure]
   799 E C0079809:Measure [Quantitative Concept]
   799 E C0242485:Measure [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the direct Biuret method."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   913   C1704536:Direct Method [Therapeutic or Preventive Procedure]
   827   C0025663:Method [Intellectual Product]
   827   C0449851:Method [Functional Concept]
   827   C0871511:METHOD [Intellectual Product]
Processing 00000000.tx.86: Albumin concentration ([Alb]) was determined by using a conventional dye-binding method. 

Phrase: "Albumin concentration"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0486291:Albumin concentration [Laboratory or Test Result]
   861   C0086045:Concentration [Mental Process]
   861   C1446561:Concentration [Quantitative Concept]
   789 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "("

Phrase: "[Alb"

Phrase: "]"

Phrase: ")"

Phrase: "was"

Phrase: "determined by"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a conventional dye-binding method."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0025663:Method [Intellectual Product]
   812   C0449851:Method [Functional Concept]
   812   C0871511:METHOD [Intellectual Product]
Processing 00000000.tx.87: ANG II was measured with a radioimmunoassay kit using 125I-labeled ANG II (Nichols Institute Diagnostics, San Juan Capistrano, CA) (30). 

Phrase: "ANG II"

Phrase: "was"

Phrase: "measured with a radioimmunoassay kit"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   760   C0034580:Radioimmunoassay [Laboratory Procedure]
   760   C0444706:Measured [Qualitative Concept]
   760   C0812225:KIT [Medical Device]
   760   C1150635:KIT [Molecular Function]
   760   C1705212:Kit [Medical Device]
   760   C1705213:KIT [Medical Device]
   760   C3273202:Kit [Manufactured Object]
   760   C3541902:MEASURED [Diagnostic Procedure]
   726 E C0079809:Measure [Quantitative Concept]
   726 E C0242485:Measure [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "125I-labeled ANG II"

Phrase: "(Nichols"

Phrase: "Institute"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021622:institute [Organization]
  1000   C1272753:Institute [Idea or Concept]

Phrase: "Diagnostics,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0011900:Diagnostic [Finding]
   966   C0348026:Diagnostic [Functional Concept]

Phrase: "San Juan Capistrano,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C1551529:San Juan [Population Group]

Phrase: "CA) (30"

Phrase: ")."
Processing 00000000.tx.88: The extraction recovery was 70%. 

Phrase: "The extraction recovery"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0237820:Recovery [Activity]
   861   C1555688:recovery [Idea or Concept]
   861   C2004454:Recovery [Organism Function]

Phrase: "was"

Phrase: "70%."
Processing 00000000.tx.89: AVP and ANP were measured by radioimmunoassay developed by Sarda et al. 

Phrase: "AVP"

Phrase: "and"

Phrase: "ANP"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
  1000   C0027481:Atrial natriuretic peptide [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   913   C0051989:atrial peptide [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   901   C1144709:natriuretic peptide [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   901   C2709270:Natriuretic peptide [Amino Acid, Peptide, or Protein,Hormone]
   901   C3537020:Natriuretic Peptide [Pharmacologic Substance]
   827   C0018792:Atrial [Body Part, Organ, or Organ Component]
   827   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   827   C0597421:natriuretic [Pharmacologic Substance]
   755 E C0524422:atria [Body Part, Organ, or Organ Component]
   755 E C1280619:Atrium [Body Part, Organ, or Organ Component]

Phrase: "were"

Phrase: "measured by radioimmunoassay"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   790   C0034580:Radioimmunoassay [Laboratory Procedure]
   790   C0444706:Measured [Qualitative Concept]
   790   C3541902:MEASURED [Diagnostic Procedure]
   756 E C0079809:Measure [Quantitative Concept]
   756 E C0242485:Measure [Functional Concept]

Phrase: "developed by Sarda et al."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1081142:Sarda [Fish]
Processing 00000000.tx.90: (26, 30). 

Phrase: "(26,"

Phrase: "30"

Phrase: ")."
Processing 00000000.tx.91: Intra- and interassay coefficients of variation were 11 and 10% for AVP and 3.8 and 9.1% for ANP. 

Phrase: "Intra-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0347985:Intra [Temporal Concept]

Phrase: "and"

Phrase: "interassay coefficients of variation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   890   C0681921:Coefficient of Variation [Quantitative Concept]
   812   C0205419:Variation [Qualitative Concept]
   779   C1707429:*Coefficient [Quantitative Concept]

Phrase: "were"

Phrase: "11"

Phrase: "and"

Phrase: "10% for AVP"

Phrase: "and"

Phrase: "3.8"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0439086:<3 [Quantitative Concept]
   861   C2827736:3+ [Quantitative Concept]
   861   C2981702:3+ [Classification]

Phrase: "and"

Phrase: "9.1% for ANP."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   833   C0027481:Atrial natriuretic peptide [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C1144709:natriuretic peptide [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   790   C2709270:Natriuretic peptide [Amino Acid, Peptide, or Protein,Hormone]
   790   C3537020:Natriuretic Peptide [Pharmacologic Substance]
   783   C0051989:atrial peptide [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   753   C0018792:Atrial [Body Part, Organ, or Organ Component]
   753   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   753   C0597421:natriuretic [Pharmacologic Substance]
Processing 00000000.tx.92: The assays for AVP and ANP have a sensitivity of within 0.2 and 15 pg/ml (1.5 pg/tube), respectively. 

Phrase: "The assays for AVP"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   737   C0005507:Assay [Laboratory Procedure]
   737   C0243073:assay [Qualitative Concept]
   737   C1510438:Assay [Laboratory Procedure]

Phrase: "and"

Phrase: "ANP"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
  1000   C0027481:Atrial natriuretic peptide [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   913   C0051989:atrial peptide [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   901   C1144709:natriuretic peptide [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   901   C2709270:Natriuretic peptide [Amino Acid, Peptide, or Protein,Hormone]
   901   C3537020:Natriuretic Peptide [Pharmacologic Substance]
   827   C0018792:Atrial [Body Part, Organ, or Organ Component]
   827   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   827   C0597421:natriuretic [Pharmacologic Substance]
   755 E C0524422:atria [Body Part, Organ, or Organ Component]
   755 E C1280619:Atrium [Body Part, Organ, or Organ Component]

Phrase: "have"

Phrase: "a sensitivity of"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   790   C0036667:Sensitivity [Quantitative Concept]
   790   C0312418:Sensitivity [Mental Process]
   790   C0427965:Sensitivity [Finding]
   790   C1511883:Sensitivity [Quantitative Concept]
   790   C1522640:Sensitivity [Qualitative Concept]
   790   C2346484:SENSITIVITY [Phenomenon or Process]
   790   C2349185:Sensitivity [Qualitative Concept]
   718 E C0332324:Sensitive [Functional Concept]
   718 E C1550474:sensitive [Idea or Concept]

Phrase: "within 0.2"

Phrase: "and"

Phrase: "15 pg/ml (1.5 pg/tube"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   795   C0175730:Tube [Medical Device]
   795   C1547937:Tube NOS [Intellectual Product]
   795   C1561954:tube [Conceptual Entity]
   795   C1704730:TUBE [Medical Device]

Phrase: ")"

Phrase: ","

Phrase: "respectively."
Processing 00000000.tx.93: Progesterone was measured by radioimmunoassay by the Core Lab at Kingston General Hospital. 

Phrase: "Progesterone"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
  1000   C0033308:Progesterone [Hormone,Pharmacologic Substance,Steroid]
  1000   C2757070:Progesterone [Pharmacologic Substance]
   944 E C0010094:Corpus luteum hormone [Hormone]
   944 E C0701112:Proluton [Hormone,Pharmacologic Substance,Steroid]
   944 E C0701115:Lutromone [Hormone,Pharmacologic Substance,Steroid]
   944 E C0701118:Lipo-Lutin [Hormone,Pharmacologic Substance,Steroid]

Phrase: "was"

Phrase: "measured by radioimmunoassay"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   790   C0034580:Radioimmunoassay [Laboratory Procedure]
   790   C0444706:Measured [Qualitative Concept]
   790   C3541902:MEASURED [Diagnostic Procedure]
   756 E C0079809:Measure [Quantitative Concept]
   756 E C0242485:Measure [Functional Concept]

Phrase: "by the Core Lab"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0022877:Lab [Manufactured Object,Organization]
   805 E C0035100:Rennin [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   777 E C0587081:Labs [Finding]

Phrase: "at Kingston General Hospital."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   901   C0020008:general hospital [Health Care Related Organization,Manufactured Object]
   827   C0019994:Hospital, NOS [Health Care Related Organization,Manufactured Object]
   827   C0205246:General [Spatial Concept]
   827   C1510665:Hospital [Qualitative Concept]
   827   C1553889:General [Idea or Concept]
   743 E C1609061:Hospitals [Intellectual Product]
Processing 00000000.tx.94: Statistical analyses. 

Phrase: "Statistical analyses."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   983   C0871424:statistical analysis [Research Activity]
   827   C0002778:Analysis [Laboratory Procedure]
   827   C0936012:Analysis [Research Activity]
   827   C1524024:analysis [Functional Concept]
Processing 00000000.tx.95: Physical characteristics, O2 at VT, and oxygen pulse at 170 beats/min were compared between groups by using Student's t-statistics for independent samples. 

Phrase: "Physical characteristics,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1521970:Characteristics [Qualitative Concept]

Phrase: "O2 at VT,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0030054:O2 [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "and"

Phrase: "oxygen pulse at 170 beats/min"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0232117:PULSE [Clinical Attribute]
   753   C0391850:Pulse [Physiologic Function]
   753   C1947910:Pulse [Phenomenon or Process]

Phrase: "were"

Phrase: "compared between groups"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   790   C0441833:Group [Idea or Concept]
   790   C0687744:group [Population Group]
   790   C1257890:Group [Population Group]
   790   C1552516:Group [Health Care Related Organization]
   790   C1552839:groups [Idea or Concept]
   790   C1705428:Group [Conceptual Entity]
   790   C1705429:Group [Population Group]
   790   C1707455:Compared [Activity]

Phrase: "by"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "Student's t-statistics for independent samples."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   753   C0038215:Statistics [Occupation or Discipline]
   753   C0600673:Statistics [Intellectual Product]
   750   C2348149:Sample Statistic [Quantitative Concept]
       E   Statistic
   719 E C2828391:Statistic [Quantitative Concept]
Processing 00000000.tx.96: Data at rest and during exercise at 70 and 110% VT were compared within and between subjects by using a two-way ANOVA (groups vs. rest/exercise level) with repeated measures on the second factor. 

Phrase: "Data at rest"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1511726:Data [Idea or Concept]
   790   C3245479:data [Medical Device]

Phrase: "and during exercise"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0015259:Exercise [Daily or Recreational Activity]
   790   C1515981:And [Idea or Concept]
   790   C1522704:Exercise [Therapeutic or Preventive Procedure]

Phrase: "at 70"

Phrase: "and"

Phrase: "110% VT"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0449864:Threshold [Qualitative Concept]

Phrase: "were"

Phrase: "compared within"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C1707455:Compared [Activity]

Phrase: "and between subjects"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C1515981:And [Idea or Concept]
   756   C0681850:Subject [Group]
   756   C1550501:{Subject} [Idea or Concept]
   756   C1706203:Subject [Idea or Concept]
   756   C2349001:Subject [Human]
   756   C2697811:Subject [Functional Concept]

Phrase: "by"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a two-way ANOVA (groups"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   812   C0441833:Group [Idea or Concept]
   812   C0687744:group [Population Group]
   812   C1257890:Group [Population Group]
   812   C1552516:Group [Health Care Related Organization]
   812   C1552839:groups [Idea or Concept]
   812   C1705428:Group [Conceptual Entity]
   812   C1705429:Group [Population Group]
   756   C1710497:Two-way ANOVA [Quantitative Concept]

Phrase: "vs. rest/exercise level"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0441889:Level [Qualitative Concept]
   827   C0456079:Level [Classification]
   827   C1547707:Level [Geographic Area]
   827   C2946261:Level [Pharmacologic Substance]

Phrase: ")"

Phrase: "with repeated measures"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0871881:repeated measures [Research Activity]
   861   C0079809:Measures [Quantitative Concept]
   861   C1879489:Measures [Functional Concept]
   827 E C0242485:Measure [Functional Concept]

Phrase: "on the second factor."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1521761:Factor [Functional Concept]
   861   C2827422:Factor [Conceptual Entity]
Processing 00000000.tx.97: When a significant between-group main effect was observed, a Tukey's post hoc test was used to identify significant differences between group means at rest, at 70% VT, and at 110% VT. 

Phrase: "When"

Phrase: "a significant between-group main effect"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0237881:significant [Quantitative Concept]
   753   C0750502:Significant [Idea or Concept]
   753   C1546944:Significant [Qualitative Concept]

Phrase: "was"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: ","

Phrase: "a Tukey's post hoc test"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0022885:Test [Laboratory Procedure]
   812   C0039593:Test [Functional Concept]
   812   C0392366:test [Intellectual Product]

Phrase: "was"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "identify"

Phrase: "significant differences between group means"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   726   C1705241:*Difference [Quantitative Concept]
   726   C1705242:Difference [Qualitative Concept]

Phrase: "at rest,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0035253:Rest [Daily or Recreational Activity]
  1000   C1622890:ResT [Molecular Function]

Phrase: "at 70% VT,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0449864:Threshold [Qualitative Concept]

Phrase: "and at 110% VT."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0449864:Threshold [Qualitative Concept]
   760   C1515981:And [Idea or Concept]
Processing 00000000.tx.98: When a significant within-subjects main effect or group x time interaction was observed, Tukey's post hoc tests were also used to detect significant differences between rest, 70% VT, and 110% VT within each group. 

Phrase: "When"

Phrase: "a significant within-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0237881:significant [Quantitative Concept]
   790   C0750502:Significant [Idea or Concept]
   790   C1546944:Significant [Qualitative Concept]

Phrase: "subjects"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0681850:Subject [Group]
  1000   C1550501:{Subject} [Idea or Concept]
  1000   C1706203:Subject [Idea or Concept]
  1000   C2349001:Subject [Human]
  1000   C2697811:Subject [Functional Concept]

Phrase: "main effect"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0205225:Main [Qualitative Concept]
   861   C1280500:Effect [Qualitative Concept]
   861   C1542147:Main [Qualitative Concept]
   861   C2348382:Effect [Qualitative Concept]

Phrase: "or"

Phrase: "group x time interaction"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1704675:Interaction [Functional Concept]

Phrase: "was"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: ","

Phrase: "Tukey's post hoc tests"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   812   C0022885:Tests [Laboratory Procedure]
   812   C0392366:Tests [Intellectual Product]
   779 E C0039593:Test [Functional Concept]

Phrase: "were"

Phrase: "also"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "detect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442726:detect [Finding]

Phrase: "significant differences between rest,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   737   C1705241:*Difference [Quantitative Concept]
   737   C1705242:Difference [Qualitative Concept]

Phrase: "70% VT,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0449864:Threshold [Qualitative Concept]

Phrase: "and"

Phrase: "110% VT within each group."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0449864:Threshold [Qualitative Concept]
Processing 00000000.tx.99: The critical alpha for significance was P < 0.05.  

Phrase: "The critical alpha for significance"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0439095:Alpha [Intellectual Product]
   760   C2003941:Alpha [Intellectual Product]
   760   C2350010:Alpha [Qualitative Concept]

Phrase: "was"

Phrase: "P < 0.05."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.100: RESULTS TOP ABSTRACT METHODS RESULTS DISCUSSION DISCLOSURES REFERENCES  By design, there were no significant differences between groups in age, body height, or parity (Table 1). 

Phrase: "RESULTS TOP ABSTRACT METHODS RESULTS DISCUSSION DISCLOSURES"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   795   C0012625:disclosures [Individual Behavior]

Phrase: "REFERENCES  By design,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C1514811:Reference [Idea or Concept]
   790   C1706462:Reference [Conceptual Entity]
   790   C1707689:Design [Activity]
   790   C2983265:DESIGN [Intellectual Product]

Phrase: "there"

Phrase: "were"

Phrase: "no significant differences between groups"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   726   C1705241:*Difference [Quantitative Concept]
   726   C1705242:Difference [Qualitative Concept]

Phrase: "in age,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001779:Age [Organism Attribute]

Phrase: "body height,"
Meta Candidates (Total=11; Excluded=5; Pruned=0; Remaining=6)
  1000   C0005890:Body Height [Organism Attribute]
  1000   C0487985:Body height [Clinical Attribute]
   861   C0242821:body [Human]
   861   C0460148:Body [Anatomical Structure]
   861   C0489786:Height [Organism Attribute]
   861   C1268086:Body [Anatomical Structure]
   789 E C0205250:High [Qualitative Concept]
   789 E C1299351:High [Qualitative Concept]
   789 E C1522410:Highest [Qualitative Concept]
   789 E C2700149:HIGH [Intellectual Product]
   777 E C1995017:Bodies [Cell Component]

Phrase: "or"

Phrase: "parity"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0030563:Parity [Finding]
  1000   C0595999:Parity [Clinical Attribute]

Phrase: "(Table 1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.101: As expected, body mass and body mass index of the PG was significantly greater than that of the CG at the time of testing. 

Phrase: "As"

Phrase: "expected"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1517001:Expected [Idea or Concept]

Phrase: ","

Phrase: "body mass"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
  1000   C0518010:body mass [Finding]
   861   C0242821:body [Human]
   861   C0460148:Body [Anatomical Structure]
   861   C0577559:Mass [Finding]
   861   C1268086:Body [Anatomical Structure]
   861   C1306372:*Mass [Quantitative Concept]
   861   C3152252:Mass [Quantitative Concept]
   777 E C1995017:Bodies [Cell Component]

Phrase: "and"

Phrase: "body mass index of the PG"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   814   C0005893:Body Mass Index [Diagnostic Procedure]
   814   C1305855:Body mass index [Clinical Attribute]
   778   C0518010:body mass [Finding]
   748   C0242821:body [Human]
   748   C0460148:Body [Anatomical Structure]
   748   C0577559:Mass [Finding]
   748   C0918012:Index [Intellectual Product]
   748   C1268086:Body [Anatomical Structure]
   748   C1306372:*Mass [Quantitative Concept]
   748   C1552854:index [Idea or Concept]
   748   C1637833:% index [Quantitative Concept]
   748   C3152252:Mass [Quantitative Concept]

Phrase: "was"

Phrase: "significantly greater than that of the CG"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0439093:Greater Than [Quantitative Concept]
   744   C0443228:greater [Quantitative Concept]
   744   C1704243:Greater [Quantitative Concept]
   711 E C0549177:Great [Quantitative Concept]

Phrase: "at the time"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0040223:Time [Temporal Concept]
  1000   C3541383:Time [Temporal Concept]
   944 E C0442043:Temporal [Spatial Concept]
   944 E C2362314:Temporal [Temporal Concept]
   916 E C1632851:Times [Quantitative Concept]

Phrase: "of testing."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0039593:Testing [Functional Concept]
  1000   C0392366:testing [Intellectual Product]
Processing 00000000.tx.102: However, the prepregnancy body mass and body mass index of the PG were similar to those of the CG. 

Phrase: "However,"

Phrase: "the prepregnancy body mass"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   901   C0518010:body mass [Finding]
   827   C0242821:body [Human]
   827   C0460148:Body [Anatomical Structure]
   827   C0577559:Mass [Finding]
   827   C1268086:Body [Anatomical Structure]
   827   C1306372:*Mass [Quantitative Concept]
   827   C3152252:Mass [Quantitative Concept]
   743 E C1995017:Bodies [Cell Component]

Phrase: "and"

Phrase: "body mass index of the PG"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   814   C0005893:Body Mass Index [Diagnostic Procedure]
   814   C1305855:Body mass index [Clinical Attribute]
   778   C0518010:body mass [Finding]
   748   C0242821:body [Human]
   748   C0460148:Body [Anatomical Structure]
   748   C0577559:Mass [Finding]
   748   C0918012:Index [Intellectual Product]
   748   C1268086:Body [Anatomical Structure]
   748   C1306372:*Mass [Quantitative Concept]
   748   C1552854:index [Idea or Concept]
   748   C1637833:% index [Quantitative Concept]
   748   C3152252:Mass [Quantitative Concept]

Phrase: "were"

Phrase: "similar to those of the CG."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C2348205:Similar [Qualitative Concept]
Processing 00000000.tx.103: There were also no significant differences between the groups in O2 at VT or O2 pulse at 170 beats/min, confirming that the two groups had a similar level of aerobic fitness. 

Phrase: "There"

Phrase: "were"

Phrase: "also"

Phrase: "no significant differences between the groups"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   719   C1705241:*Difference [Quantitative Concept]
   719   C1705242:Difference [Qualitative Concept]

Phrase: "in O2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030054:O2 [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "at VT"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0449864:Threshold [Qualitative Concept]

Phrase: "or"

Phrase: "O2 pulse at 170 beats/min,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0232117:PULSE [Clinical Attribute]
   753   C0391850:Pulse [Physiologic Function]
   753   C1947910:Pulse [Phenomenon or Process]

Phrase: "confirming"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0521093:confirming [Qualitative Concept]
  1000   C0750484:confirming [Idea or Concept]
   966 E C1456348:Confirm [Qualitative Concept]

Phrase: "that"

Phrase: "the two groups"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   861   C0441833:Group [Idea or Concept]
   861   C0687744:group [Population Group]
   861   C1257890:Group [Population Group]
   861   C1552516:Group [Health Care Related Organization]
   861   C1552839:groups [Idea or Concept]
   861   C1705428:Group [Conceptual Entity]
   861   C1705429:Group [Population Group]

Phrase: "had"

Phrase: "a similar level of aerobic fitness."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0441889:Level [Qualitative Concept]
   753   C0456079:Level [Classification]
   753   C1547707:Level [Geographic Area]
   753   C2946261:Level [Pharmacologic Substance]
Processing 00000000.tx.104: Of the 22 subjects in the PG and the 17 subjects in the CG, not all subjects produced complete data sets for [ANG II], [AVP], [ANP], [progesterone], and [TP] due to hemolysis of individual blood samples or individual blood sample acquisition problems. 

Phrase: "Of the 22 subjects"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0681850:Subject [Group]
   827   C1550501:{Subject} [Idea or Concept]
   827   C1706203:Subject [Idea or Concept]
   827   C2349001:Subject [Human]
   827   C2697811:Subject [Functional Concept]

Phrase: "in the PG"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0441833:Group [Idea or Concept]
   861   C0687744:group [Population Group]
   861   C1257890:Group [Population Group]
   861   C1552516:Group [Health Care Related Organization]
   861   C1705428:Group [Conceptual Entity]
   861   C1705429:Group [Population Group]

Phrase: "and"

Phrase: "the 17 subjects in the CG,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   714   C0681850:Subject [Group]
   714   C1550501:{Subject} [Idea or Concept]
   714   C1706203:Subject [Idea or Concept]
   714   C2349001:Subject [Human]
   714   C2697811:Subject [Functional Concept]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "all"

Phrase: "subjects"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0681850:Subject [Group]
  1000   C1550501:{Subject} [Idea or Concept]
  1000   C1706203:Subject [Idea or Concept]
  1000   C2349001:Subject [Human]
  1000   C2697811:Subject [Functional Concept]

Phrase: "produced complete data sets for"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C0150098:data sets [Intellectual Product]
   760   C0036849:Set [Mental Process]
   760   C1442518:Set [Functional Concept]
   760   C1511726:Data [Idea or Concept]
   760   C1705195:Set [Conceptual Entity]
   760   C3245479:data [Medical Device]

Phrase: "[ANG II"

Phrase: "],"

Phrase: "[AVP"

Phrase: "],"

Phrase: "[ANP"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
  1000   C0027481:Atrial natriuretic peptide [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   913   C0051989:atrial peptide [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   901   C1144709:natriuretic peptide [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   901   C2709270:Natriuretic peptide [Amino Acid, Peptide, or Protein,Hormone]
   901   C3537020:Natriuretic Peptide [Pharmacologic Substance]
   827   C0018792:Atrial [Body Part, Organ, or Organ Component]
   827   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   827   C0597421:natriuretic [Pharmacologic Substance]
   755 E C0524422:atria [Body Part, Organ, or Organ Component]
   755 E C1280619:Atrium [Body Part, Organ, or Organ Component]

Phrase: "],"

Phrase: "[progesterone"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
  1000   C0033308:Progesterone [Hormone,Pharmacologic Substance,Steroid]
  1000   C2757070:Progesterone [Pharmacologic Substance]
   944 E C0010094:Corpus luteum hormone [Hormone]
   944 E C0701112:Proluton [Hormone,Pharmacologic Substance,Steroid]
   944 E C0701115:Lutromone [Hormone,Pharmacologic Substance,Steroid]
   944 E C0701118:Lipo-Lutin [Hormone,Pharmacologic Substance,Steroid]

Phrase: "],"

Phrase: "and ["

Phrase: "TP"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0555903:Total protein [Laboratory Procedure]
  1000   C1261360:total protein [Laboratory or Test Result]
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0439175:% total [Quantitative Concept]
   861   C0439810:Total [Qualitative Concept]

Phrase: "]"

Phrase: "due to hemolysis"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0019054:HAEMOLYSIS [Pathologic Function]
  1000   C1630417:% haemolysis [Quantitative Concept]
  1000   C2937287:Haemolysis [Cell Function]
  1000   C2945560:Haemolysis [Laboratory or Test Result]
   928 E C0312853:Haemolytic [Qualitative Concept]

Phrase: "of individual blood samples"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0178913:blood samples [Body Substance]
   793   C0370003:Sample [Substance]
   793   C2347026:Sample [Conceptual Entity]

Phrase: "or"

Phrase: "individual blood sample acquisition problems."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   808   C0042373:VASCULAR PROBLEM, NOS [Disease or Syndrome]
   804   C1546466:Problems [Idea or Concept]
   771 E C0033213:Problem [Finding]
Processing 00000000.tx.105: Only subjects with complete data sets (i.e., data at rest, 70% VT, and 110% VT) were included in a variables analysis. 

Phrase: "Only"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205171:Only [Quantitative Concept]
  1000   C1720467:Only [Intellectual Product]

Phrase: "subjects with complete data sets"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   806   C0150098:data sets [Intellectual Product]
   760   C0036849:Set [Mental Process]
   760   C0205197:Complete [Qualitative Concept]
   760   C0681850:Subject [Group]
   760   C0725685:COMPLEAT [Food]
   760   C1442518:Set [Functional Concept]
   760   C1511726:Data [Idea or Concept]
   760   C1550501:{Subject} [Idea or Concept]
   760   C1705195:Set [Conceptual Entity]
   760   C1706203:Subject [Idea or Concept]
   760   C2349001:Subject [Human]
   760   C2697811:Subject [Functional Concept]
   760   C3245479:data [Medical Device]

Phrase: "(i.e., data at rest,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1511726:Data [Idea or Concept]
   760   C3245479:data [Medical Device]

Phrase: "70% VT,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0449864:Threshold [Qualitative Concept]

Phrase: "and"

Phrase: "110% VT"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0449864:Threshold [Qualitative Concept]

Phrase: ")"

Phrase: "were"

Phrase: "included in a variables analysis."
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   760   C0002778:Analysis [Laboratory Procedure]
   760   C0332257:included [Functional Concept]
   760   C0439828:variables [Qualitative Concept]
   760   C0936012:Analysis [Research Activity]
   760   C1524024:analysis [Functional Concept]
   760   C3538986:INCLUDED [Gene or Genome]
   726 E C1552866:include [Idea or Concept]
   726 E C2700399:Include [Activity]
Processing 00000000.tx.106: The sample sizes used in the analysis of each variable are shown in Tables 2, 3, 4, 5 and Figs. 

Phrase: "The sample sizes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0242618:Sizes, Sample [Quantitative Concept]
   861   C0456389:SIZES [Spatial Concept]

Phrase: "used in the analysis of each variable"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   757   C1524063:Use of [Functional Concept]
   748   C0002778:Analysis [Laboratory Procedure]
   748   C0439828:Variable [Qualitative Concept]
   748   C0936012:Analysis [Research Activity]
   748   C1273517:used [Finding]
   748   C1524024:analysis [Functional Concept]
   714 E C0042153:use [Functional Concept]
   714 E C0457083:Use [Functional Concept]
   714 E C1947944:Use [Intellectual Product]

Phrase: "are"

Phrase: "shown in Tables 2,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0039224:tables [Manufactured Object]
   770   C1706074:Tables [Intellectual Product]
   737   C1547282:Show [Intellectual Product]
   737 E C1706073:Table [Medical Device]

Phrase: "3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "4,"

Phrase: "5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "and"

Phrase: "Figs."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0349966:Figs [Food]
   966 E C1337208:FIG [Food]
Processing 00000000.tx.107: 1, 2, 3. 

Phrase: "1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "3."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]
Processing 00000000.tx.108: View this table: [in this window] [in a new window]  Table 1. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "this table"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039224:Table [Manufactured Object]
  1000   C1706073:Table [Medical Device]
  1000   C1706074:Table [Intellectual Product]

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Table 1."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]
Processing 00000000.tx.109: Physical characteristics of subjects  View this table: [in this window] [in a new window]  Table 2. 

Phrase: "Physical characteristics of subjects"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   802   C0681884:subject characteristics [Research Activity]
   802   C1519021:Subject Characteristics [Organism Attribute]
   802   C1706465:Subject Characteristics [Idea or Concept]
   770   C1521970:Characteristics [Qualitative Concept]

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "this table"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039224:Table [Manufactured Object]
  1000   C1706073:Table [Medical Device]
  1000   C1706074:Table [Intellectual Product]

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Table 2."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]
Processing 00000000.tx.110: O2 and heart rate at rest and at 2 work rates  View this table: [in this window] [in a new window]  Table 3. 

Phrase: "O2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030054:O2 [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "and"

Phrase: "heart rate at rest"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0018810:heart rate [Clinical Attribute]
   770   C0018787:Heart [Body Part, Organ, or Organ Component]
   770   C0871208:Rate [Activity]
   770   C1281570:Heart [Body Part, Organ, or Organ Component]
   770   C1521828:Rate [Quantitative Concept]

Phrase: "and"

Phrase: "at 2 work rates"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0043227:Work [Occupational Activity]
   779   C0871208:Rate [Activity]
   779   C1521828:Rate [Quantitative Concept]

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "this table"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039224:Table [Manufactured Object]
  1000   C1706073:Table [Medical Device]
  1000   C1706074:Table [Intellectual Product]

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Table 3."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]
Processing 00000000.tx.111: Plasma electrolytes and osmolality at rest and at 2 work rates  View this table: [in this window] [in a new window]  Table 4. 

Phrase: "Plasma electrolytes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0858120:plasma electrolytes nos [Laboratory Procedure]
   861   C0013832:Electrolytes [Inorganic Chemical,Pharmacologic Substance]
   861   C3536863:Electrolytes [Pharmacologic Substance]

Phrase: "and"

Phrase: "osmolality at rest"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0086741:Osmolality [Clinical Attribute]
   790   C0201803:Osmolality [Laboratory Procedure]
   790   C1547034:*Osmolality [Quantitative Concept]

Phrase: "and"

Phrase: "at 2 work rates"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0043227:Work [Occupational Activity]
   779   C0871208:Rate [Activity]
   779   C1521828:Rate [Quantitative Concept]

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "this table"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039224:Table [Manufactured Object]
  1000   C1706073:Table [Medical Device]
  1000   C1706074:Table [Intellectual Product]

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Table 4."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]
Processing 00000000.tx.112: Plasma total protein and albumin at rest and at 2 work rates  View this table: [in this window] [in a new window]  Table 5. 

Phrase: "Plasma total protein"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   913   C0032120:Plasma protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   913   C0036825:Plasma Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C0555903:Total protein [Laboratory Procedure]
   901   C1261360:total protein [Laboratory or Test Result]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0439175:% total [Quantitative Concept]
   827   C0439810:Total [Qualitative Concept]

Phrase: "and"

Phrase: "albumin at rest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0001924:Albumin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "at 2 work rates"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0043227:Work [Occupational Activity]
   779   C0871208:Rate [Activity]
   779   C1521828:Rate [Quantitative Concept]

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "this table"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039224:Table [Manufactured Object]
  1000   C1706073:Table [Medical Device]
  1000   C1706074:Table [Intellectual Product]

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Table 5."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]
Processing 00000000.tx.113: Serum progesterone at rest and at 2 work rates  View larger version (15K): [in this window] [in a new window]  Fig. 

Phrase: "Serum progesterone at rest"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   833   C1318402:serum progesterone [Laboratory or Test Result]
   770   C0033308:Progesterone [Hormone,Pharmacologic Substance,Steroid]
   770   C2757070:Progesterone [Pharmacologic Substance]
   715 E C0010094:Corpus luteum hormone [Hormone]
   715 E C0701112:Proluton [Hormone,Pharmacologic Substance,Steroid]
   715 E C0701115:Lutromone [Hormone,Pharmacologic Substance,Steroid]
   715 E C0701118:Lipo-Lutin [Hormone,Pharmacologic Substance,Steroid]

Phrase: "and"

Phrase: "at 2 work rates"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0043227:Work [Occupational Activity]
   779   C0871208:Rate [Activity]
   779   C1521828:Rate [Quantitative Concept]

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(15K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.114: 1. 

Phrase: "1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]
Processing 00000000.tx.115: Plasma ANG II concentration ([ANG II]) at rest and at 2 work rates. 

Phrase: "Plasma ANG II concentration"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   902   C0683150:plasma concentration [Quantitative Concept]
   812   C0086045:Concentration [Mental Process]
   812   C1446561:Concentration [Quantitative Concept]
   741 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "("

Phrase: "[ANG II"

Phrase: "]"

Phrase: ")"

Phrase: "at rest"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0035253:Rest [Daily or Recreational Activity]
  1000   C1622890:ResT [Molecular Function]

Phrase: "and"

Phrase: "at 2 work rates."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0043227:Work [Occupational Activity]
   779   C0871208:Rate [Activity]
   779   C1521828:Rate [Quantitative Concept]
Processing 00000000.tx.116: VT, ventilatory threshold. 

Phrase: "VT,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0449864:Threshold [Qualitative Concept]

Phrase: "ventilatory threshold."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0449864:Threshold [Qualitative Concept]
Processing 00000000.tx.117: *Significant difference (P < 0.05) between groups. 

Phrase: "*Significant difference"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C1705241:*Difference [Quantitative Concept]
   861   C1705242:Difference [Qualitative Concept]
   789 E C0443199:Differential [Qualitative Concept]

Phrase: "(P < 0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "between groups."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0441833:Group [Idea or Concept]
  1000   C0687744:group [Population Group]
  1000   C1257890:Group [Population Group]
  1000   C1552516:Group [Health Care Related Organization]
  1000   C1552839:groups [Idea or Concept]
  1000   C1705428:Group [Conceptual Entity]
  1000   C1705429:Group [Population Group]
Processing 00000000.tx.118: #Significant change (P < 0.05) within group from rest.  

Phrase: "#Significant change"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0392747:Change [Functional Concept]
   861   C0443172:change [Quantitative Concept]
   861   C1705241:Change [Quantitative Concept]

Phrase: "(P < 0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "within group"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0441833:Group [Idea or Concept]
  1000   C0687744:group [Population Group]
  1000   C1257890:Group [Population Group]
  1000   C1552516:Group [Health Care Related Organization]
  1000   C1705428:Group [Conceptual Entity]
  1000   C1705429:Group [Population Group]

Phrase: "from rest."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0035253:Rest [Daily or Recreational Activity]
  1000   C1622890:ResT [Molecular Function]
Processing 00000000.tx.119: View larger version (16K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(16K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.120: 2. 

Phrase: "2."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]
Processing 00000000.tx.121: Plasma AVP concentration ([AVP]) at rest and at 2 work rates. 

Phrase: "Plasma AVP concentration"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   913   C0683150:plasma concentration [Quantitative Concept]
   827   C0086045:Concentration [Mental Process]
   827   C1446561:Concentration [Quantitative Concept]
   755 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "("

Phrase: "[AVP]) at rest"

Phrase: "and"

Phrase: "at 2 work rates."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0043227:Work [Occupational Activity]
   779   C0871208:Rate [Activity]
   779   C1521828:Rate [Quantitative Concept]
Processing 00000000.tx.122: *Significant difference (P < 0.05) between groups. 

Phrase: "*Significant difference"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C1705241:*Difference [Quantitative Concept]
   861   C1705242:Difference [Qualitative Concept]
   789 E C0443199:Differential [Qualitative Concept]

Phrase: "(P < 0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "between groups."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0441833:Group [Idea or Concept]
  1000   C0687744:group [Population Group]
  1000   C1257890:Group [Population Group]
  1000   C1552516:Group [Health Care Related Organization]
  1000   C1552839:groups [Idea or Concept]
  1000   C1705428:Group [Conceptual Entity]
  1000   C1705429:Group [Population Group]
Processing 00000000.tx.123: #Significant change (P < 0.05) within group from rest. 

Phrase: "#Significant change"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0392747:Change [Functional Concept]
   861   C0443172:change [Quantitative Concept]
   861   C1705241:Change [Quantitative Concept]

Phrase: "(P < 0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "within group"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0441833:Group [Idea or Concept]
  1000   C0687744:group [Population Group]
  1000   C1257890:Group [Population Group]
  1000   C1552516:Group [Health Care Related Organization]
  1000   C1705428:Group [Conceptual Entity]
  1000   C1705429:Group [Population Group]

Phrase: "from rest."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0035253:Rest [Daily or Recreational Activity]
  1000   C1622890:ResT [Molecular Function]
Processing 00000000.tx.124: &Significant change (P < 0.05) within group from cycling at 70% VT to cycling at 110% VT.  

Phrase: "&Significant change"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0392747:Change [Functional Concept]
   861   C0443172:change [Quantitative Concept]
   861   C1705241:Change [Quantitative Concept]

Phrase: "(P < 0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "within group"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0441833:Group [Idea or Concept]
  1000   C0687744:group [Population Group]
  1000   C1257890:Group [Population Group]
  1000   C1552516:Group [Health Care Related Organization]
  1000   C1705428:Group [Conceptual Entity]
  1000   C1705429:Group [Population Group]

Phrase: "from cycling"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1511572:Cycle [Temporal Concept]

Phrase: "at 70% VT"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0449864:Threshold [Qualitative Concept]

Phrase: "to cycling"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1511572:Cycle [Temporal Concept]

Phrase: "at 110% VT."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0449864:Threshold [Qualitative Concept]
Processing 00000000.tx.125: View larger version (16K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(16K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.126: 3. 

Phrase: "3."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]
Processing 00000000.tx.127: Plasma atrial natriuretic peptide concentration ([ANP]) at rest and at 2 work rates. 

Phrase: "Plasma atrial natriuretic peptide concentration"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   897   C0683150:plasma concentration [Quantitative Concept]
   804   C0086045:Concentration [Mental Process]
   804   C1446561:Concentration [Quantitative Concept]
   733 E C1880165:Concentrated [Biomedical or Dental Material]
   717   C0027481:Atrial natriuretic peptide [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "("

Phrase: "[ANP"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
  1000   C0027481:Atrial natriuretic peptide [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   913   C0051989:atrial peptide [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   901   C1144709:natriuretic peptide [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   901   C2709270:Natriuretic peptide [Amino Acid, Peptide, or Protein,Hormone]
   901   C3537020:Natriuretic Peptide [Pharmacologic Substance]
   827   C0018792:Atrial [Body Part, Organ, or Organ Component]
   827   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   827   C0597421:natriuretic [Pharmacologic Substance]
   755 E C0524422:atria [Body Part, Organ, or Organ Component]
   755 E C1280619:Atrium [Body Part, Organ, or Organ Component]

Phrase: "]"

Phrase: ")"

Phrase: "at rest"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0035253:Rest [Daily or Recreational Activity]
  1000   C1622890:ResT [Molecular Function]

Phrase: "and"

Phrase: "at 2 work rates."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0043227:Work [Occupational Activity]
   779   C0871208:Rate [Activity]
   779   C1521828:Rate [Quantitative Concept]
Processing 00000000.tx.128: #Significant change (P < 0.05) within group from rest. 

Phrase: "#Significant change"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0392747:Change [Functional Concept]
   861   C0443172:change [Quantitative Concept]
   861   C1705241:Change [Quantitative Concept]

Phrase: "(P < 0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "within group"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0441833:Group [Idea or Concept]
  1000   C0687744:group [Population Group]
  1000   C1257890:Group [Population Group]
  1000   C1552516:Group [Health Care Related Organization]
  1000   C1705428:Group [Conceptual Entity]
  1000   C1705429:Group [Population Group]

Phrase: "from rest."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0035253:Rest [Daily or Recreational Activity]
  1000   C1622890:ResT [Molecular Function]
Processing 00000000.tx.129: &Significant change (P < 0.05) within group from cycling at 70% VT to cycling at 110% VT.  

Phrase: "&Significant change"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0392747:Change [Functional Concept]
   861   C0443172:change [Quantitative Concept]
   861   C1705241:Change [Quantitative Concept]

Phrase: "(P < 0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "within group"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0441833:Group [Idea or Concept]
  1000   C0687744:group [Population Group]
  1000   C1257890:Group [Population Group]
  1000   C1552516:Group [Health Care Related Organization]
  1000   C1705428:Group [Conceptual Entity]
  1000   C1705429:Group [Population Group]

Phrase: "from cycling"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1511572:Cycle [Temporal Concept]

Phrase: "at 70% VT"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0449864:Threshold [Qualitative Concept]

Phrase: "to cycling"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1511572:Cycle [Temporal Concept]

Phrase: "at 110% VT."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0449864:Threshold [Qualitative Concept]
Processing 00000000.tx.130: HR was significantly higher in the PG vs. the CG at rest, whereas O2 was not (Table 2). 

Phrase: "HR"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0018810:heart rate [Clinical Attribute]
   861   C0018787:Heart [Body Part, Organ, or Organ Component]
   861   C0871208:Rate [Activity]
   861   C1281570:Heart [Body Part, Organ, or Organ Component]
   861   C1521828:Rate [Quantitative Concept]

Phrase: "was"

Phrase: "significantly higher in the PG"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   719   C0205250:High [Qualitative Concept]
   719   C1299351:High [Qualitative Concept]
   719   C2700149:HIGH [Intellectual Product]

Phrase: "vs."

Phrase: "the CG at rest,"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   806   C0009932:Control Group [Group]
   760   C0243148:control [Qualitative Concept]
   760   C0441833:Group [Idea or Concept]
   760   C0687744:group [Population Group]
   760   C1257890:Group [Population Group]
   760   C1550141:Control [Substance]
   760   C1552516:Group [Health Care Related Organization]
   760   C1705428:Group [Conceptual Entity]
   760   C1705429:Group [Population Group]
   760   C1882979:Control [Conceptual Entity]
   760   C2587213:Control [Functional Concept]
   760   C3274648:Control [Qualitative Concept]

Phrase: "whereas"

Phrase: "O2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030054:O2 [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "was"

Phrase: "not (Table 2"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0039224:Table [Manufactured Object]
   827   C1518422:Not [Functional Concept]
   827   C1706073:Table [Medical Device]
   827   C1706074:Table [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.131: There was no difference between groups in O2 at 70 or 110% VT. 

Phrase: "There"

Phrase: "was"

Phrase: "no difference between groups"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1705241:*Difference [Quantitative Concept]
   770   C1705242:Difference [Qualitative Concept]

Phrase: "in O2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030054:O2 [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "at 70"

Phrase: "or"

Phrase: "110% VT."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0449864:Threshold [Qualitative Concept]
Processing 00000000.tx.132: HR was significantly higher in the PG vs. the CG at 70% VT but not at 110% VT. 

Phrase: "HR"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0018810:heart rate [Clinical Attribute]
   861   C0018787:Heart [Body Part, Organ, or Organ Component]
   861   C0871208:Rate [Activity]
   861   C1281570:Heart [Body Part, Organ, or Organ Component]
   861   C1521828:Rate [Quantitative Concept]

Phrase: "was"

Phrase: "significantly higher in the PG"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   719   C0205250:High [Qualitative Concept]
   719   C1299351:High [Qualitative Concept]
   719   C2700149:HIGH [Intellectual Product]

Phrase: "vs."

Phrase: "the CG at 70% VT"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   778   C0009932:Control Group [Group]
   748   C0243148:control [Qualitative Concept]
   748   C0441833:Group [Idea or Concept]
   748   C0687744:group [Population Group]
   748   C1257890:Group [Population Group]
   748   C1550141:Control [Substance]
   748   C1552516:Group [Health Care Related Organization]
   748   C1705428:Group [Conceptual Entity]
   748   C1705429:Group [Population Group]
   748   C1882979:Control [Conceptual Entity]
   748   C2587213:Control [Functional Concept]
   748   C3274648:Control [Qualitative Concept]

Phrase: "but"

Phrase: "not at 110% VT."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0449864:Threshold [Qualitative Concept]
   760   C1518422:Not [Functional Concept]
Processing 00000000.tx.133: Both O2 and HR increased in both groups from rest to 70% VT and 70 to 110% VT. 

Phrase: "Both O2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030054:O2 [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "and"

Phrase: "HR"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0018810:heart rate [Clinical Attribute]
   861   C0018787:Heart [Body Part, Organ, or Organ Component]
   861   C0871208:Rate [Activity]
   861   C1281570:Heart [Body Part, Organ, or Organ Component]
   861   C1521828:Rate [Quantitative Concept]

Phrase: "increased in both"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0205217:Increased [Quantitative Concept]
   790   C0442805:Increased [Functional Concept]
   718 E C1517378:Gain [Quantitative Concept]

Phrase: "groups from rest"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   790   C0035253:Rest [Daily or Recreational Activity]
   790   C0441833:Group [Idea or Concept]
   790   C0687744:group [Population Group]
   790   C1257890:Group [Population Group]
   790   C1552516:Group [Health Care Related Organization]
   790   C1552839:groups [Idea or Concept]
   790   C1622890:ResT [Molecular Function]
   790   C1705428:Group [Conceptual Entity]
   790   C1705429:Group [Population Group]

Phrase: "to 70% VT"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0449864:Threshold [Qualitative Concept]

Phrase: "and"

Phrase: "70 to 110% VT."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0449864:Threshold [Qualitative Concept]
Processing 00000000.tx.134: Osmolality was significantly lower in the PG vs. 

Phrase: "Osmolality"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0086741:Osmolality [Clinical Attribute]
  1000   C0201803:Osmolality [Laboratory Procedure]
  1000   C1547034:*Osmolality [Quantitative Concept]
   900 E C0439186:osmol [Quantitative Concept]

Phrase: "was"

Phrase: "significantly lower in the PG"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0441994:Lower [Spatial Concept]
   753   C1548802:Lower [Body Location or Region]
   753   C2003888:Lower [Activity]

Phrase: "vs."
Processing 00000000.tx.135: CG at rest and at both work rates. 

Phrase: "CG at rest"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   833   C0009932:Control Group [Group]
   770   C0243148:control [Qualitative Concept]
   770   C0441833:Group [Idea or Concept]
   770   C0687744:group [Population Group]
   770   C1257890:Group [Population Group]
   770   C1550141:Control [Substance]
   770   C1552516:Group [Health Care Related Organization]
   770   C1705428:Group [Conceptual Entity]
   770   C1705429:Group [Population Group]
   770   C1882979:Control [Conceptual Entity]
   770   C2587213:Control [Functional Concept]
   770   C3274648:Control [Qualitative Concept]

Phrase: "and at both work rates."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0043227:Work [Occupational Activity]
   760   C1515981:And [Idea or Concept]
   726   C0871208:Rate [Activity]
   726   C1521828:Rate [Quantitative Concept]
Processing 00000000.tx.136: Osmolality increased significantly from rest to 70% VT and from 70 to 110% VT in both groups (Table 3). 

Phrase: "Osmolality"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0086741:Osmolality [Clinical Attribute]
  1000   C0201803:Osmolality [Laboratory Procedure]
  1000   C1547034:*Osmolality [Quantitative Concept]
   900 E C0439186:osmol [Quantitative Concept]

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "significantly from rest"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0035253:Rest [Daily or Recreational Activity]
   790   C1622890:ResT [Molecular Function]

Phrase: "to 70% VT"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0449864:Threshold [Qualitative Concept]

Phrase: "and from 70"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1515981:And [Idea or Concept]

Phrase: "to 110% VT"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0449864:Threshold [Qualitative Concept]

Phrase: "in both groups"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0441833:Group [Idea or Concept]
  1000   C0687744:group [Population Group]
  1000   C1257890:Group [Population Group]
  1000   C1552516:Group [Health Care Related Organization]
  1000   C1552839:groups [Idea or Concept]
  1000   C1705428:Group [Conceptual Entity]
  1000   C1705429:Group [Population Group]

Phrase: "(Table 3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.137: There was a significant interaction between group and exercise level for osmolality. 

Phrase: "There"

Phrase: "was"

Phrase: "a significant interaction between group"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1704675:Interaction [Functional Concept]

Phrase: "and"

Phrase: "exercise level for osmolality."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0441889:Level [Qualitative Concept]
   770   C0456079:Level [Classification]
   770   C1547707:Level [Geographic Area]
   770   C2946261:Level [Pharmacologic Substance]
Processing 00000000.tx.138: [Na+] and [K+] were significantly lower in the PG vs. the CG at rest and both work rates. 

Phrase: "[Na+]"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597484:Na+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1272460:{NA} [Qualitative Concept]

Phrase: "and ["

Phrase: "K+]"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "were"

Phrase: "significantly lower in the PG"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0441994:Lower [Spatial Concept]
   753   C1548802:Lower [Body Location or Region]
   753   C2003888:Lower [Activity]

Phrase: "vs."

Phrase: "the CG at rest"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   806   C0009932:Control Group [Group]
   760   C0243148:control [Qualitative Concept]
   760   C0441833:Group [Idea or Concept]
   760   C0687744:group [Population Group]
   760   C1257890:Group [Population Group]
   760   C1550141:Control [Substance]
   760   C1552516:Group [Health Care Related Organization]
   760   C1705428:Group [Conceptual Entity]
   760   C1705429:Group [Population Group]
   760   C1882979:Control [Conceptual Entity]
   760   C2587213:Control [Functional Concept]
   760   C3274648:Control [Qualitative Concept]

Phrase: "and"

Phrase: "both work rates."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0043227:Work [Occupational Activity]
   827   C0871208:Rate [Activity]
   827   C1521828:Rate [Quantitative Concept]
Processing 00000000.tx.139: [Na+] and [K+] increased significantly from rest to 70% VT and from 70 to 110% VT in both groups, except for [Na+] in the CG from 70 to 110% VT. 

Phrase: "[Na+]"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597484:Na+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1272460:{NA} [Qualitative Concept]

Phrase: "and ["

Phrase: "K+]"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "significantly from rest"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0035253:Rest [Daily or Recreational Activity]
   790   C1622890:ResT [Molecular Function]

Phrase: "to 70% VT"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0449864:Threshold [Qualitative Concept]

Phrase: "and from 70"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1515981:And [Idea or Concept]

Phrase: "to 110% VT"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0449864:Threshold [Qualitative Concept]

Phrase: "in both groups,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0441833:Group [Idea or Concept]
  1000   C0687744:group [Population Group]
  1000   C1257890:Group [Population Group]
  1000   C1552516:Group [Health Care Related Organization]
  1000   C1552839:groups [Idea or Concept]
  1000   C1705428:Group [Conceptual Entity]
  1000   C1705429:Group [Population Group]

Phrase: "except for"

Phrase: "[Na+] in the CG"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0597484:Na+ [Element, Ion, or Isotope,Pharmacologic Substance]
   760   C1272460:{NA} [Qualitative Concept]

Phrase: "from 70"

Phrase: "to 110% VT."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0449864:Threshold [Qualitative Concept]
Processing 00000000.tx.140: There was no significant interaction between group and exercise level for [Na+] or [K+]. 

Phrase: "There"

Phrase: "was"

Phrase: "no significant interaction between group"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1704675:Interaction [Functional Concept]

Phrase: "and"

Phrase: "exercise level for"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0441889:Level [Qualitative Concept]
   790   C0456079:Level [Classification]
   790   C1547707:Level [Geographic Area]
   790   C2946261:Level [Pharmacologic Substance]

Phrase: "[Na+] or [K+"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   827   C1708601:K' [Quantitative Concept]

Phrase: "]."
Processing 00000000.tx.141: [Ca2+] was not significantly different between groups at rest but was significantly higher in the PG vs. the CG at 70 and 110% VT. 

Phrase: "[Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "]"

Phrase: "was"

Phrase: "not significantly different between groups"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1705242:Different [Qualitative Concept]

Phrase: "at rest"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0035253:Rest [Daily or Recreational Activity]
  1000   C1622890:ResT [Molecular Function]

Phrase: "but"

Phrase: "was"

Phrase: "significantly higher in the PG"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   719   C0205250:High [Qualitative Concept]
   719   C1299351:High [Qualitative Concept]
   719   C2700149:HIGH [Intellectual Product]

Phrase: "vs."

Phrase: "the CG at 70"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   806   C0009932:Control Group [Group]
   760   C0243148:control [Qualitative Concept]
   760   C0441833:Group [Idea or Concept]
   760   C0687744:group [Population Group]
   760   C1257890:Group [Population Group]
   760   C1550141:Control [Substance]
   760   C1552516:Group [Health Care Related Organization]
   760   C1705428:Group [Conceptual Entity]
   760   C1705429:Group [Population Group]
   760   C1882979:Control [Conceptual Entity]
   760   C2587213:Control [Functional Concept]
   760   C3274648:Control [Qualitative Concept]

Phrase: "and"

Phrase: "110% VT."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0449864:Threshold [Qualitative Concept]
Processing 00000000.tx.142: [Ca2+] increased from rest to 70% VT in the PG and from 70 to 110% VT in both groups. 

Phrase: "[Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "]"

Phrase: "increased from rest"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   790   C0035253:Rest [Daily or Recreational Activity]
   790   C0205217:Increased [Quantitative Concept]
   790   C0442805:Increased [Functional Concept]
   790   C1622890:ResT [Molecular Function]
   718 E C1517378:Gain [Quantitative Concept]

Phrase: "to 70% VT"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0449864:Threshold [Qualitative Concept]

Phrase: "in the PG"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0441833:Group [Idea or Concept]
   861   C0687744:group [Population Group]
   861   C1257890:Group [Population Group]
   861   C1552516:Group [Health Care Related Organization]
   861   C1705428:Group [Conceptual Entity]
   861   C1705429:Group [Population Group]

Phrase: "and from 70"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1515981:And [Idea or Concept]

Phrase: "to 110% VT"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0449864:Threshold [Qualitative Concept]

Phrase: "in both groups."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0441833:Group [Idea or Concept]
  1000   C0687744:group [Population Group]
  1000   C1257890:Group [Population Group]
  1000   C1552516:Group [Health Care Related Organization]
  1000   C1552839:groups [Idea or Concept]
  1000   C1705428:Group [Conceptual Entity]
  1000   C1705429:Group [Population Group]
Processing 00000000.tx.143: There was a significant interaction between group and exercise level for [Ca2+]. 

Phrase: "There"

Phrase: "was"

Phrase: "a significant interaction between group"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1704675:Interaction [Functional Concept]

Phrase: "and"

Phrase: "exercise level for"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0441889:Level [Qualitative Concept]
   790   C0456079:Level [Classification]
   790   C1547707:Level [Geographic Area]
   790   C2946261:Level [Pharmacologic Substance]

Phrase: "[Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "]."
Processing 00000000.tx.144: [Cl] increased from rest to 70% VT in the PG and rest to 110% VT in both groups. 

Phrase: "[Cl]"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596019:Cl - [Element, Ion, or Isotope]

Phrase: "increased from rest"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   790   C0035253:Rest [Daily or Recreational Activity]
   790   C0205217:Increased [Quantitative Concept]
   790   C0442805:Increased [Functional Concept]
   790   C1622890:ResT [Molecular Function]
   718 E C1517378:Gain [Quantitative Concept]

Phrase: "to 70% VT"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0449864:Threshold [Qualitative Concept]

Phrase: "in the PG"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0441833:Group [Idea or Concept]
   861   C0687744:group [Population Group]
   861   C1257890:Group [Population Group]
   861   C1552516:Group [Health Care Related Organization]
   861   C1705428:Group [Conceptual Entity]
   861   C1705429:Group [Population Group]

Phrase: "and"

Phrase: "rest to 110% VT"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0035253:Rest [Daily or Recreational Activity]
   760   C1622890:ResT [Molecular Function]

Phrase: "in both groups."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0441833:Group [Idea or Concept]
  1000   C0687744:group [Population Group]
  1000   C1257890:Group [Population Group]
  1000   C1552516:Group [Health Care Related Organization]
  1000   C1552839:groups [Idea or Concept]
  1000   C1705428:Group [Conceptual Entity]
  1000   C1705429:Group [Population Group]
Processing 00000000.tx.145: There was no significant interaction between group and exercise level for [Cl]. 

Phrase: "There"

Phrase: "was"

Phrase: "no significant interaction between group"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1704675:Interaction [Functional Concept]

Phrase: "and"

Phrase: "exercise level for"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0441889:Level [Qualitative Concept]
   790   C0456079:Level [Classification]
   790   C1547707:Level [Geographic Area]
   790   C2946261:Level [Pharmacologic Substance]

Phrase: "[Cl"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596019:Cl - [Element, Ion, or Isotope]

Phrase: "]."
Processing 00000000.tx.146: Both TP and albumin levels were significantly lower in the PG compared with the CG at all measurement times (Table 4). 

Phrase: "Both TP"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0555903:Total protein [Laboratory Procedure]
  1000   C1261360:total protein [Laboratory or Test Result]
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0439175:% total [Quantitative Concept]
   861   C0439810:Total [Qualitative Concept]

Phrase: "and"

Phrase: "albumin levels"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0428519:albumin levels [Laboratory or Test Result]
   861   C0001924:Albumin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0441889:Levels [Qualitative Concept]
   827 E C0456079:Level [Classification]
   827 E C1547707:Level [Geographic Area]
   827 E C2946261:Level [Pharmacologic Substance]

Phrase: "were"

Phrase: "significantly lower in the PG"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0441994:Lower [Spatial Concept]
   753   C1548802:Lower [Body Location or Region]
   753   C2003888:Lower [Activity]

Phrase: "compared with the CG"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   806   C0009932:Control Group [Group]
   760   C0243148:control [Qualitative Concept]
   760   C0441833:Group [Idea or Concept]
   760   C0687744:group [Population Group]
   760   C1257890:Group [Population Group]
   760   C1550141:Control [Substance]
   760   C1552516:Group [Health Care Related Organization]
   760   C1705428:Group [Conceptual Entity]
   760   C1705429:Group [Population Group]
   760   C1707455:Compared [Activity]
   760   C1882979:Control [Conceptual Entity]
   760   C2587213:Control [Functional Concept]
   760   C3274648:Control [Qualitative Concept]

Phrase: "at all measurement times"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0040223:times [Temporal Concept]
   861   C1632851:Times [Quantitative Concept]
   827 E C3541383:Time [Temporal Concept]
   789 E C0442043:Temporal [Spatial Concept]
   789 E C2362314:Temporal [Temporal Concept]

Phrase: "(Table 4"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.147: Both TP and albumin levels increased significantly from rest to 70% VT and from 70 to 110% VT in both groups. 

Phrase: "Both TP"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0555903:Total protein [Laboratory Procedure]
  1000   C1261360:total protein [Laboratory or Test Result]
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0439175:% total [Quantitative Concept]
   861   C0439810:Total [Qualitative Concept]

Phrase: "and"

Phrase: "albumin levels"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0428519:albumin levels [Laboratory or Test Result]
   861   C0001924:Albumin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0441889:Levels [Qualitative Concept]
   827 E C0456079:Level [Classification]
   827 E C1547707:Level [Geographic Area]
   827 E C2946261:Level [Pharmacologic Substance]

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "significantly from rest"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0035253:Rest [Daily or Recreational Activity]
   790   C1622890:ResT [Molecular Function]

Phrase: "to 70% VT"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0449864:Threshold [Qualitative Concept]

Phrase: "and from 70"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1515981:And [Idea or Concept]

Phrase: "to 110% VT"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0449864:Threshold [Qualitative Concept]

Phrase: "in both groups."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0441833:Group [Idea or Concept]
  1000   C0687744:group [Population Group]
  1000   C1257890:Group [Population Group]
  1000   C1552516:Group [Health Care Related Organization]
  1000   C1552839:groups [Idea or Concept]
  1000   C1705428:Group [Conceptual Entity]
  1000   C1705429:Group [Population Group]
Processing 00000000.tx.148: There was no significant interaction between group and exercise level for TP or albumin levels. 

Phrase: "There"

Phrase: "was"

Phrase: "no significant interaction between group"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1704675:Interaction [Functional Concept]

Phrase: "and"

Phrase: "exercise level for TP"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   797   C0428479:Protein level [Laboratory or Test Result]
   760   C0441889:Level [Qualitative Concept]
   760   C0456079:Level [Classification]
   760   C1547707:Level [Geographic Area]
   760   C2946261:Level [Pharmacologic Substance]

Phrase: "or"

Phrase: "albumin levels."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0428519:albumin levels [Laboratory or Test Result]
   861   C0001924:Albumin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0441889:Levels [Qualitative Concept]
   827 E C0456079:Level [Classification]
   827 E C1547707:Level [Geographic Area]
   827 E C2946261:Level [Pharmacologic Substance]
Processing 00000000.tx.149: [ANG II] was significantly higher in the PG vs. 

Phrase: "[ANG II"

Phrase: "]"

Phrase: "was"

Phrase: "significantly higher in the PG"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   719   C0205250:High [Qualitative Concept]
   719   C1299351:High [Qualitative Concept]
   719   C2700149:HIGH [Intellectual Product]

Phrase: "vs."
Processing 00000000.tx.150: CG at rest but not at either work rate. 

Phrase: "CG at rest"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   833   C0009932:Control Group [Group]
   770   C0243148:control [Qualitative Concept]
   770   C0441833:Group [Idea or Concept]
   770   C0687744:group [Population Group]
   770   C1257890:Group [Population Group]
   770   C1550141:Control [Substance]
   770   C1552516:Group [Health Care Related Organization]
   770   C1705428:Group [Conceptual Entity]
   770   C1705429:Group [Population Group]
   770   C1882979:Control [Conceptual Entity]
   770   C2587213:Control [Functional Concept]
   770   C3274648:Control [Qualitative Concept]

Phrase: "but"

Phrase: "not at either work rate."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0043227:Work [Occupational Activity]
   760   C0871208:Rate [Activity]
   760   C1518422:Not [Functional Concept]
   760   C1521828:Rate [Quantitative Concept]
Processing 00000000.tx.151: In the transition from rest to 110% VT, [ANG II] increased significantly in the CG but not in the PG (Fig. 1). 

Phrase: "In the transition"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0599156:Transition [Cell or Molecular Dysfunction]
  1000   C2700061:Transition [Activity]
   928 E C1182674:Transitional [Spatial Concept]
   928 E C1548597:Transitional [Idea or Concept]

Phrase: "from rest"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0035253:Rest [Daily or Recreational Activity]
  1000   C1622890:ResT [Molecular Function]

Phrase: "to 110% VT,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0449864:Threshold [Qualitative Concept]

Phrase: "[ANG II"

Phrase: "]"

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "significantly in the CG"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   806   C0009932:Control Group [Group]
   760   C0243148:control [Qualitative Concept]
   760   C0441833:Group [Idea or Concept]
   760   C0687744:group [Population Group]
   760   C1257890:Group [Population Group]
   760   C1550141:Control [Substance]
   760   C1552516:Group [Health Care Related Organization]
   760   C1705428:Group [Conceptual Entity]
   760   C1705429:Group [Population Group]
   760   C1882979:Control [Conceptual Entity]
   760   C2587213:Control [Functional Concept]
   760   C3274648:Control [Qualitative Concept]

Phrase: "but"

Phrase: "not in the PG"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   797   C0232973:Not pregnant [Finding]
   797   C2826362:Not Pregnant [Finding]
   760   C0441833:Group [Idea or Concept]
   760   C0549206:Pregnant [Finding]
   760   C0553641:Pregnant [Functional Concept]
   760   C0600457:PREGNANT [Finding]
   760   C0687744:group [Population Group]
   760   C1257890:Group [Population Group]
   760   C1518422:Not [Functional Concept]
   760   C1552516:Group [Health Care Related Organization]
   760   C1705428:Group [Conceptual Entity]
   760   C1705429:Group [Population Group]

Phrase: "(Fig. 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.152: There was a significant group x time interaction for [ANG II]. 

Phrase: "There"

Phrase: "was"

Phrase: "a significant group x time interaction for"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1704675:Interaction [Functional Concept]

Phrase: "[ANG II"

Phrase: "]."
Processing 00000000.tx.153: Plasma [AVP] was significantly lower in the PG vs. 

Phrase: "Plasma"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032105:Plasma [Body Substance]
  1000   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]

Phrase: "[AVP]"

Phrase: "was"

Phrase: "significantly lower in the PG"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0441994:Lower [Spatial Concept]
   753   C1548802:Lower [Body Location or Region]
   753   C2003888:Lower [Activity]

Phrase: "vs."
Processing 00000000.tx.154: CG at rest and both work rates. 

Phrase: "CG at rest"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   833   C0009932:Control Group [Group]
   770   C0243148:control [Qualitative Concept]
   770   C0441833:Group [Idea or Concept]
   770   C0687744:group [Population Group]
   770   C1257890:Group [Population Group]
   770   C1550141:Control [Substance]
   770   C1552516:Group [Health Care Related Organization]
   770   C1705428:Group [Conceptual Entity]
   770   C1705429:Group [Population Group]
   770   C1882979:Control [Conceptual Entity]
   770   C2587213:Control [Functional Concept]
   770   C3274648:Control [Qualitative Concept]

Phrase: "and"

Phrase: "both work rates."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0043227:Work [Occupational Activity]
   827   C0871208:Rate [Activity]
   827   C1521828:Rate [Quantitative Concept]
Processing 00000000.tx.155: Arginine vasopressin concentration increased significantly from rest and 70% VT to 110% VT in the CG (Fig. 2). 

Phrase: "Arginine vasopressin concentration"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   827   C0086045:Concentration [Mental Process]
   827   C1446561:Concentration [Quantitative Concept]
   755 E C1880165:Concentrated [Biomedical or Dental Material]
   734   C0003779:Arginine Vasopressin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   734   C1527128:Arginine Vasopressin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "significantly from rest"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0035253:Rest [Daily or Recreational Activity]
   790   C1622890:ResT [Molecular Function]

Phrase: "and"

Phrase: "70% VT to 110% VT"

Phrase: "in the CG"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
  1000   C0009932:Control Group [Group]
   861   C0243148:control [Qualitative Concept]
   861   C0441833:Group [Idea or Concept]
   861   C0687744:group [Population Group]
   861   C1257890:Group [Population Group]
   861   C1550141:Control [Substance]
   861   C1552516:Group [Health Care Related Organization]
   861   C1705428:Group [Conceptual Entity]
   861   C1705429:Group [Population Group]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]

Phrase: "(Fig. 2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.156: There was no significant interaction between group and exercise level for [AVP]. 

Phrase: "There"

Phrase: "was"

Phrase: "no significant interaction between group"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1704675:Interaction [Functional Concept]

Phrase: "and"

Phrase: "exercise level for"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0441889:Level [Qualitative Concept]
   790   C0456079:Level [Classification]
   790   C1547707:Level [Geographic Area]
   790   C2946261:Level [Pharmacologic Substance]

Phrase: "[AVP"

Phrase: "]."
Processing 00000000.tx.157: ANP was not significantly different at rest or either work rate between groups. 

Phrase: "ANP"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
  1000   C0027481:Atrial natriuretic peptide [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   913   C0051989:atrial peptide [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   901   C1144709:natriuretic peptide [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   901   C2709270:Natriuretic peptide [Amino Acid, Peptide, or Protein,Hormone]
   901   C3537020:Natriuretic Peptide [Pharmacologic Substance]
   827   C0018792:Atrial [Body Part, Organ, or Organ Component]
   827   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   827   C0597421:natriuretic [Pharmacologic Substance]
   755 E C0524422:atria [Body Part, Organ, or Organ Component]
   755 E C1280619:Atrium [Body Part, Organ, or Organ Component]

Phrase: "was"

Phrase: "not significantly different at rest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1705242:Different [Qualitative Concept]

Phrase: "or"

Phrase: "either work rate between groups."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0043227:Work [Occupational Activity]
   760   C0871208:Rate [Activity]
   760   C1521828:Rate [Quantitative Concept]
Processing 00000000.tx.158: [ANP] increased significantly from rest to 70% VT and from 70 to 110% VT in the PG and was significantly higher at 110% VT than at rest in both groups (Fig. 3). 

Phrase: "[ANP"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
  1000   C0027481:Atrial natriuretic peptide [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   913   C0051989:atrial peptide [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   901   C1144709:natriuretic peptide [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   901   C2709270:Natriuretic peptide [Amino Acid, Peptide, or Protein,Hormone]
   901   C3537020:Natriuretic Peptide [Pharmacologic Substance]
   827   C0018792:Atrial [Body Part, Organ, or Organ Component]
   827   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   827   C0597421:natriuretic [Pharmacologic Substance]
   755 E C0524422:atria [Body Part, Organ, or Organ Component]
   755 E C1280619:Atrium [Body Part, Organ, or Organ Component]

Phrase: "]"

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "significantly from rest"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0035253:Rest [Daily or Recreational Activity]
   790   C1622890:ResT [Molecular Function]

Phrase: "to 70% VT"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0449864:Threshold [Qualitative Concept]

Phrase: "and from 70"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1515981:And [Idea or Concept]

Phrase: "to 110% VT"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0449864:Threshold [Qualitative Concept]

Phrase: "in the PG"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0441833:Group [Idea or Concept]
   861   C0687744:group [Population Group]
   861   C1257890:Group [Population Group]
   861   C1552516:Group [Health Care Related Organization]
   861   C1705428:Group [Conceptual Entity]
   861   C1705429:Group [Population Group]

Phrase: "and"

Phrase: "was"

Phrase: "significantly higher at 110% VT"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   719   C0205250:High [Qualitative Concept]
   719   C1299351:High [Qualitative Concept]
   719   C2700149:HIGH [Intellectual Product]

Phrase: "than"

Phrase: "at rest"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0035253:Rest [Daily or Recreational Activity]
  1000   C1622890:ResT [Molecular Function]

Phrase: "in both groups"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0441833:Group [Idea or Concept]
  1000   C0687744:group [Population Group]
  1000   C1257890:Group [Population Group]
  1000   C1552516:Group [Health Care Related Organization]
  1000   C1552839:groups [Idea or Concept]
  1000   C1705428:Group [Conceptual Entity]
  1000   C1705429:Group [Population Group]

Phrase: "(Fig. 3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.159: There was no significant interaction between group and exercise level for [ANP]. 

Phrase: "There"

Phrase: "was"

Phrase: "no significant interaction between group"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1704675:Interaction [Functional Concept]

Phrase: "and"

Phrase: "exercise level for"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0441889:Level [Qualitative Concept]
   790   C0456079:Level [Classification]
   790   C1547707:Level [Geographic Area]
   790   C2946261:Level [Pharmacologic Substance]

Phrase: "[ANP"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
  1000   C0027481:Atrial natriuretic peptide [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   913   C0051989:atrial peptide [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   901   C1144709:natriuretic peptide [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   901   C2709270:Natriuretic peptide [Amino Acid, Peptide, or Protein,Hormone]
   901   C3537020:Natriuretic Peptide [Pharmacologic Substance]
   827   C0018792:Atrial [Body Part, Organ, or Organ Component]
   827   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   827   C0597421:natriuretic [Pharmacologic Substance]
   755 E C0524422:atria [Body Part, Organ, or Organ Component]
   755 E C1280619:Atrium [Body Part, Organ, or Organ Component]

Phrase: "]."
Processing 00000000.tx.160: As expected, values for circulating plasma progesterone were substantially higher in the PG vs. 

Phrase: "As"

Phrase: "expected"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1517001:Expected [Idea or Concept]

Phrase: ","

Phrase: "values for circulating plasma progesterone"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0042295:Values [Qualitative Concept]
   726 E C1522609:Value [Quantitative Concept]

Phrase: "were"

Phrase: "substantially higher in the PG"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   719   C0205250:High [Qualitative Concept]
   719   C1299351:High [Qualitative Concept]
   719   C2700149:HIGH [Intellectual Product]

Phrase: "vs."
Processing 00000000.tx.161: CG under all experimental conditions (Table 5). 

Phrase: "CG under all experimental conditions"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   790   C0009932:Control Group [Group]
   753   C0243148:control [Qualitative Concept]
   753   C0441833:Group [Idea or Concept]
   753   C0687744:group [Population Group]
   753   C1257890:Group [Population Group]
   753   C1550141:Control [Substance]
   753   C1552516:Group [Health Care Related Organization]
   753   C1705428:Group [Conceptual Entity]
   753   C1705429:Group [Population Group]
   753   C1882979:Control [Conceptual Entity]
   753   C2587213:Control [Functional Concept]
   753   C3274648:Control [Qualitative Concept]

Phrase: "(Table 5"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.162: Values within the CG reflected the fact that subjects were tested in varying phases of the menstrual cycle. 

Phrase: "Values within the CG"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0042295:Values [Qualitative Concept]
   726 E C1522609:Value [Quantitative Concept]

Phrase: "reflected"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0558058:reflected [Mental Process]

Phrase: "the fact"

Phrase: "that subjects"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0681850:Subject [Group]
   966   C1550501:{Subject} [Idea or Concept]
   966   C1706203:Subject [Idea or Concept]
   966   C2349001:Subject [Human]
   966   C2697811:Subject [Functional Concept]

Phrase: "were"

Phrase: "tested in varying phases of the menstrual cycle."
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   776   C1818633:menstrual cycle phase [Organism Function]
   770   C0025329:Menstrual cycle [Organism Function]
   744   C0025344:Menstrual [Organism Function]
   744   C0392366:tested [Intellectual Product]
   744   C0585064:Phases [Temporal Concept]
   744   C1067936:Phasis [Eukaryote]
   744   C1511572:Cycle [Temporal Concept]
   711 E C0022885:Test [Laboratory Procedure]
   711 E C0039593:Test [Functional Concept]
   711 E C0205390:Phase [Temporal Concept]
Processing 00000000.tx.163: Progesterone levels increased significantly in the PG from rest to 110% VT and from 70 to 110% VT. 

Phrase: "Progesterone levels"
Meta Candidates (Total=11; Excluded=7; Pruned=0; Remaining=4)
  1000   C0428409:progesterone levels [Laboratory or Test Result]
   861   C0033308:Progesterone [Hormone,Pharmacologic Substance,Steroid]
   861   C0441889:Levels [Qualitative Concept]
   861   C2757070:Progesterone [Pharmacologic Substance]
   827 E C0456079:Level [Classification]
   827 E C1547707:Level [Geographic Area]
   827 E C2946261:Level [Pharmacologic Substance]
   805 E C0010094:Corpus luteum hormone [Hormone]
   805 E C0701112:Proluton [Hormone,Pharmacologic Substance,Steroid]
   805 E C0701115:Lutromone [Hormone,Pharmacologic Substance,Steroid]
   805 E C0701118:Lipo-Lutin [Hormone,Pharmacologic Substance,Steroid]

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "significantly in the PG"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   760   C0441833:Group [Idea or Concept]
   760   C0549206:Pregnant [Finding]
   760   C0553641:Pregnant [Functional Concept]
   760   C0600457:PREGNANT [Finding]
   760   C0687744:group [Population Group]
   760   C1257890:Group [Population Group]
   760   C1552516:Group [Health Care Related Organization]
   760   C1705428:Group [Conceptual Entity]
   760   C1705429:Group [Population Group]

Phrase: "from rest"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0035253:Rest [Daily or Recreational Activity]
  1000   C1622890:ResT [Molecular Function]

Phrase: "to 110% VT"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0449864:Threshold [Qualitative Concept]

Phrase: "and from 70"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1515981:And [Idea or Concept]

Phrase: "to 110% VT."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0449864:Threshold [Qualitative Concept]
Processing 00000000.tx.164: There was a significant interaction between group and exercise level for progesterone.  

Phrase: "There"

Phrase: "was"

Phrase: "a significant interaction between group"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1704675:Interaction [Functional Concept]

Phrase: "and"

Phrase: "exercise level for progesterone."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   819   C0428409:Progesterone level [Laboratory or Test Result]
   770   C0441889:Level [Qualitative Concept]
   770   C0456079:Level [Classification]
   770   C1547707:Level [Geographic Area]
   770   C2946261:Level [Pharmacologic Substance]
Processing 00000000.tx.165: DISCUSSION TOP ABSTRACT METHODS RESULTS DISCUSSION DISCLOSURES REFERENCES  This study tested the hypothesis that pregnancy attenuates ANG II and AVP responses to short-term dynamic exercise. 

Phrase: "DISCUSSION TOP ABSTRACT METHODS RESULTS DISCUSSION DISCLOSURES"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   795   C0012625:disclosures [Individual Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "This study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "tested"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392366:tested [Intellectual Product]
   966 E C0022885:Test [Laboratory Procedure]
   966 E C0039593:Test [Functional Concept]

Phrase: "the hypothesis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1512571:Hypothesis [Idea or Concept]

Phrase: "that pregnancy"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
  1000   C0032961:Pregnancy [Organism Function]
  1000   C3484365:Pregnancy [Clinical Attribute]
   928 E C0549206:Pregnant [Finding]
   928 E C0553641:Pregnant [Functional Concept]
   928 E C0600457:PREGNANT [Finding]
   916 E C0552112:Pregnancies [Clinical Attribute]

Phrase: "attenuates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0599946:Attenuate [Activity]

Phrase: "ANG II"

Phrase: "and"

Phrase: "AVP responses to short-term dynamic exercise."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   793   C2265833:response to exercise [Organism Function]
   748   C0871261:responses [Organism Attribute]
   714 E C1704632:Response [Finding]
   714 E C1706817:Response [Intellectual Product]
   714 E C2911692:Response [Mental Process]
Processing 00000000.tx.166: As postulated, the main finding was that the normal response for the activation of the renin-angiotensin system and the secretion of AVP in response to exercise was blunted in late gestation. 

Phrase: "As"

Phrase: "postulated"

Phrase: ","

Phrase: "the main finding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0037088:Finding [Sign or Symptom]
   861   C0243095:Finding [Finding]
   861   C2825141:Finding [Finding]

Phrase: "was"

Phrase: "that"

Phrase: "the normal response for the activation of the renin-angiotensin system"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   738   C0871261:Response [Organism Attribute]
   738   C1704632:Response [Finding]
   738   C1706817:Response [Intellectual Product]
   738   C2911692:Response [Mental Process]

Phrase: "and"

Phrase: "the secretion of AVP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0036536:secretion [Biologic Function]
   770   C0036537:Secretion [Body Substance]

Phrase: "in response to"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0871261:Response [Organism Attribute]
   861   C1704632:Response [Finding]
   861   C1706817:Response [Intellectual Product]
   861   C2911692:Response [Mental Process]

Phrase: "exercise"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0015259:Exercise [Daily or Recreational Activity]
  1000   C1522704:Exercise [Therapeutic or Preventive Procedure]

Phrase: "was"

Phrase: "blunted in late gestation."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0032961:Gestation [Organism Function]
   770   C0205087:Late [Temporal Concept]
   770   C1997138:Blunted [Qualitative Concept]
Processing 00000000.tx.167: In contrast, ANP responses were not attenuated. 

Phrase: "In contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "ANP responses"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   812   C0871261:responses [Organism Attribute]
   779 E C1704632:Response [Finding]
   779 E C1706817:Response [Intellectual Product]
   779 E C2911692:Response [Mental Process]
   756   C0027481:Atrial natriuretic peptide [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   708   C0051989:atrial peptide [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "were"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "attenuated."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332161:Attenuated [Qualitative Concept]
  1000   C0599946:Attenuated [Activity]
Processing 00000000.tx.168: Although changes in blood volume were not measured directly in this study, the use of plasma protein measurements to reflect fluid volume shift in response to exercise has been used successfully in previous studies of pregnant (3) and nonpregnant women (4). 

Phrase: "Although"

Phrase: "changes in blood volume"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0392747:changes [Functional Concept]
   770   C0443172:changes [Quantitative Concept]
   737 E C1705241:Change [Quantitative Concept]

Phrase: "were"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "measured"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0444706:Measured [Qualitative Concept]
  1000   C3541902:MEASURED [Diagnostic Procedure]
   966 E C0079809:Measure [Quantitative Concept]
   966 E C0242485:Measure [Functional Concept]

Phrase: "directly in this study,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0557651:Study [Manufactured Object]
   770   C1947931:Directly [Qualitative Concept]
   770   C2603343:Study [Research Activity]

Phrase: "the use of plasma protein measurements to"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   778   C1524063:Use of [Functional Concept]
   748   C0042153:use [Functional Concept]
   748   C0457083:Use [Functional Concept]
   748   C1947944:Use [Intellectual Product]

Phrase: "reflect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0558058:reflect [Mental Process]

Phrase: "fluid volume shift in response to"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   783   C0242705:fluid shift [Physiologic Function]
   753   C0333051:Shift [Functional Concept]
   753   C2347509:Shift [Phenomenon or Process]

Phrase: "exercise"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0015259:Exercise [Daily or Recreational Activity]
  1000   C1522704:Exercise [Therapeutic or Preventive Procedure]

Phrase: "has"

Phrase: "been"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "successfully in previous studies of pregnant"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   753   C0205156:Previous [Temporal Concept]
   753   C0549206:Pregnant [Finding]
   753   C0553641:Pregnant [Functional Concept]
   753   C0600457:PREGNANT [Finding]
   753   C0947630:studies [Laboratory Procedure]
   753   C1552607:previous [Temporal Concept]
   719 E C0557651:Study [Manufactured Object]
   719 E C2603343:Study [Research Activity]

Phrase: "(3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: ")"

Phrase: "and"

Phrase: "nonpregnant women"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0043210:Women [Population Group]

Phrase: "(4"

Phrase: ")."
Processing 00000000.tx.169: This practice is based on the assumption that macromolecules such as albumin and other plasma proteins do not cross vascular barriers in important amounts in response to hydrostatic and osmotic forces during exercise. 

Phrase: "This practice"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0237607:practice [Mental Process]
  1000   C3245512:practice [Intellectual Product]

Phrase: "is"

Phrase: "based on the assumption"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   770   C1527178:Based [Functional Concept]
   770   C1705938:Based [Idea or Concept]
   737 E C0002055:base [Inorganic Chemical]
   737 E C0178499:Base [Chemical Viewed Functionally]
   737 E C1880279:Base [Biomedical or Dental Material]

Phrase: "that macromolecules such as albumin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0178735:macromolecules [Chemical Viewed Structurally]

Phrase: "and"

Phrase: "other plasma proteins"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0032120:Plasma Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   966 E C0036825:Plasma Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0032105:Plasma [Body Substance]
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]

Phrase: "do"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "cross"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2828360:Cross [Conceptual Entity]

Phrase: "vascular barriers in important amounts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   726   C1706912:BARRIER [Medical Device]

Phrase: "in response"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0871261:Response [Organism Attribute]
  1000   C1704632:Response [Finding]
  1000   C1706817:Response [Intellectual Product]
  1000   C2911692:Response [Mental Process]

Phrase: "to hydrostatic"

Phrase: "and"

Phrase: "osmotic forces during exercise."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0441722:forces [Phenomenon or Process]
   737 E C0563538:Force [Phenomenon or Process]
Processing 00000000.tx.170: In this regard, Pivarnik et al. 

Phrase: "In this regard,"

Phrase: "Pivarnik et al."
Processing 00000000.tx.171: (23) reported moderate increases in exercise-induced loss of total plasma protein and albumin at 2933 wk of gestation; 

Phrase: "(23"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: ")"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "moderate increases in exercise-induced loss of total plasma protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C0442805:increases [Functional Concept]

Phrase: "and"

Phrase: "albumin at 2933 wk of gestation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0001924:Albumin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ";"
Processing 00000000.tx.172: values in late gestation (3336 wk) were similar to postpartum control. 

Phrase: "values in late gestation"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0042295:Values [Qualitative Concept]
   737 E C1522609:Value [Quantitative Concept]

Phrase: "(3336 wk)"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0332174:/wk [Temporal Concept]
   861   C0439230:wk [Temporal Concept]

Phrase: "were"

Phrase: "similar to postpartum control."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C2348205:Similar [Qualitative Concept]
Processing 00000000.tx.173: These losses were small under all experimental conditions. 

Phrase: "These losses"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1517945:Loss [Quantitative Concept]

Phrase: "were"

Phrase: "small under all experimental conditions."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0700321:Small [Quantitative Concept]
Processing 00000000.tx.174: Resting measurements from this study reflected the substantial expansion of plasma volume and hemodilution that occurs in normal human pregnancy. 

Phrase: "Resting measurements from this study"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0242485:measurements [Functional Concept]

Phrase: "reflected"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0558058:reflected [Mental Process]

Phrase: "the substantial expansion of plasma volume"

Phrase: "and"

Phrase: "hemodilution"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0019009:Hemodilution [Therapeutic or Preventive Procedure]

Phrase: "that"

Phrase: "occurs in normal human pregnancy."
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   797   C0232989:Normal pregnancy [Finding]
   760   C0032961:Pregnancy [Organism Function]
   760   C0086418:Human [Human]
   760   C0205307:Normal [Qualitative Concept]
   760   C0439166:% normal [Quantitative Concept]
   760   C1709305:Occur [Activity]
   760   C2347086:% Normal [Quantitative Concept]
   760   C2745955:OCCUR [Temporal Concept]
   760   C3484365:Pregnancy [Clinical Attribute]
   756 E C0700573:normal pregnancies [Finding]
Processing 00000000.tx.175: In this regard, values for TP and albumin were significantly lower in the PG vs. nonpregnant subjects in the resting state. 

Phrase: "In this regard,"

Phrase: "values for TP"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0042295:Values [Qualitative Concept]
   737 E C1522609:Value [Quantitative Concept]

Phrase: "and"

Phrase: "albumin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001924:Albumin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "were"

Phrase: "significantly lower in the PG"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0441994:Lower [Spatial Concept]
   753   C1548802:Lower [Body Location or Region]
   753   C2003888:Lower [Activity]

Phrase: "vs. nonpregnant subjects in the resting state."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   714   C0681850:Subject [Group]
   714   C1550501:{Subject} [Idea or Concept]
   714   C1706203:Subject [Idea or Concept]
   714   C2349001:Subject [Human]
   714   C2697811:Subject [Functional Concept]
Processing 00000000.tx.176: In response to exercise, hemoconcentration was observed in both groups at both work rates as TP and albumin concentrations and osmolality increased significantly from rest. 

Phrase: "In response to"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0871261:Response [Organism Attribute]
   861   C1704632:Response [Finding]
   861   C1706817:Response [Intellectual Product]
   861   C2911692:Response [Mental Process]

Phrase: "exercise"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0015259:Exercise [Daily or Recreational Activity]
  1000   C1522704:Exercise [Therapeutic or Preventive Procedure]

Phrase: ","

Phrase: "hemoconcentration"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0854379:Hemoconcentration [Laboratory Procedure]

Phrase: "was"

Phrase: "observed in both"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1441672:Observed [Functional Concept]

Phrase: "groups at both work rates"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   760   C0043227:Work [Occupational Activity]
   760   C0441833:Group [Idea or Concept]
   760   C0687744:group [Population Group]
   760   C1257890:Group [Population Group]
   760   C1552516:Group [Health Care Related Organization]
   760   C1552839:groups [Idea or Concept]
   760   C1705428:Group [Conceptual Entity]
   760   C1705429:Group [Population Group]
   726   C0871208:Rate [Activity]
   726   C1521828:Rate [Quantitative Concept]

Phrase: "as TP"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0555903:Total protein [Laboratory Procedure]
  1000   C1261360:total protein [Laboratory or Test Result]
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0439175:% total [Quantitative Concept]
   861   C0439810:Total [Qualitative Concept]

Phrase: "and"

Phrase: "albumin concentrations"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0486291:albumin concentrations [Laboratory or Test Result]
   861   C0086045:Concentrations [Mental Process]
   827 E C1446561:Concentration [Quantitative Concept]
   777 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "and"

Phrase: "osmolality"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0086741:Osmolality [Clinical Attribute]
  1000   C0201803:Osmolality [Laboratory Procedure]
  1000   C1547034:*Osmolality [Quantitative Concept]
   900 E C0439186:osmol [Quantitative Concept]

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "significantly from rest."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0035253:Rest [Daily or Recreational Activity]
   790   C1622890:ResT [Molecular Function]
Processing 00000000.tx.177: The two groups were similar in the extent of the hemoconcentration as indicated by similar changes in TP and albumin concentration. 

Phrase: "The two groups"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   861   C0441833:Group [Idea or Concept]
   861   C0687744:group [Population Group]
   861   C1257890:Group [Population Group]
   861   C1552516:Group [Health Care Related Organization]
   861   C1552839:groups [Idea or Concept]
   861   C1705428:Group [Conceptual Entity]
   861   C1705429:Group [Population Group]

Phrase: "were"

Phrase: "similar in the extent of the hemoconcentration"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C2348205:Similar [Qualitative Concept]

Phrase: "as"

Phrase: "indicated by similar changes"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   770   C0392747:changes [Functional Concept]
   770   C0443172:changes [Quantitative Concept]
   770   C1444656:Indicated [Finding]
   770   C2348205:Similar [Qualitative Concept]
   737 E C1705241:Change [Quantitative Concept]

Phrase: "in TP"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0555903:Total protein [Laboratory Procedure]
  1000   C1261360:total protein [Laboratory or Test Result]
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0439175:% total [Quantitative Concept]
   861   C0439810:Total [Qualitative Concept]

Phrase: "and"

Phrase: "albumin concentration."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0486291:Albumin concentration [Laboratory or Test Result]
   861   C0086045:Concentration [Mental Process]
   861   C1446561:Concentration [Quantitative Concept]
   789 E C1880165:Concentrated [Biomedical or Dental Material]
Processing 00000000.tx.178: Both TP and albumin concentrations increased in the PG from rest to 70% VT by 5% and from rest to 110% VT by 1011%, with the CG increasing by 34 and 8%, respectively. 

Phrase: "Both TP"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0555903:Total protein [Laboratory Procedure]
  1000   C1261360:total protein [Laboratory or Test Result]
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0439175:% total [Quantitative Concept]
   861   C0439810:Total [Qualitative Concept]

Phrase: "and"

Phrase: "albumin concentrations"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0486291:albumin concentrations [Laboratory or Test Result]
   861   C0086045:Concentrations [Mental Process]
   827 E C1446561:Concentration [Quantitative Concept]
   777 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "increased in the PG"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   760   C0205217:Increased [Quantitative Concept]
   760   C0441833:Group [Idea or Concept]
   760   C0442805:Increased [Functional Concept]
   760   C0549206:Pregnant [Finding]
   760   C0553641:Pregnant [Functional Concept]
   760   C0600457:PREGNANT [Finding]
   760   C0687744:group [Population Group]
   760   C1257890:Group [Population Group]
   760   C1552516:Group [Health Care Related Organization]
   760   C1705428:Group [Conceptual Entity]
   760   C1705429:Group [Population Group]

Phrase: "from rest"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0035253:Rest [Daily or Recreational Activity]
  1000   C1622890:ResT [Molecular Function]

Phrase: "to 70% VT"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0449864:Threshold [Qualitative Concept]

Phrase: "by 5%"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "and from rest"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0035253:Rest [Daily or Recreational Activity]
   790   C1515981:And [Idea or Concept]
   790   C1622890:ResT [Molecular Function]

Phrase: "to 110% VT"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0449864:Threshold [Qualitative Concept]

Phrase: "by 1011%,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450317:1011 [Intellectual Product]

Phrase: "with the CG increasing"
Meta Candidates (Total=9; Excluded=7; Pruned=0; Remaining=2)
   827   C0442808:Increasing [Functional Concept]
   793 E C0442805:Increase [Functional Concept]
   755 E C1517378:Gain [Quantitative Concept]
   734   C0009932:Control Group [Group]
   734 E C0205217:Increased [Quantitative Concept]
   734 E C0439661:Acquired [Temporal Concept]
   734 E C1301820:Obtain [Functional Concept]
   734 E C1706701:Acquire [Activity]
   734 E C3245488:acquired [Intellectual Product]

Phrase: "by 34"

Phrase: "and"

Phrase: "8%,"

Phrase: "respectively."
Processing 00000000.tx.179: This is consistent with the findings of Pivarnik et al. 

Phrase: "This"

Phrase: "is"

Phrase: "consistent with the findings of Pivarnik et al."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0332290:Consistent with [Idea or Concept]
           Consistent
   714   C0332529:Consistency finding [Qualitative Concept]
Processing 00000000.tx.180: (23), who observed similar decreases in plasma volume in women 3336 wk pregnant compared with 4 wk postpartum in response to 5 min of cycling at 75 W. 

Phrase: "(23"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "who"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "similar decreases in plasma volume"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0547047:decreases [Quantitative Concept]
   726 E C0392756:Decrease [Qualitative Concept]

Phrase: "in women 3336 wk"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0332174:/wk [Temporal Concept]
   827   C0439230:wk [Temporal Concept]

Phrase: "pregnant"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0549206:Pregnant [Finding]
  1000   C0553641:Pregnant [Functional Concept]
  1000   C0600457:PREGNANT [Finding]

Phrase: "compared with 4 wk"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0332174:/wk [Temporal Concept]
   770   C0439230:wk [Temporal Concept]
   770   C1707455:Compared [Activity]

Phrase: "postpartum in response"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0086839:Postpartum [Temporal Concept]

Phrase: "to 5 min"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0702093:/min [Temporal Concept]

Phrase: "of cycling"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1511572:Cycle [Temporal Concept]

Phrase: "at 75 W."
Processing 00000000.tx.181: The significantly higher [ANG II] of the PG vs. 

Phrase: "The significantly higher"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0205250:High [Qualitative Concept]
   827   C1299351:High [Qualitative Concept]
   827   C2700149:HIGH [Intellectual Product]
   777 E C0489786:Height [Organism Attribute]

Phrase: "[ANG II"

Phrase: "]"

Phrase: "of the PG"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0441833:Group [Idea or Concept]
   861   C0687744:group [Population Group]
   861   C1257890:Group [Population Group]
   861   C1552516:Group [Health Care Related Organization]
   861   C1705428:Group [Conceptual Entity]
   861   C1705429:Group [Population Group]

Phrase: "vs."
Processing 00000000.tx.182: CG at rest is consistent with the findings of other studies, which have found elevated plasma renin concentration (9), PRA (32), and [ANG II] (21) in pregnancy. 

Phrase: "CG at rest"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   833   C0009932:Control Group [Group]
   770   C0243148:control [Qualitative Concept]
   770   C0441833:Group [Idea or Concept]
   770   C0687744:group [Population Group]
   770   C1257890:Group [Population Group]
   770   C1550141:Control [Substance]
   770   C1552516:Group [Health Care Related Organization]
   770   C1705428:Group [Conceptual Entity]
   770   C1705429:Group [Population Group]
   770   C1882979:Control [Conceptual Entity]
   770   C2587213:Control [Functional Concept]
   770   C3274648:Control [Qualitative Concept]

Phrase: "is"

Phrase: "consistent with the findings of other studies,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   778   C0332290:Consistent with [Idea or Concept]
           Consistent
   721   C0332529:Consistency finding [Qualitative Concept]

Phrase: "which"

Phrase: "have"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "elevated plasma renin concentration"
Meta Candidates (Total=12; Excluded=3; Pruned=0; Remaining=9)
   923   C0240783:Elevated plasma renin [Finding]
   875   C0683150:plasma concentration [Quantitative Concept]
   812   C0032105:Plasma [Body Substance]
   812   C0035094:Renin [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0035100:Rennin [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   812   C0086045:Concentration [Mental Process]
   812   C1419338:RENIN [Gene or Genome]
   812   C1446561:Concentration [Quantitative Concept]
   812   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   756 E C0022877:Lab [Manufactured Object,Organization]
   756 E C0587081:Labs [Finding]
   741 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "(9"

Phrase: ")"

Phrase: ","

Phrase: "PRA"
Meta Candidates (Total=13; Excluded=3; Pruned=0; Remaining=10)
   901   C1150120:renin activity [Molecular Function]
   873 E C1150116:chymosin activity [Molecular Function]
   827   C0032105:Plasma [Body Substance]
   827   C0035094:Renin [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0035100:Rennin [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1419338:RENIN [Gene or Genome]
   827   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   827   C1561536:*Activity [Idea or Concept]
   771 E C0022877:Lab [Manufactured Object,Organization]
   771 E C0587081:Labs [Finding]

Phrase: "(32"

Phrase: ")"

Phrase: ","

Phrase: "and ["

Phrase: "ANG II"

Phrase: "]"

Phrase: "(21"

Phrase: ")"

Phrase: "in pregnancy."
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
  1000   C0032961:Pregnancy [Organism Function]
  1000   C3484365:Pregnancy [Clinical Attribute]
   928 E C0549206:Pregnant [Finding]
   928 E C0553641:Pregnant [Functional Concept]
   928 E C0600457:PREGNANT [Finding]
   916 E C0552112:Pregnancies [Clinical Attribute]
Processing 00000000.tx.183: The lower circulating [AVP] in the PG vs. the CG at rest may be the result of a large increase in the metabolic clearance rate of AVP during pregnancy (16). 

Phrase: "The lower circulating"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0175630:Circulating [Functional Concept]

Phrase: "[AVP] in the PG"

Phrase: "vs."

Phrase: "the CG at rest"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   806   C0009932:Control Group [Group]
   760   C0243148:control [Qualitative Concept]
   760   C0441833:Group [Idea or Concept]
   760   C0687744:group [Population Group]
   760   C1257890:Group [Population Group]
   760   C1550141:Control [Substance]
   760   C1552516:Group [Health Care Related Organization]
   760   C1705428:Group [Conceptual Entity]
   760   C1705429:Group [Population Group]
   760   C1882979:Control [Conceptual Entity]
   760   C2587213:Control [Functional Concept]
   760   C3274648:Control [Qualitative Concept]

Phrase: "may"

Phrase: "be"

Phrase: "the result of a large increase"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C1274040:Result [Functional Concept]
   753   C1546471:Result [Idea or Concept]
   753   C2825142:Result [Finding]

Phrase: "in the metabolic clearance rate"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
  1000   C0025515:Metabolic Clearance Rate [Clinical Attribute]
           clearance rate
   913   C0870882:Metabolic rate [Physiologic Function]
   827   C0311400:Metabolic [Functional Concept]
   827   C0449297:Clearance [Qualitative Concept]
   827   C0871208:Rate [Activity]
   827   C1382187:Clearance [Clinical Attribute]
   827   C1521828:Rate [Quantitative Concept]
   827   C1524026:Metabolic [Cell Function]
   827   C2707259:Metabolic [Clinical Attribute]
   827   C2825073:Clearance [Natural Phenomenon or Process]

Phrase: "of AVP"

Phrase: "during pregnancy"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
  1000   C0032961:Pregnancy [Organism Function]
  1000   C3484365:Pregnancy [Clinical Attribute]
   928 E C0549206:Pregnant [Finding]
   928 E C0553641:Pregnant [Functional Concept]
   928 E C0600457:PREGNANT [Finding]
   916 E C0552112:Pregnancies [Clinical Attribute]

Phrase: "(16"

Phrase: ")."
Processing 00000000.tx.184: Progesterone may also contribute to the lowering of [AVP] as progesterone administration has been demonstrated to decrease AVP levels in women (31). 

Phrase: "Progesterone"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
  1000   C0033308:Progesterone [Hormone,Pharmacologic Substance,Steroid]
  1000   C2757070:Progesterone [Pharmacologic Substance]
   944 E C0010094:Corpus luteum hormone [Hormone]
   944 E C0701112:Proluton [Hormone,Pharmacologic Substance,Steroid]
   944 E C0701115:Lutromone [Hormone,Pharmacologic Substance,Steroid]
   944 E C0701118:Lipo-Lutin [Hormone,Pharmacologic Substance,Steroid]

Phrase: "may"

Phrase: "also"

Phrase: "contribute to the lowering of [AVP]"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   753   C0441994:lowering [Spatial Concept]
   753   C1880177:Contribute [Activity]
   753   C2003888:Lowering [Activity]
   719 E C1548802:Lower [Body Location or Region]

Phrase: "as"

Phrase: "progesterone administration"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0001554:Administration [Occupational Activity]
   861   C1533734:Administration [Therapeutic or Preventive Procedure]

Phrase: "has"

Phrase: "been"

Phrase: "demonstrated"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "decrease"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0392756:Decrease [Qualitative Concept]
  1000   C0547047:Decrease [Quantitative Concept]

Phrase: "AVP levels in women"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   770   C0441889:Levels [Qualitative Concept]
   737 E C0456079:Level [Classification]
   737 E C1547707:Level [Geographic Area]
   737 E C2946261:Level [Pharmacologic Substance]

Phrase: "(31"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450355:31 [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.185: However, elevated circulating estrogen concentration (not measured in this study) is the probable stimulus for the decrease in the osmotic threshold for AVP release during pregnancy (17) because this hormone decreases the osmotic threshold for AVP release in nonpregnant women (27). 

Phrase: "However,"

Phrase: "elevated circulating estrogen concentration"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   812   C0086045:Concentration [Mental Process]
   812   C1446561:Concentration [Quantitative Concept]
   741 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "("

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "measured in this study"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   770   C0444706:Measured [Qualitative Concept]
   770   C0557651:Study [Manufactured Object]
   770   C2603343:Study [Research Activity]
   770   C3541902:MEASURED [Diagnostic Procedure]
   737 E C0079809:Measure [Quantitative Concept]
   737 E C0242485:Measure [Functional Concept]

Phrase: ")"

Phrase: "is"

Phrase: "the probable stimulus for the decrease"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0234402:Stimulus [Phenomenon or Process]

Phrase: "in the osmotic threshold"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0449864:Threshold [Qualitative Concept]

Phrase: "for AVP release"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0030685:Release [Health Care Activity]
   861   C0391871:Release [Functional Concept]
   861   C0439180:% release [Quantitative Concept]
   861   C0680255:release [Health Care Activity]
   861   C1283071:Release [Functional Concept]
   861   C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "during pregnancy"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
  1000   C0032961:Pregnancy [Organism Function]
  1000   C3484365:Pregnancy [Clinical Attribute]
   928 E C0549206:Pregnant [Finding]
   928 E C0553641:Pregnant [Functional Concept]
   928 E C0600457:PREGNANT [Finding]
   916 E C0552112:Pregnancies [Clinical Attribute]

Phrase: "(17"

Phrase: ")"

Phrase: "because"

Phrase: "this hormone"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0019932:Hormone [Hormone]
   928 E C0458083:Hormonal [Qualitative Concept]

Phrase: "decreases"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0392756:Decrease [Qualitative Concept]
  1000   C0547047:Decrease [Quantitative Concept]

Phrase: "the osmotic threshold for AVP release"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0449864:Threshold [Qualitative Concept]

Phrase: "in nonpregnant women"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0043210:Women [Population Group]

Phrase: "(27"

Phrase: ")."
Processing 00000000.tx.186: The level of ANP at rest was not different between the PG and CG. 

Phrase: "The level of ANP"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0441889:Level [Qualitative Concept]
   753   C0456079:Level [Classification]
   753   C1547707:Level [Geographic Area]
   753   C2946261:Level [Pharmacologic Substance]

Phrase: "at rest"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0035253:Rest [Daily or Recreational Activity]
  1000   C1622890:ResT [Molecular Function]

Phrase: "was"

Phrase: "not different between the PG"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1705242:Different [Qualitative Concept]

Phrase: "and"

Phrase: "CG."
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
  1000   C0009932:Control Group [Group]
   861   C0243148:control [Qualitative Concept]
   861   C0441833:Group [Idea or Concept]
   861   C0687744:group [Population Group]
   861   C1257890:Group [Population Group]
   861   C1550141:Control [Substance]
   861   C1552516:Group [Health Care Related Organization]
   861   C1705428:Group [Conceptual Entity]
   861   C1705429:Group [Population Group]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.187: Atrial enlargement during pregnancy (33) may reduce atrial stretch from the expanded blood volume and contribute to the maintenance of normal ANP levels. 

Phrase: "Atrial enlargement during pregnancy"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0741276:ATRIAL ENLARGEMENT [Disease or Syndrome]
   833   C2348360:ATRIAL ENLARGEMENT [Finding]
   770   C0020564:Enlargement, NOS [Pathologic Function]
   770   C1293134:Enlargement [Therapeutic or Preventive Procedure]
   770   C2711450:Enlargement [Anatomical Abnormality]

Phrase: "(33"

Phrase: ")"

Phrase: "may"

Phrase: "reduce"

Phrase: "atrial stretch from the expanded blood volume"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0600080:stretch [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "contribute to the maintenance of normal ANP levels."
Meta Candidates (Total=17; Excluded=3; Pruned=0; Remaining=14)
   782   C0027481:Atrial natriuretic peptide [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C1144709:natriuretic peptide [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C2709270:Natriuretic peptide [Amino Acid, Peptide, or Protein,Hormone]
   760   C3537020:Natriuretic Peptide [Pharmacologic Substance]
   757   C0051989:atrial peptide [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   739   C0018792:Atrial [Body Part, Organ, or Organ Component]
   739   C0024501:Maintenance [Activity]
   739   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   739   C0205307:Normal [Qualitative Concept]
   739   C0439166:% normal [Quantitative Concept]
   739   C0441889:Levels [Qualitative Concept]
   739   C0597421:natriuretic [Pharmacologic Substance]
   739   C1880177:Contribute [Activity]
   739   C2347086:% Normal [Quantitative Concept]
   706 E C0456079:Level [Classification]
   706 E C1547707:Level [Geographic Area]
   706 E C2946261:Level [Pharmacologic Substance]
Processing 00000000.tx.188: As hypothesized, the ANG II response to exercise was attenuated in the PG but not in the CG as reflected by a significant group x time interaction. 

Phrase: "As"

Phrase: "hypothesized"

Phrase: ","

Phrase: "the ANG II response to"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0871261:Response [Organism Attribute]
   812   C1704632:Response [Finding]
   812   C1706817:Response [Intellectual Product]
   812   C2911692:Response [Mental Process]

Phrase: "exercise"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0015259:Exercise [Daily or Recreational Activity]
  1000   C1522704:Exercise [Therapeutic or Preventive Procedure]

Phrase: "was"

Phrase: "attenuated in the PG"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   760   C0332161:Attenuated [Qualitative Concept]
   760   C0441833:Group [Idea or Concept]
   760   C0549206:Pregnant [Finding]
   760   C0553641:Pregnant [Functional Concept]
   760   C0599946:Attenuated [Activity]
   760   C0600457:PREGNANT [Finding]
   760   C0687744:group [Population Group]
   760   C1257890:Group [Population Group]
   760   C1552516:Group [Health Care Related Organization]
   760   C1705428:Group [Conceptual Entity]
   760   C1705429:Group [Population Group]

Phrase: "but"

Phrase: "not in the CG"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   806   C0009932:Control Group [Group]
   760   C0243148:control [Qualitative Concept]
   760   C0441833:Group [Idea or Concept]
   760   C0687744:group [Population Group]
   760   C1257890:Group [Population Group]
   760   C1518422:Not [Functional Concept]
   760   C1550141:Control [Substance]
   760   C1552516:Group [Health Care Related Organization]
   760   C1705428:Group [Conceptual Entity]
   760   C1705429:Group [Population Group]
   760   C1882979:Control [Conceptual Entity]
   760   C2587213:Control [Functional Concept]
   760   C3274648:Control [Qualitative Concept]

Phrase: "as"

Phrase: "reflected by a significant group x time interaction."
Meta Candidates (Total=15; Excluded=0; Pruned=0; Remaining=15)
   770   C0441857:Group X [Intellectual Product]
   767   C0441835:Group A [Classification]
   744   C0040223:Time [Temporal Concept]
   744   C0237881:significant [Quantitative Concept]
   744   C0441833:Group [Idea or Concept]
   744   C0558058:reflected [Mental Process]
   744   C0687744:group [Population Group]
   744   C0750502:Significant [Idea or Concept]
   744   C1257890:Group [Population Group]
   744   C1546944:Significant [Qualitative Concept]
   744   C1552516:Group [Health Care Related Organization]
   744   C1704675:Interaction [Functional Concept]
   744   C1705428:Group [Conceptual Entity]
   744   C1705429:Group [Population Group]
   744   C3541383:Time [Temporal Concept]
Processing 00000000.tx.189: Although the rise in [ANG II] in the CG group in response to exercise is consistent with the literature on the response of the RAAS to dynamic exercise in the CG (6, 7, 11) values in the PG did not rise at either intensity. 

Phrase: "Although"

Phrase: "the rise in [ANG II"

Phrase: "]"

Phrase: "in the CG group"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C0009932:Control Group [Group]

Phrase: "in response to"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0871261:Response [Organism Attribute]
   861   C1704632:Response [Finding]
   861   C1706817:Response [Intellectual Product]
   861   C2911692:Response [Mental Process]

Phrase: "exercise"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0015259:Exercise [Daily or Recreational Activity]
  1000   C1522704:Exercise [Therapeutic or Preventive Procedure]

Phrase: "is"

Phrase: "consistent with the literature"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "on the response"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0871261:Response [Organism Attribute]
  1000   C1704632:Response [Finding]
  1000   C1706817:Response [Intellectual Product]
  1000   C2911692:Response [Mental Process]

Phrase: "of the RAAS"

Phrase: "to dynamic exercise"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0015259:Exercise [Daily or Recreational Activity]
   861   C1522704:Exercise [Therapeutic or Preventive Procedure]

Phrase: "in the CG"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
  1000   C0009932:Control Group [Group]
   861   C0243148:control [Qualitative Concept]
   861   C0441833:Group [Idea or Concept]
   861   C0687744:group [Population Group]
   861   C1257890:Group [Population Group]
   861   C1550141:Control [Substance]
   861   C1552516:Group [Health Care Related Organization]
   861   C1705428:Group [Conceptual Entity]
   861   C1705429:Group [Population Group]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]

Phrase: "(6,"

Phrase: "7,"

Phrase: "11"

Phrase: ")"

Phrase: "values in the PG"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0042295:Values [Qualitative Concept]
   726 E C1522609:Value [Quantitative Concept]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "rise at either intensity."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0522510:Intensity [Qualitative Concept]
Processing 00000000.tx.190: This may indicate that blood flow to the kidney was not reduced in pregnancy during the exercise, and thus renin production was not stimulated. 

Phrase: "This"

Phrase: "may"

Phrase: "indicate"

Phrase: "that blood flow to the kidney"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   793   C0035070:renal blood flow [Organ or Tissue Function]
   793   C1527409:Renal blood flow [Organ or Tissue Function]
   790   C0232338:Blood flow [Organism Function]
   753   C0005767:Blood [Tissue]
   753   C0005768:blood [Body Substance]
   753   C0229664:Blood [Body Substance]
   753   C0806140:Flow [Natural Phenomenon or Process]

Phrase: "was"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "reduced in pregnancy"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   790   C0032961:Pregnancy [Organism Function]
   790   C0392756:Reduced [Qualitative Concept]
   790   C3484365:Pregnancy [Clinical Attribute]
   718 E C0549206:Pregnant [Finding]
   718 E C0553641:Pregnant [Functional Concept]
   718 E C0600457:PREGNANT [Finding]
   706 E C0552112:Pregnancies [Clinical Attribute]

Phrase: "during the exercise,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0015259:Exercise [Daily or Recreational Activity]
  1000   C1522704:Exercise [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "thus renin production"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0033268:production [Occupational Activity]

Phrase: "was"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "stimulated."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1948023:Stimulated [Natural Phenomenon or Process]
Processing 00000000.tx.191: If renin concentration did not change, then ANG I levels and subsequently [ANG II] would not rise. 

Phrase: "If"

Phrase: "renin concentration"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0086045:Concentration [Mental Process]
   861   C1446561:Concentration [Quantitative Concept]
   789 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "change"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0392747:Change [Functional Concept]
  1000   C0443172:change [Quantitative Concept]
  1000   C1705241:Change [Quantitative Concept]

Phrase: ","

Phrase: "then ANG I levels"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0441925:i levels [Intellectual Product]
   812   C0441889:Levels [Qualitative Concept]
   779 E C0456079:Level [Classification]
   779 E C1547707:Level [Geographic Area]
   779 E C2946261:Level [Pharmacologic Substance]

Phrase: "and"

Phrase: "subsequently"

Phrase: "[ANG II"

Phrase: "]"

Phrase: "would"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "rise."
Processing 00000000.tx.192: The large increase in blood volume during pregnancy (18, 23) may have resulted in improved renal perfusion during exercise. 

Phrase: "The large increase in blood volume"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0442805:Increase [Functional Concept]

Phrase: "during pregnancy"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
  1000   C0032961:Pregnancy [Organism Function]
  1000   C3484365:Pregnancy [Clinical Attribute]
   928 E C0549206:Pregnant [Finding]
   928 E C0553641:Pregnant [Functional Concept]
   928 E C0600457:PREGNANT [Finding]
   916 E C0552112:Pregnancies [Clinical Attribute]

Phrase: "(18,"

Phrase: "23"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: ")"

Phrase: "may"

Phrase: "have"

Phrase: "resulted in improved renal perfusion"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   806   C0194133:Renal perfusion [Therapeutic or Preventive Procedure]
   760   C0022646:Renal [Body Part, Organ, or Organ Component]
   760   C0031001:Perfusion [Therapeutic or Preventive Procedure]
   760   C0184511:Improved [Qualitative Concept]
   760   C0332272:Improved [Qualitative Concept]
   760   C1561611:Improved [Intellectual Product]
   726   C1274040:Result [Functional Concept]
   726   C1546471:Result [Idea or Concept]
   726   C2825142:Result [Finding]

Phrase: "during exercise."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0015259:Exercise [Daily or Recreational Activity]
  1000   C1522704:Exercise [Therapeutic or Preventive Procedure]
Processing 00000000.tx.193: Grant et al. 

Phrase: "Grant et al."
Processing 00000000.tx.194: (13) and Roy et al. 

Phrase: "(13"

Phrase: ")"

Phrase: "and"

Phrase: "Roy et al."
Processing 00000000.tx.195: (24) also hypothesized that the blunted plasma [Aldo] response to exercise observed in men after acute plasma volume expansion was related to improved renal blood flow during exercise. 

Phrase: "(24"

Phrase: ")"

Phrase: "also"

Phrase: "hypothesized"

Phrase: "that"

Phrase: "the blunted plasma [Aldo"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0002006:Aldosterone [Hormone,Pharmacologic Substance,Steroid]
   827   C0032105:Plasma [Body Substance]
   827   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]

Phrase: "] response to"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0871261:Response [Organism Attribute]
   861   C1704632:Response [Finding]
   861   C1706817:Response [Intellectual Product]
   861   C2911692:Response [Mental Process]

Phrase: "exercise"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0015259:Exercise [Daily or Recreational Activity]
  1000   C1522704:Exercise [Therapeutic or Preventive Procedure]

Phrase: "observed in men"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0025266:Men [Population Group]
   790   C1441672:Observed [Functional Concept]
   756 E C0024554:MAN [Finding]
   756 E C0086418:Man [Human]

Phrase: "after acute plasma volume expansion"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   861   C0032127:Plasma Volume [Clinical Attribute]
   812   C0032105:Plasma [Body Substance]
   812   C0449468:*Volume [Quantitative Concept]
   812   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   812   C1690016:% volume [Qualitative Concept]
   812   C1705102:Volume [Intellectual Product]
   812   C2700258:Volume [Laboratory Procedure]

Phrase: "was"

Phrase: "related to improved renal blood flow"
Meta Candidates (Total=14; Excluded=1; Pruned=0; Remaining=13)
   833   C0035070:renal blood flow [Organ or Tissue Function]
   833   C1527409:Renal blood flow [Organ or Tissue Function]
   790   C0232338:Blood flow [Organism Function]
   753   C0005767:Blood [Tissue]
   753   C0005768:blood [Body Substance]
   753   C0022646:Renal [Body Part, Organ, or Organ Component]
   753   C0184511:Improved [Qualitative Concept]
   753   C0229664:Blood [Body Substance]
   753   C0332272:Improved [Qualitative Concept]
   753   C0439849:Related [Qualitative Concept]
   753   C0445223:Related [Finding]
   753   C0806140:Flow [Natural Phenomenon or Process]
   753   C1561611:Improved [Intellectual Product]
   719 E C0163712:Relate [Organic Chemical]

Phrase: "during exercise."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0015259:Exercise [Daily or Recreational Activity]
  1000   C1522704:Exercise [Therapeutic or Preventive Procedure]
Processing 00000000.tx.196: Attenuation of the RAAS response to exercise in pregnancy was similar qualitatively to that reported by Grant et al. 

Phrase: "Attenuation of the RAAS response to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0599946:Attenuation [Activity]

Phrase: "exercise in pregnancy"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   790   C0015259:Exercise [Daily or Recreational Activity]
   790   C0032961:Pregnancy [Organism Function]
   790   C1522704:Exercise [Therapeutic or Preventive Procedure]
   790   C3484365:Pregnancy [Clinical Attribute]
   718 E C0549206:Pregnant [Finding]
   718 E C0553641:Pregnant [Functional Concept]
   718 E C0600457:PREGNANT [Finding]
   706 E C0552112:Pregnancies [Clinical Attribute]

Phrase: "was"

Phrase: "similar qualitatively to that"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C2348205:Similar [Qualitative Concept]

Phrase: "reported by Grant et al."
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   806   C1709908:Reported By [Group]
   760   C0018173:Grant [Quantitative Concept]
   760   C0684224:Reported [Intellectual Product]
   760   C0700287:Reported [Health Care Activity]
   760   C1548284:Grant [Idea or Concept]
   760   C3496591:Reported [Clinical Attribute]
   726 E C3273238:Report [Intellectual Product]
Processing 00000000.tx.197: (13) and Roy et al. 

Phrase: "(13"

Phrase: ")"

Phrase: "and"

Phrase: "Roy et al."
Processing 00000000.tx.198: (24) in response to acute plasma volume expansion in men. 

Phrase: "(24"

Phrase: ")"

Phrase: "in response"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0871261:Response [Organism Attribute]
  1000   C1704632:Response [Finding]
  1000   C1706817:Response [Intellectual Product]
  1000   C2911692:Response [Mental Process]

Phrase: "to acute plasma volume expansion"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   861   C0032127:Plasma Volume [Clinical Attribute]
   812   C0032105:Plasma [Body Substance]
   812   C0449468:*Volume [Quantitative Concept]
   812   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   812   C1690016:% volume [Qualitative Concept]
   812   C1705102:Volume [Intellectual Product]
   812   C2700258:Volume [Laboratory Procedure]

Phrase: "in men."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0025266:Men [Population Group]
   966 E C0024554:MAN [Finding]
   966 E C0086418:Man [Human]
Processing 00000000.tx.199: The size of this effect appears to be related to the extent of hypervolemia. 

Phrase: "The size of this effect"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   797   C0814843:effect size [Quantitative Concept]
   760   C0456389:size [Spatial Concept]

Phrase: "appears"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "related to the extent of hypervolemia."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   753   C0439792:Extent [Spatial Concept]
   753   C0439849:Related [Qualitative Concept]
   753   C0445223:Related [Finding]
   753   C0546817:Hypervolaemia [Disease or Syndrome]
   719 E C0163712:Relate [Organic Chemical]
Processing 00000000.tx.200: Since plasma volume is usually increased by 4555% in pregnancy (18, 23) our results may be viewed as an extension of the investigations of Grant et al. 

Phrase: "Since"

Phrase: "plasma volume"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0032127:Plasma Volume [Clinical Attribute]
   861   C0032105:Plasma [Body Substance]
   861   C0449468:*Volume [Quantitative Concept]
   861   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   861   C1690016:% volume [Qualitative Concept]
   861   C1705102:Volume [Intellectual Product]
   861   C2700258:Volume [Laboratory Procedure]

Phrase: "is"

Phrase: "usually"

Phrase: "increased by 4555%"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0205217:Increased [Quantitative Concept]
   790   C0442805:Increased [Functional Concept]
   718 E C1517378:Gain [Quantitative Concept]

Phrase: "in pregnancy"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
  1000   C0032961:Pregnancy [Organism Function]
  1000   C3484365:Pregnancy [Clinical Attribute]
   928 E C0549206:Pregnant [Finding]
   928 E C0553641:Pregnant [Functional Concept]
   928 E C0600457:PREGNANT [Finding]
   916 E C0552112:Pregnancies [Clinical Attribute]

Phrase: "(18,"

Phrase: "23"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: ")"

Phrase: "our results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "may"

Phrase: "be"

Phrase: "viewed as an extension of the investigations of Grant et al."
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   738   C0018173:Grant [Quantitative Concept]
   738   C0231448:Extension [Functional Concept]
   738   C1261322:Investigations [Health Care Activity]
   738   C1548284:Grant [Idea or Concept]
   738   C1880641:Extension [Conceptual Entity]
   704   C0449911:View [Spatial Concept]
   704 E C1552578:investigation [Idea or Concept]
Processing 00000000.tx.201: (13) and Roy et al. 

Phrase: "(13"

Phrase: ")"

Phrase: "and"

Phrase: "Roy et al."
Processing 00000000.tx.202: (24). 

Phrase: "(24"

Phrase: ")."
Processing 00000000.tx.203: Grant et al. used plasma volume expansion of 14 and 21% in a study of responses of untrained men to prolonged exercise (120 min at 46% of maximal aerobic power). 

Phrase: "Grant et al. used plasma volume expansion of 14"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   781   C0365304:Volume of Plasma [Clinical Attribute]
   764   C0032127:Plasma Volume [Clinical Attribute]
   742   C0032105:Plasma [Body Substance]
   742   C0449468:*Volume [Quantitative Concept]
   742   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   742   C1690016:% volume [Qualitative Concept]
   742   C1705102:Volume [Intellectual Product]
   742   C2700258:Volume [Laboratory Procedure]

Phrase: "and"

Phrase: "21% in a study of responses of untrained men"
Meta Candidates (Total=9; Excluded=5; Pruned=0; Remaining=4)
   742   C0025266:Men [Population Group]
   742   C0557651:Study [Manufactured Object]
   742   C0871261:responses [Organism Attribute]
   742   C2603343:Study [Research Activity]
   708 E C0024554:MAN [Finding]
   708 E C0086418:Man [Human]
   708 E C1704632:Response [Finding]
   708 E C1706817:Response [Intellectual Product]
   708 E C2911692:Response [Mental Process]

Phrase: "to prolonged exercise"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0015259:Exercise [Daily or Recreational Activity]
   861   C1522704:Exercise [Therapeutic or Preventive Procedure]

Phrase: "(120 min at 46% of maximal aerobic power"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0702093:/min [Temporal Concept]

Phrase: ")."
Processing 00000000.tx.204: The subsequent study by Roy et al. examined the effects of a 16% plasma volume expansion on responses of similar subjects to 90 min of exercise at 62% of maximal aerobic power. 

Phrase: "The subsequent study by Roy et al."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0557651:Study [Manufactured Object]
   748   C2603343:Study [Research Activity]

Phrase: "examined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]

Phrase: "the effects of a 16% plasma volume expansion"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   744   C1280500:effects [Qualitative Concept]
   711 E C2348382:Effect [Qualitative Concept]

Phrase: "on responses"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0871261:responses [Organism Attribute]
   966 E C1704632:Response [Finding]
   966 E C1706817:Response [Intellectual Product]
   966 E C2911692:Response [Mental Process]

Phrase: "of similar subjects"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0681850:Subject [Group]
   827   C1550501:{Subject} [Idea or Concept]
   827   C1706203:Subject [Idea or Concept]
   827   C2349001:Subject [Human]
   827   C2697811:Subject [Functional Concept]

Phrase: "to 90 min"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0702093:/min [Temporal Concept]

Phrase: "of exercise"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0015259:Exercise [Daily or Recreational Activity]
  1000   C1522704:Exercise [Therapeutic or Preventive Procedure]

Phrase: "at 62%"

Phrase: "of maximal aerobic power."
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   827   C0032863:Power [Human-caused Phenomenon or Process]
   827   C0205289:Maximal [Qualitative Concept]
   827   C0806909:Maximal [Quantitative Concept]
   827   C1510824:Aerobic [Qualitative Concept]
   755 E C1552615:maximum [Quantitative Concept]
   755 E C2826546:MAXIMUM [Quantitative Concept]
Processing 00000000.tx.205: Thus the results from the study of the larger plasma volume expansion in the pregnant state continued the trend for a decreasing RAAS response with increasing plasma volume expansion, established by Grant et al. and Roy et al., by using smaller percentage increases in plasma volume. 

Phrase: "Thus"

Phrase: "the results from the study of the larger plasma volume expansion"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   754   C0683954:results study [Finding]
   704   C1274040:Result [Functional Concept]
   704   C1546471:Result [Idea or Concept]
   704   C2825142:Result [Finding]

Phrase: "in the pregnant state"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0868560:Pregnant state [Finding]
   861   C1301808:State [Geographic Area]
   861   C1442792:State [Functional Concept]
   861   C3148680:State [Geographic Area]

Phrase: "continued"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0549178:Continued [Idea or Concept]

Phrase: "the trend for a decreasing RAAS response"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1521798:trend [Temporal Concept]

Phrase: "with increasing plasma volume expansion,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   861   C0032127:Plasma Volume [Clinical Attribute]
   812   C0032105:Plasma [Body Substance]
   812   C0449468:*Volume [Quantitative Concept]
   812   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   812   C1690016:% volume [Qualitative Concept]
   812   C1705102:Volume [Intellectual Product]
   812   C2700258:Volume [Laboratory Procedure]

Phrase: "established by Grant et al."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0018173:Grant [Quantitative Concept]
   760   C0443211:Established [Qualitative Concept]
   760   C1272684:Established [Qualitative Concept]
   760   C1548284:Grant [Idea or Concept]

Phrase: "and"

Phrase: "Roy et al.,"

Phrase: "by"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "smaller percentage"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0439165:Percentage [Quantitative Concept]
   861   C1549488:Percentage [Idea or Concept]
   861   C1561533:Percentage [Idea or Concept]

Phrase: "increases in plasma volume."
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   840   C0232097:Increased plasma volume [Finding]
   833   C0032127:Plasma Volume [Clinical Attribute]
   770   C0032105:Plasma [Body Substance]
   770   C0442805:Increase [Functional Concept]
   770   C0449468:*Volume [Quantitative Concept]
   770   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   770   C1690016:% volume [Qualitative Concept]
   770   C1705102:Volume [Intellectual Product]
   770   C2700258:Volume [Laboratory Procedure]
   715 E C1517378:Gain [Quantitative Concept]
Processing 00000000.tx.206: A reduced sympathetic drive (i.e., lower epinephrine and norepinephrine levels) was also observed by Grant et al. 

Phrase: "A reduced sympathetic drive"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0013126:Drive [Mental Process]

Phrase: "(i.e.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0683454:I-E [Diagnostic Procedure,Intellectual Product]
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "lower"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0441994:Lower [Spatial Concept]
  1000   C1548802:Lower [Body Location or Region]
  1000   C2003888:Lower [Activity]

Phrase: "epinephrine"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0014563:Epinephrine [Hormone,Neuroreactive Substance or Biogenic Amine,Organic Chemical,Pharmacologic Substance]
   944 E C1963284:Adrenalin [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine,Pharmacologic Substance]

Phrase: "and"

Phrase: "norepinephrine levels"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0441889:Levels [Qualitative Concept]
   827 E C0456079:Level [Classification]
   827 E C1547707:Level [Geographic Area]
   827 E C2946261:Level [Pharmacologic Substance]

Phrase: ")"

Phrase: "was"

Phrase: "also"

Phrase: "observed by Grant et al."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0018173:Grant [Quantitative Concept]
   760   C1441672:Observed [Functional Concept]
   760   C1548284:Grant [Idea or Concept]
Processing 00000000.tx.207: (13) and Roy et al. 

Phrase: "(13"

Phrase: ")"

Phrase: "and"

Phrase: "Roy et al."
Processing 00000000.tx.208: (24) and was hypothesized to be a potential contributor to the observed lower [Aldo] (13). 

Phrase: "(24"

Phrase: ")"

Phrase: "and"

Phrase: "was"

Phrase: "hypothesized"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "a potential contributor to the observed lower"

Phrase: "[Aldo"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0002006:Aldosterone [Hormone,Pharmacologic Substance,Steroid]

Phrase: "]"

Phrase: "(13"

Phrase: ")."
Processing 00000000.tx.209: Sympathetic activity reduces renal blood flow and causes the juxtaglomerular cells of the kidney to increase their renin secretion. 

Phrase: "Sympathetic activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]

Phrase: "reduces"

Phrase: "renal blood flow"
Meta Candidates (Total=15; Excluded=7; Pruned=0; Remaining=8)
  1000   C0035070:renal blood flow [Organ or Tissue Function]
  1000   C1527409:Renal blood flow [Organ or Tissue Function]
   901   C0232338:Blood flow [Organism Function]
   827   C0005767:Blood [Tissue]
   827   C0005768:blood [Body Substance]
   827   C0022646:Renal [Body Part, Organ, or Organ Component]
   827   C0229664:Blood [Body Substance]
   827   C0806140:Flow [Natural Phenomenon or Process]
   755 E C0333275:Bloody [Qualitative Concept]
   743 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   743 E C0392895:Bloods [Population Group]
   743 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   743 E C1511228:VESSEL, BLOOD [Tissue]
   727 E C1558950:VASCULAR [Finding]
   727 E C1801960:Vascular [Qualitative Concept]

Phrase: "and"

Phrase: "causes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0015127:cause [Functional Concept]
  1000   C1314792:Causes [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "the juxtaglomerular cells of the kidney to"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   774   C0553257:cells kidney [Cell]
   757   C0007634:THE CELL [Cell]
           Cells
   748   C3282337:Cells [Cell]
   745   C0227650:Juxtaglomerular cell [Cell]
   714 E C1269647:Cell [Cell]
   714 E C1704653:Cell [Medical Device]
   714 E C1948049:Cell [Spatial Concept]

Phrase: "increase"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "their renin secretion."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0522116:Renin secretion [Clinical Attribute]
   861   C0036536:secretion [Biologic Function]
   861   C0036537:Secretion [Body Substance]
Processing 00000000.tx.210: This in turn results in elevated circulating [ANG II] and [Aldo]. 

Phrase: "This in turn"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0541749:turn [Finding]
   861   C1709743:Turn [Spatial Concept]

Phrase: "results in elevated circulating"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0175630:Circulating [Functional Concept]
   770   C0205250:Elevated [Qualitative Concept]
   770   C1274040:Result [Functional Concept]
   770   C1546471:Result [Idea or Concept]
   770   C2825142:Result [Finding]
   770   C3163633:Elevated [Qualitative Concept]

Phrase: "[ANG II"

Phrase: "]"

Phrase: "and ["

Phrase: "Aldo"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0002006:Aldosterone [Hormone,Pharmacologic Substance,Steroid]

Phrase: "]."
Processing 00000000.tx.211: In our laboratory, a reduction in sympathetic activity has also been observed during exercise in similar pregnant subjects in late gestation at work rates corresponding to 60 and 110% VT as indicated by lower epinephrine levels at 60% VT and lower epinephrine and norepinephrine levels at 110% VT (1). 

Phrase: "In our laboratory,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0022877:Laboratory [Manufactured Object,Organization]
  1000   C3244292:laboratory [Functional Concept]

Phrase: "a reduction in sympathetic activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   797   C2267000:Reduction Activity [Molecular Function]
   760   C0301630:Reduction [Natural Phenomenon or Process]
   760   C0392756:Reduction [Qualitative Concept]
   760   C0441610:Reduction [Therapeutic or Preventive Procedure]

Phrase: "has"

Phrase: "also"

Phrase: "been"

Phrase: "observed during exercise"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0015259:Exercise [Daily or Recreational Activity]
   790   C1441672:Observed [Functional Concept]
   790   C1522704:Exercise [Therapeutic or Preventive Procedure]

Phrase: "in similar pregnant subjects"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   793   C0681850:Subject [Group]
   793   C1550501:{Subject} [Idea or Concept]
   793   C1706203:Subject [Idea or Concept]
   793   C2349001:Subject [Human]
   793   C2697811:Subject [Functional Concept]

Phrase: "in late gestation"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0032961:Gestation [Organism Function]
   789 E C0439671:Gestational [Temporal Concept]

Phrase: "at work rates"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0043227:Work [Occupational Activity]
   827   C0871208:Rate [Activity]
   827   C1521828:Rate [Quantitative Concept]

Phrase: "corresponding to 60"

Phrase: "and"

Phrase: "110% VT"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0449864:Threshold [Qualitative Concept]

Phrase: "as"

Phrase: "indicated by lower epinephrine levels"
Meta Candidates (Total=11; Excluded=4; Pruned=0; Remaining=7)
   790   C0201998:Epinephrine level [Laboratory Procedure]
   760   C0014563:Epinephrine [Hormone,Neuroreactive Substance or Biogenic Amine,Organic Chemical,Pharmacologic Substance]
   760   C0441889:Levels [Qualitative Concept]
   760   C0441994:Lower [Spatial Concept]
   760   C1444656:Indicated [Finding]
   760   C1548802:Lower [Body Location or Region]
   760   C2003888:Lower [Activity]
   726 E C0456079:Level [Classification]
   726 E C1547707:Level [Geographic Area]
   726 E C2946261:Level [Pharmacologic Substance]
   704 E C1963284:Adrenalin [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine,Pharmacologic Substance]

Phrase: "at 60% VT"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0449864:Threshold [Qualitative Concept]

Phrase: "and"

Phrase: "lower epinephrine"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0014563:Epinephrine [Hormone,Neuroreactive Substance or Biogenic Amine,Organic Chemical,Pharmacologic Substance]
   805 E C1963284:Adrenalin [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine,Pharmacologic Substance]

Phrase: "and"

Phrase: "norepinephrine levels at 110% VT"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   753   C0441889:Levels [Qualitative Concept]
   719 E C0456079:Level [Classification]
   719 E C1547707:Level [Geographic Area]
   719 E C2946261:Level [Pharmacologic Substance]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")."
Processing 00000000.tx.212: Thus the reduced [ANG II] during exercise in the PG may also be the consequence of a reduction in sympathetic drive. 

Phrase: "Thus"

Phrase: "the reduced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392756:Reduced [Qualitative Concept]

Phrase: "[ANG II"

Phrase: "]"

Phrase: "during exercise"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0015259:Exercise [Daily or Recreational Activity]
  1000   C1522704:Exercise [Therapeutic or Preventive Procedure]

Phrase: "in the PG"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0441833:Group [Idea or Concept]
   861   C0687744:group [Population Group]
   861   C1257890:Group [Population Group]
   861   C1552516:Group [Health Care Related Organization]
   861   C1705428:Group [Conceptual Entity]
   861   C1705429:Group [Population Group]

Phrase: "may"

Phrase: "also"

Phrase: "be"

Phrase: "the consequence of a reduction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   806   C0686907:Consequence of [Functional Concept]
           Consequence

Phrase: "in sympathetic drive."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0013126:Drive [Mental Process]
Processing 00000000.tx.213: Regardless of the cause, the lack of rise in [ANG II] means that Aldo secretion will not be stimulated to increase Na+ retention during exercise in pregnancy. 

Phrase: "Regardless of the cause,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0015127:cause [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "the lack of rise in [ANG II"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0332268:lack [Qualitative Concept]

Phrase: "] means"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1704970:Means [Conceptual Entity]
   966 E C0444504:Mean [Quantitative Concept]
   966 E C2347634:Mean [Quantitative Concept]
   966 E C2348143:Mean [Quantitative Concept]

Phrase: "that Aldo secretion"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C3271396:aldosterone secretion [Organ or Tissue Function]
   861   C0036536:secretion [Biologic Function]
   861   C0036537:Secretion [Body Substance]

Phrase: "will"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "be"

Phrase: "stimulated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1948023:Stimulated [Natural Phenomenon or Process]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "increase"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "Na+ retention during exercise"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0035280:Retention [Mental Process]
   770   C0333117:Retention [Functional Concept]
   770   C1753315:retention [Cell Function]

Phrase: "in pregnancy."
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
  1000   C0032961:Pregnancy [Organism Function]
  1000   C3484365:Pregnancy [Clinical Attribute]
   928 E C0549206:Pregnant [Finding]
   928 E C0553641:Pregnant [Functional Concept]
   928 E C0600457:PREGNANT [Finding]
   916 E C0552112:Pregnancies [Clinical Attribute]
Processing 00000000.tx.214: The AVP response to exercise in the PG differed from that of the CG. 

Phrase: "The AVP response to"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0871261:Response [Organism Attribute]
   827   C1704632:Response [Finding]
   827   C1706817:Response [Intellectual Product]
   827   C2911692:Response [Mental Process]

Phrase: "exercise in the PG"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   797   C1276393:Group exercise [Therapeutic or Preventive Procedure]
   760   C0015259:Exercise [Daily or Recreational Activity]
   760   C0441833:Group [Idea or Concept]
   760   C0549206:Pregnant [Finding]
   760   C0553641:Pregnant [Functional Concept]
   760   C0600457:PREGNANT [Finding]
   760   C0687744:group [Population Group]
   760   C1257890:Group [Population Group]
   760   C1522704:Exercise [Therapeutic or Preventive Procedure]
   760   C1552516:Group [Health Care Related Organization]
   760   C1705428:Group [Conceptual Entity]
   760   C1705429:Group [Population Group]

Phrase: "differed from that of the CG."
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   778   C0009932:Control Group [Group]
   748   C0243148:control [Qualitative Concept]
   748   C0441833:Group [Idea or Concept]
   748   C0687744:group [Population Group]
   748   C1257890:Group [Population Group]
   748   C1550141:Control [Substance]
   748   C1552516:Group [Health Care Related Organization]
   748   C1705428:Group [Conceptual Entity]
   748   C1705429:Group [Population Group]
   748   C1882979:Control [Conceptual Entity]
   748   C2587213:Control [Functional Concept]
   748   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.215: Again, the CG responded as expected, increasing significantly in response to strenuous exercise, but not in response to the less intense exercise (7, 11). 

Phrase: "Again,"

Phrase: "the CG"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
  1000   C0009932:Control Group [Group]
   861   C0243148:control [Qualitative Concept]
   861   C0441833:Group [Idea or Concept]
   861   C0687744:group [Population Group]
   861   C1257890:Group [Population Group]
   861   C1550141:Control [Substance]
   861   C1552516:Group [Health Care Related Organization]
   861   C1705428:Group [Conceptual Entity]
   861   C1705429:Group [Population Group]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]

Phrase: "responded"

Phrase: "as"

Phrase: "expected"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1517001:Expected [Idea or Concept]

Phrase: ","

Phrase: "increasing"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442808:Increasing [Functional Concept]
   966 E C0442805:Increase [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0205217:Increased [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "significantly in response"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0871261:Response [Organism Attribute]
   790   C1704632:Response [Finding]
   790   C1706817:Response [Intellectual Product]
   790   C2911692:Response [Mental Process]

Phrase: "to strenuous exercise,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1514989:Strenuous Exercise [Daily or Recreational Activity]
   861   C0015259:Exercise [Daily or Recreational Activity]
   861   C1522704:Exercise [Therapeutic or Preventive Procedure]

Phrase: "but"

Phrase: "not in response"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0871261:Response [Organism Attribute]
   790   C1518422:Not [Functional Concept]
   790   C1704632:Response [Finding]
   790   C1706817:Response [Intellectual Product]
   790   C2911692:Response [Mental Process]

Phrase: "to the less intense exercise"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0015259:Exercise [Daily or Recreational Activity]
   827   C1522704:Exercise [Therapeutic or Preventive Procedure]

Phrase: "(7,"

Phrase: "11"

Phrase: ")."
Processing 00000000.tx.216: Values in the PG, however, did not increase in response to either work rate. 

Phrase: "Values in the PG,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0042295:Values [Qualitative Concept]
   726 E C1522609:Value [Quantitative Concept]

Phrase: "however,"

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "increase in response"
Meta Candidates (Total=12; Excluded=7; Pruned=0; Remaining=5)
   790   C0442805:Increase [Functional Concept]
   790   C0871261:Response [Organism Attribute]
   790   C1704632:Response [Finding]
   790   C1706817:Response [Intellectual Product]
   790   C2911692:Response [Mental Process]
   734 E C1517378:Gain [Quantitative Concept]
   706 E C0205217:Increased [Quantitative Concept]
   706 E C0439661:Acquired [Temporal Concept]
   706 E C0442808:Increasing [Functional Concept]
   706 E C1301820:Obtain [Functional Concept]
   706 E C1706701:Acquire [Activity]
   706 E C3245488:acquired [Intellectual Product]

Phrase: "to either work rate."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0043227:Work [Occupational Activity]
   827   C0871208:Rate [Activity]
   827   C1521828:Rate [Quantitative Concept]
Processing 00000000.tx.217: Both groups had similar increases in osmolality at the 110% VT work rate, and thus it would be expected that the stimulus for AVP release would be similar in both groups. 

Phrase: "Both groups"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0441833:Group [Idea or Concept]
  1000   C0687744:group [Population Group]
  1000   C1257890:Group [Population Group]
  1000   C1552516:Group [Health Care Related Organization]
  1000   C1552839:groups [Idea or Concept]
  1000   C1705428:Group [Conceptual Entity]
  1000   C1705429:Group [Population Group]

Phrase: "had"

Phrase: "similar increases in osmolality"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0442805:increases [Functional Concept]

Phrase: "at the 110% VT work rate,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0043227:Work [Occupational Activity]
   804   C0871208:Rate [Activity]
   804   C1521828:Rate [Quantitative Concept]

Phrase: "and"

Phrase: "thus"

Phrase: "it"

Phrase: "would"

Phrase: "be"

Phrase: "expected"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1517001:Expected [Idea or Concept]

Phrase: "that"

Phrase: "the stimulus for AVP release"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0234402:Stimulus [Phenomenon or Process]

Phrase: "would"

Phrase: "be"

Phrase: "similar in both groups."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C2348205:Similar [Qualitative Concept]
Processing 00000000.tx.218: However, because the [ANG II] response of the PG was blunted, there may have been a lesser stimulus for AVP release. 

Phrase: "However,"

Phrase: "because"

Phrase: "the [ANG II"

Phrase: "] response of the PG"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0871261:Response [Organism Attribute]
   760   C1704632:Response [Finding]
   760   C1706817:Response [Intellectual Product]
   760   C2911692:Response [Mental Process]

Phrase: "was"

Phrase: "blunted"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1997138:Blunted [Qualitative Concept]

Phrase: ","

Phrase: "there"

Phrase: "may"

Phrase: "have"

Phrase: "been"

Phrase: "a lesser stimulus for AVP release."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0234402:Stimulus [Phenomenon or Process]
Processing 00000000.tx.219: Roy et al. 

Phrase: "Roy et al."
Processing 00000000.tx.220: (24) observed a similar blunting of the AVP response to exercise after plasma volume expansion, especially during the first hour of their protocol. 

Phrase: "(24"

Phrase: ")"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "a similar blunting of the AVP response to"

Phrase: "exercise after plasma volume expansion,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   806   C0032127:Plasma Volume [Clinical Attribute]
   760   C0015259:Exercise [Daily or Recreational Activity]
   760   C0032105:Plasma [Body Substance]
   760   C0449468:*Volume [Quantitative Concept]
   760   C1522704:Exercise [Therapeutic or Preventive Procedure]
   760   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   760   C1690016:% volume [Qualitative Concept]
   760   C1705102:Volume [Intellectual Product]
   760   C2700258:Volume [Laboratory Procedure]

Phrase: "especially during the first hour of their protocol."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   744   C0205435:First [Quantitative Concept]
   744   C0439227:Hour [Temporal Concept]
   744   C0442711:Protocol [Intellectual Product]
   744   C0564385:/hour [Quantitative Concept]
   744   C1279901:First [Qualitative Concept]
   744   C1507394:Protocol [Intellectual Product]
   744   C1522729:Protocol [Intellectual Product]
   744   C2348563:Protocol [Intellectual Product]
Processing 00000000.tx.221: Whether other cardiovascular pressure receptors and reflexes are involved in the blunted ANG II and AVP responses to exercise is an open question. 

Phrase: "Whether"

Phrase: "other cardiovascular pressure receptors"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]
   734   C0232104:Cardiovascular pressure [Organism Attribute]

Phrase: "and"

Phrase: "reflexes"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0034929:reflexes [Organ or Tissue Function]
  1000   C0596002:Reflexes [Finding]
   966 E C0439840:reflex [Organ or Tissue Function]

Phrase: "are"

Phrase: "involved in the blunted ANG II"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1314939:Involved [Functional Concept]
   753   C1997138:Blunted [Qualitative Concept]

Phrase: "and"

Phrase: "AVP responses to"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   827   C0871261:responses [Organism Attribute]
   793 E C1704632:Response [Finding]
   793 E C1706817:Response [Intellectual Product]
   793 E C2911692:Response [Mental Process]

Phrase: "exercise"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0015259:Exercise [Daily or Recreational Activity]
  1000   C1522704:Exercise [Therapeutic or Preventive Procedure]

Phrase: "is"

Phrase: "an open question."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1522634:Question [Intellectual Product]
Processing 00000000.tx.222: Although blood pressure during exercise was not measured during the present study, an earlier study from this laboratory (1), which used a very similar cycling test protocol and many of the same subjects, observed no significant differences in systolic blood pressure immediately before exercise (sitting) or during short bouts of exercise (7 min) at 60 and 110% VT, respectively, in late pregnancy vs. the nonpregnant state. 

Phrase: "Although"

Phrase: "blood pressure during exercise"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   833   C0005823:Blood Pressure [Organism Function]
   833   C1271104:Blood Pressure [Finding]
   833   C1272641:Blood pressure [Finding]
   770   C0005767:Blood [Tissue]
   770   C0005768:blood [Body Substance]
   770   C0033095:Pressure [Phenomenon or Process]
   770   C0229664:Blood [Body Substance]
   770   C0460139:Pressure [Finding]
   770   C1306345:Pressure [Functional Concept]

Phrase: "was"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "measured during the present study,"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   760   C0150312:Present [Quantitative Concept]
   760   C0444706:Measured [Qualitative Concept]
   760   C0449450:Present [Idea or Concept]
   760   C0557651:Study [Manufactured Object]
   760   C2603343:Study [Research Activity]
   760   C3541902:MEASURED [Diagnostic Procedure]
   726 E C0079809:Measure [Quantitative Concept]
   726 E C0242485:Measure [Functional Concept]

Phrase: "an earlier study from this laboratory"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   783   C0681827:Laboratory Study [Laboratory Procedure]
   753   C0557651:Study [Manufactured Object]
   753   C2603343:Study [Research Activity]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")"

Phrase: ","

Phrase: "which"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a very similar cycling test protocol"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   840   C0449876:test protocol [Research Activity]
   804   C0442711:Protocol [Intellectual Product]
   804   C1507394:Protocol [Intellectual Product]
   804   C1522729:Protocol [Intellectual Product]
   804   C2348563:Protocol [Intellectual Product]

Phrase: "and"

Phrase: "many of the same subjects,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   760   C0439064:Many [Quantitative Concept]
   760   C0445247:Same [Qualitative Concept]
   760   C0747726:many [Conceptual Entity]
   726   C0681850:Subject [Group]
   726   C1550501:{Subject} [Idea or Concept]
   726   C1706203:Subject [Idea or Concept]
   726   C2349001:Subject [Human]
   726   C2697811:Subject [Functional Concept]

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "no significant differences in systolic blood pressure immediately"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   711   C1705241:*Difference [Quantitative Concept]
   711   C1705242:Difference [Qualitative Concept]

Phrase: "before"

Phrase: "exercise"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0015259:Exercise [Daily or Recreational Activity]
  1000   C1522704:Exercise [Therapeutic or Preventive Procedure]

Phrase: "(sitting"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0277814:Sitting [Finding]
  1000   C2584297:Sitting [Physiologic Function]

Phrase: ")"

Phrase: "or during short bouts of exercise"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0015259:Exercise [Daily or Recreational Activity]
   753   C0741605:bouts [Temporal Concept]
   753   C1282927:short [Qualitative Concept]
   753   C1522704:Exercise [Therapeutic or Preventive Procedure]
   753   C1806781:Short [Quantitative Concept]
   753   C2350002:Short [Quantitative Concept]

Phrase: "(7 min) at 60"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0702093:/min [Temporal Concept]

Phrase: "and"

Phrase: "110% VT,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0449864:Threshold [Qualitative Concept]

Phrase: "respectively,"

Phrase: "in late pregnancy"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
  1000   C0878751:Late pregnancy [Pathologic Function]
   861   C0032961:Pregnancy [Organism Function]
   861   C3484365:Pregnancy [Clinical Attribute]
   789 E C0549206:Pregnant [Finding]
   789 E C0553641:Pregnant [Functional Concept]
   789 E C0600457:PREGNANT [Finding]
   777 E C0552112:Pregnancies [Clinical Attribute]

Phrase: "vs."

Phrase: "the nonpregnant state."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1301808:State [Geographic Area]
   861   C1442792:State [Functional Concept]
   861   C3148680:State [Geographic Area]
Processing 00000000.tx.223: Thus there is no solid basis at this time to suggest that cardiovascular pressure or volume receptors are involved in these blunted hormone responses. 

Phrase: "Thus there"

Phrase: "is"

Phrase: "no solid basis at this time to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1527178:Basis [Functional Concept]
   748   C1874451:Basis [Pharmacologic Substance]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that cardiovascular pressure"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0232104:Cardiovascular pressure [Organism Attribute]
   861   C0007226:Cardiovascular [Body System]
   861   C0033095:Pressure [Phenomenon or Process]
   861   C0460139:Pressure [Finding]
   861   C1306345:Pressure [Functional Concept]

Phrase: "or"

Phrase: "volume receptors"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0449468:*Volume [Quantitative Concept]
   861   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]
   861   C1690016:% volume [Qualitative Concept]
   861   C1705102:Volume [Intellectual Product]
   861   C2700258:Volume [Laboratory Procedure]

Phrase: "are"

Phrase: "involved in these blunted hormone responses."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   753   C0019932:Hormone [Hormone]
   753   C0871261:responses [Organism Attribute]
   753   C1314939:Involved [Functional Concept]
   753   C1997138:Blunted [Qualitative Concept]
   719 E C1704632:Response [Finding]
   719 E C1706817:Response [Intellectual Product]
   719 E C2911692:Response [Mental Process]
Processing 00000000.tx.224: However, further study is needed to clarify this issue. 

Phrase: "However,"

Phrase: "further study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0557651:Study [Manufactured Object]
   861   C2603343:Study [Research Activity]

Phrase: "is"

Phrase: "needed"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027552:Needed [Qualitative Concept]
  1000   C0686904:needed [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "clarify"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2986669:Clarify [Activity]

Phrase: "this issue."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0033213:Issue [Finding]
  1000   C1706387:Issue [Intellectual Product]
Processing 00000000.tx.225: Despite minor statistical differences, [ANP] rose in both groups at both work rates, and responses were similar from a physiological viewpoint. 

Phrase: "Despite minor statistical differences,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   793   C1705241:*Difference [Quantitative Concept]
   793   C1705242:Difference [Qualitative Concept]
   743 E C0443199:Differential [Qualitative Concept]

Phrase: "[ANP"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
  1000   C0027481:Atrial natriuretic peptide [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   913   C0051989:atrial peptide [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   901   C1144709:natriuretic peptide [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   901   C2709270:Natriuretic peptide [Amino Acid, Peptide, or Protein,Hormone]
   901   C3537020:Natriuretic Peptide [Pharmacologic Substance]
   827   C0018792:Atrial [Body Part, Organ, or Organ Component]
   827   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   827   C0597421:natriuretic [Pharmacologic Substance]
   755 E C0524422:atria [Body Part, Organ, or Organ Component]
   755 E C1280619:Atrium [Body Part, Organ, or Organ Component]

Phrase: "]"

Phrase: "rose in both"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0035853:Rose [Plant]
   790   C0995005:ROSE [Pharmacologic Substance]

Phrase: "groups at both work rates,"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   760   C0043227:Work [Occupational Activity]
   760   C0441833:Group [Idea or Concept]
   760   C0687744:group [Population Group]
   760   C1257890:Group [Population Group]
   760   C1552516:Group [Health Care Related Organization]
   760   C1552839:groups [Idea or Concept]
   760   C1705428:Group [Conceptual Entity]
   760   C1705429:Group [Population Group]
   726   C0871208:Rate [Activity]
   726   C1521828:Rate [Quantitative Concept]

Phrase: "and"

Phrase: "responses"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0871261:responses [Organism Attribute]
   966 E C1704632:Response [Finding]
   966 E C1706817:Response [Intellectual Product]
   966 E C2911692:Response [Mental Process]

Phrase: "were"

Phrase: "similar from a physiological viewpoint."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C2348205:Similar [Qualitative Concept]
Processing 00000000.tx.226: The increase in ANP in response to exercise in both groups in the present study was expected at both the 70 and 110% VT work rates because relative intensity exceeded the usual threshold to evoke an ANP response. 

Phrase: "The increase in ANP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0442805:Increase [Functional Concept]

Phrase: "in response to"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0871261:Response [Organism Attribute]
   861   C1704632:Response [Finding]
   861   C1706817:Response [Intellectual Product]
   861   C2911692:Response [Mental Process]

Phrase: "exercise in both"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0015259:Exercise [Daily or Recreational Activity]
   790   C1522704:Exercise [Therapeutic or Preventive Procedure]

Phrase: "groups in the present study"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   760   C0150312:Present [Quantitative Concept]
   760   C0441833:Group [Idea or Concept]
   760   C0449450:Present [Idea or Concept]
   760   C0557651:Study [Manufactured Object]
   760   C0687744:group [Population Group]
   760   C1257890:Group [Population Group]
   760   C1552516:Group [Health Care Related Organization]
   760   C1552839:groups [Idea or Concept]
   760   C1705428:Group [Conceptual Entity]
   760   C1705429:Group [Population Group]
   760   C2603343:Study [Research Activity]

Phrase: "was"

Phrase: "expected at both"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1517001:Expected [Idea or Concept]

Phrase: "the 70"

Phrase: "and"

Phrase: "110% VT work rates"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0043227:Work [Occupational Activity]
   771   C0871208:Rate [Activity]
   771   C1521828:Rate [Quantitative Concept]

Phrase: "because"

Phrase: "relative intensity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0522510:Intensity [Qualitative Concept]

Phrase: "exceeded"

Phrase: "the usual threshold to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0449864:Threshold [Qualitative Concept]

Phrase: "evoke"

Phrase: "an ANP response."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   812   C0871261:Response [Organism Attribute]
   812   C1704632:Response [Finding]
   812   C1706817:Response [Intellectual Product]
   812   C2911692:Response [Mental Process]
   756   C0027481:Atrial natriuretic peptide [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   708   C0051989:atrial peptide [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
Processing 00000000.tx.227: This is consistent with the earlier findings of Grant et al. 

Phrase: "This"

Phrase: "is"

Phrase: "consistent with the earlier findings of Grant et al."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   764   C0332290:Consistent with [Idea or Concept]
           Consistent
   709   C0332529:Consistency finding [Qualitative Concept]
Processing 00000000.tx.228: (13) and Roy et al. 

Phrase: "(13"

Phrase: ")"

Phrase: "and"

Phrase: "Roy et al."
Processing 00000000.tx.229: (24), who showed that the response in normal subjects to increase ANP in response to exercise was also present in subjects with acute plasma volume expansion. 

Phrase: "(24"

Phrase: ")"

Phrase: ","

Phrase: "who"

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that"

Phrase: "the response in normal subjects to"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0871261:Response [Organism Attribute]
   753   C1704632:Response [Finding]
   753   C1706817:Response [Intellectual Product]
   753   C2911692:Response [Mental Process]

Phrase: "increase"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "ANP in response to"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   833   C0027481:Atrial natriuretic peptide [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   820   C3547105:response to peptide [Cell Function]
   790   C1144709:natriuretic peptide [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   790   C2709270:Natriuretic peptide [Amino Acid, Peptide, or Protein,Hormone]
   790   C3537020:Natriuretic Peptide [Pharmacologic Substance]
   783   C0051989:atrial peptide [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   753   C0018792:Atrial [Body Part, Organ, or Organ Component]
   753   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   753   C0597421:natriuretic [Pharmacologic Substance]

Phrase: "exercise"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0015259:Exercise [Daily or Recreational Activity]
  1000   C1522704:Exercise [Therapeutic or Preventive Procedure]

Phrase: "was"

Phrase: "also"

Phrase: "present in subjects"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C0150312:Present [Quantitative Concept]
   790   C0449450:Present [Idea or Concept]
   756   C0681850:Subject [Group]
   756   C1550501:{Subject} [Idea or Concept]
   756   C1706203:Subject [Idea or Concept]
   756   C2349001:Subject [Human]
   756   C2697811:Subject [Functional Concept]

Phrase: "with acute plasma volume expansion."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   861   C0032127:Plasma Volume [Clinical Attribute]
   812   C0032105:Plasma [Body Substance]
   812   C0449468:*Volume [Quantitative Concept]
   812   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   812   C1690016:% volume [Qualitative Concept]
   812   C1705102:Volume [Intellectual Product]
   812   C2700258:Volume [Laboratory Procedure]
Processing 00000000.tx.230: The fact that, in the present study, ANP levels at rest and in response to exercise were generally similar in the pregnant vs. nonpregnant state may be that the augmented venous return observed at rest and during standard submaximal exercise in pregnancy is offset by atrial enlargement (33) so that the degree of atrial distention and stimulus for ANP release is not affected. 

Phrase: "The fact"

Phrase: "that,"

Phrase: "in the present study,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0150312:Present [Quantitative Concept]
   861   C0449450:Present [Idea or Concept]
   861   C0557651:Study [Manufactured Object]
   861   C2603343:Study [Research Activity]

Phrase: "ANP levels at rest"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   753   C0441889:Levels [Qualitative Concept]
   719 E C0456079:Level [Classification]
   719 E C1547707:Level [Geographic Area]
   719 E C2946261:Level [Pharmacologic Substance]

Phrase: "and in response to"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0871261:Response [Organism Attribute]
   770   C1515981:And [Idea or Concept]
   770   C1704632:Response [Finding]
   770   C1706817:Response [Intellectual Product]
   770   C2911692:Response [Mental Process]

Phrase: "exercise"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0015259:Exercise [Daily or Recreational Activity]
  1000   C1522704:Exercise [Therapeutic or Preventive Procedure]

Phrase: "were"

Phrase: "generally similar in the pregnant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C2348205:Similar [Qualitative Concept]

Phrase: "vs. nonpregnant state"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1301808:State [Geographic Area]
   861   C1442792:State [Functional Concept]
   861   C3148680:State [Geographic Area]

Phrase: "may"

Phrase: "be"

Phrase: "that"

Phrase: "the augmented venous return"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0042449:Venous [Body Part, Organ, or Organ Component]
   827   C0332156:Return [Qualitative Concept]
   827   C0348013:Venous [Spatial Concept]

Phrase: "observed at rest"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0035253:Rest [Daily or Recreational Activity]
   790   C1441672:Observed [Functional Concept]
   790   C1622890:ResT [Molecular Function]

Phrase: "and during standard submaximal exercise"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0015259:Exercise [Daily or Recreational Activity]
   760   C1442989:Standard [Qualitative Concept]
   760   C1515981:And [Idea or Concept]
   760   C1522704:Exercise [Therapeutic or Preventive Procedure]
   760   C2828392:Standard [Intellectual Product]

Phrase: "in pregnancy"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
  1000   C0032961:Pregnancy [Organism Function]
  1000   C3484365:Pregnancy [Clinical Attribute]
   928 E C0549206:Pregnant [Finding]
   928 E C0553641:Pregnant [Functional Concept]
   928 E C0600457:PREGNANT [Finding]
   916 E C0552112:Pregnancies [Clinical Attribute]

Phrase: "is"

Phrase: "offset by atrial enlargement"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   833   C0741276:ATRIAL ENLARGEMENT [Disease or Syndrome]
   833   C2348360:ATRIAL ENLARGEMENT [Finding]
   770   C0018792:Atrial [Body Part, Organ, or Organ Component]
   770   C0020564:Enlargement, NOS [Pathologic Function]
   770   C1293134:Enlargement [Therapeutic or Preventive Procedure]
   770   C1711330:Offset [Quantitative Concept]
   770   C2711450:Enlargement [Anatomical Abnormality]

Phrase: "(33"

Phrase: ")"

Phrase: "so"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0037640:SO [Geographic Area]

Phrase: "that"

Phrase: "the degree of atrial distention"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0441889:Degree [Qualitative Concept]
   760   C0449286:Degree [Quantitative Concept]
   760   C0542560:Degree [Intellectual Product]
   760   C1561545:degree [Quantitative Concept]
   760   C2348088:Degree [Quantitative Concept]

Phrase: "and"

Phrase: "stimulus for ANP release"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0234402:Stimulus [Phenomenon or Process]

Phrase: "is"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "affected."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0392760:Affected [Functional Concept]
  1000   C1314939:Affected [Functional Concept]
   966 E C0001721:Affect [Mental Process]
Processing 00000000.tx.231: Thus the acute plasma volume expansion in the Grant et al. and Roy et al. studies, which resulted in higher ANP values compared with controls at rest, with the higher levels also persisting into exercise, may have resulted because the acute plasma volume expansion (resulting in enhanced venous return) would not be offset by atrial enlargement. 

Phrase: "Thus"

Phrase: "the acute plasma volume expansion in the Grant et al."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0032127:Plasma Volume [Clinical Attribute]
   739   C0032105:Plasma [Body Substance]
   739   C0449468:*Volume [Quantitative Concept]
   739   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   739   C1690016:% volume [Qualitative Concept]
   739   C1705102:Volume [Intellectual Product]
   739   C2700258:Volume [Laboratory Procedure]

Phrase: "and"

Phrase: "Roy et al. studies,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   812   C0947630:studies [Laboratory Procedure]
   779 E C0557651:Study [Manufactured Object]
   779 E C2603343:Study [Research Activity]

Phrase: "which"

Phrase: "resulted in higher ANP values"
Meta Candidates (Total=16; Excluded=1; Pruned=0; Remaining=15)
   814   C0027481:Atrial natriuretic peptide [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   778   C1144709:natriuretic peptide [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   778   C2709270:Natriuretic peptide [Amino Acid, Peptide, or Protein,Hormone]
   778   C3537020:Natriuretic Peptide [Pharmacologic Substance]
   774   C0051989:atrial peptide [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   748   C0018792:Atrial [Body Part, Organ, or Organ Component]
   748   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   748   C0042295:Values [Qualitative Concept]
   748   C0597421:natriuretic [Pharmacologic Substance]
   714   C0205250:High [Qualitative Concept]
   714   C1274040:Result [Functional Concept]
   714   C1299351:High [Qualitative Concept]
   714 E C1522609:Value [Quantitative Concept]
   714   C1546471:Result [Idea or Concept]
   714   C2700149:HIGH [Intellectual Product]
   714   C2825142:Result [Finding]

Phrase: "compared with controls"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C1707455:Compared [Activity]
   756   C0243148:control [Qualitative Concept]
   756   C1550141:Control [Substance]
   756   C1882979:Control [Conceptual Entity]
   756   C2587213:Control [Functional Concept]
   756   C3274648:Control [Qualitative Concept]

Phrase: "at rest,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0035253:Rest [Daily or Recreational Activity]
  1000   C1622890:ResT [Molecular Function]

Phrase: "with the higher levels also"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   827   C0441889:Levels [Qualitative Concept]
   793 E C0456079:Level [Classification]
   793 E C1547707:Level [Geographic Area]
   793 E C2946261:Level [Pharmacologic Substance]

Phrase: "persisting into exercise,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0015259:Exercise [Daily or Recreational Activity]
   790   C1522704:Exercise [Therapeutic or Preventive Procedure]

Phrase: "may"

Phrase: "have"

Phrase: "resulted"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "because"

Phrase: "the acute plasma volume expansion"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   861   C0032127:Plasma Volume [Clinical Attribute]
   812   C0032105:Plasma [Body Substance]
   812   C0449468:*Volume [Quantitative Concept]
   812   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   812   C1690016:% volume [Qualitative Concept]
   812   C1705102:Volume [Intellectual Product]
   812   C2700258:Volume [Laboratory Procedure]

Phrase: "("

Phrase: "resulting in enhanced venous return"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   806   C0332294:Resulting in [Functional Concept]
   760   C0042449:Venous [Body Part, Organ, or Organ Component]
   760   C0332156:Return [Qualitative Concept]
   760   C0348013:Venous [Spatial Concept]
   760   C0678226:resulting [Functional Concept]
   760   C2349975:Enhanced [Activity]
   726 E C1274040:Result [Functional Concept]
   726 E C1546471:Result [Idea or Concept]
   726 E C2825142:Result [Finding]

Phrase: ")"

Phrase: "would"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "be"

Phrase: "offset by atrial enlargement."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   833   C0741276:ATRIAL ENLARGEMENT [Disease or Syndrome]
   833   C2348360:ATRIAL ENLARGEMENT [Finding]
   770   C0018792:Atrial [Body Part, Organ, or Organ Component]
   770   C0020564:Enlargement, NOS [Pathologic Function]
   770   C1293134:Enlargement [Therapeutic or Preventive Procedure]
   770   C1711330:Offset [Quantitative Concept]
   770   C2711450:Enlargement [Anatomical Abnormality]
Processing 00000000.tx.232: The fact that the RAAS and AVP were affected by pregnancy during exercise and ANP responses were not can be explained by the fact that the stimuli for activation of the two systems are different (19). 

Phrase: "The fact"

Phrase: "that"

Phrase: "the RAAS"

Phrase: "and"

Phrase: "AVP"

Phrase: "were"

Phrase: "affected by pregnancy"
Meta Candidates (Total=9; Excluded=5; Pruned=0; Remaining=4)
   790   C0032961:Pregnancy [Organism Function]
   790   C0392760:Affected [Functional Concept]
   790   C1314939:Affected [Functional Concept]
   790   C3484365:Pregnancy [Clinical Attribute]
   756 E C0001721:Affect [Mental Process]
   718 E C0549206:Pregnant [Finding]
   718 E C0553641:Pregnant [Functional Concept]
   718 E C0600457:PREGNANT [Finding]
   706 E C0552112:Pregnancies [Clinical Attribute]

Phrase: "during exercise"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0015259:Exercise [Daily or Recreational Activity]
  1000   C1522704:Exercise [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "ANP responses"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   812   C0871261:responses [Organism Attribute]
   779 E C1704632:Response [Finding]
   779 E C1706817:Response [Intellectual Product]
   779 E C2911692:Response [Mental Process]
   756   C0027481:Atrial natriuretic peptide [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   708   C0051989:atrial peptide [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "were"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "can"

Phrase: "be"

Phrase: "explained by the fact"

Phrase: "that"

Phrase: "the stimuli for activation of the two systems"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0234402:Stimuli [Phenomenon or Process]

Phrase: "are"

Phrase: "different"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C1705242:Different [Qualitative Concept]
   928 E C1705241:*Difference [Quantitative Concept]
   900 E C0443199:Differential [Qualitative Concept]

Phrase: "(19"

Phrase: ")."
Processing 00000000.tx.233: In this regard, the RAAS-AVP axis responds primarily to changes in blood volume, renal perfusion pressure, and sympathetic stimulation (with osmotic changes also being a major stimulus for AVP), whereas the ANP secretion is stimulated by increased venous return and atrial distention (19). 

Phrase: "In this regard,"

Phrase: "the RAAS-AVP axis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0004457:Axis [Body Part, Organ, or Organ Component]
   827   C0999597:Axis [Mammal]
   827   C1522496:Axis [Spatial Concept]

Phrase: "responds"

Phrase: "primarily to changes"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0392747:changes [Functional Concept]
   790   C0443172:changes [Quantitative Concept]
   756 E C1705241:Change [Quantitative Concept]

Phrase: "in blood volume,"
Meta Candidates (Total=15; Excluded=7; Pruned=0; Remaining=8)
  1000   C0005850:Blood Volume [Organism Attribute]
   861   C0005767:Blood [Tissue]
   861   C0005768:blood [Body Substance]
   861   C0229664:Blood [Body Substance]
   861   C0449468:*Volume [Quantitative Concept]
   861   C1690016:% volume [Qualitative Concept]
   861   C1705102:Volume [Intellectual Product]
   861   C2700258:Volume [Laboratory Procedure]
   789 E C0333275:Bloody [Qualitative Concept]
   777 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   777 E C0392895:Bloods [Population Group]
   777 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   777 E C1511228:VESSEL, BLOOD [Tissue]
   761 E C1558950:VASCULAR [Finding]
   761 E C1801960:Vascular [Qualitative Concept]

Phrase: "renal perfusion pressure,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   901   C0194133:Renal perfusion [Therapeutic or Preventive Procedure]
   827   C0022646:Renal [Body Part, Organ, or Organ Component]
   827   C0031001:Perfusion [Therapeutic or Preventive Procedure]
   827   C0033095:Pressure [Phenomenon or Process]
   827   C0460139:Pressure [Finding]
   827   C1306345:Pressure [Functional Concept]

Phrase: "and"

Phrase: "sympathetic stimulation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1292856:Stimulation [Therapeutic or Preventive Procedure]
   861   C1948023:Stimulation [Natural Phenomenon or Process]

Phrase: "("

Phrase: "with osmotic changes also"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0392747:changes [Functional Concept]
   827   C0443172:changes [Quantitative Concept]
   793 E C1705241:Change [Quantitative Concept]

Phrase: "being"

Phrase: "a major stimulus for AVP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0234402:Stimulus [Phenomenon or Process]

Phrase: ")"

Phrase: ","

Phrase: "whereas"

Phrase: "the ANP secretion"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C1819802:peptide secretion [Cell Function]
   812   C0036536:secretion [Biologic Function]
   812   C0036537:Secretion [Body Substance]
   756   C0027481:Atrial natriuretic peptide [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   708   C0051989:atrial peptide [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "is"

Phrase: "stimulated by increased venous return"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0042449:Venous [Body Part, Organ, or Organ Component]
   760   C0205217:Increased [Quantitative Concept]
   760   C0332156:Return [Qualitative Concept]
   760   C0348013:Venous [Spatial Concept]
   760   C0442805:Increased [Functional Concept]
   760   C1948023:Stimulated [Natural Phenomenon or Process]

Phrase: "and"

Phrase: "atrial distention"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0012359:Distension [Pathologic Function]

Phrase: "(19"

Phrase: ")."
Processing 00000000.tx.234: In conclusion, our results support our original hypothesis that pregnant subjects exhibit blunted RAAS and AVP responses to short-term exercise. 

Phrase: "In conclusion,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707478:Conclusion [Idea or Concept]

Phrase: "our results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "support"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0183683:Support [Medical Device]
  1000   C1521721:Support [Conceptual Entity]

Phrase: "our original hypothesis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1512571:Hypothesis [Idea or Concept]

Phrase: "that pregnant subjects"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0681850:Subject [Group]
   827   C1550501:{Subject} [Idea or Concept]
   827   C1706203:Subject [Idea or Concept]
   827   C2349001:Subject [Human]
   827   C2697811:Subject [Functional Concept]

Phrase: "exhibit"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015272:Exhibit [Intellectual Product]

Phrase: "blunted RAAS"

Phrase: "and"

Phrase: "AVP responses to short-term exercise."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   809   C2265833:response to exercise [Organism Function]
   753   C0871261:responses [Organism Attribute]
   719 E C1704632:Response [Finding]
   719 E C1706817:Response [Intellectual Product]
   719 E C2911692:Response [Mental Process]
Processing 00000000.tx.235: This effect may have been the result of reduced sympathetic drive to the kidney and/or reduced circulating norepinephrine resulting in an attenuation of the normal decrease in renal blood flow in response to exercise and reduced renin output of juxtaglomerular cells of the kidney. 

Phrase: "This effect"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1280500:Effect [Qualitative Concept]
  1000   C2348382:Effect [Qualitative Concept]

Phrase: "may"

Phrase: "have"

Phrase: "been"

Phrase: "the result of reduced sympathetic drive"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C1274040:Result [Functional Concept]
   753   C1546471:Result [Idea or Concept]
   753   C2825142:Result [Finding]

Phrase: "to the kidney"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0022646:Kidney [Body Part, Organ, or Organ Component]
  1000   C0227665:kidney [Body Part, Organ, or Organ Component]
  1000   C1278978:Kidney [Body Part, Organ, or Organ Component]
  1000   C1514845:KIDNEY [Tissue]
   907 E C0027697:Nephritides [Disease or Syndrome]

Phrase: "and/or"

Phrase: "reduced circulating norepinephrine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0028351:Norepinephrine [Neuroreactive Substance or Biogenic Amine,Organic Chemical,Pharmacologic Substance]

Phrase: "resulting in an attenuation of the normal decrease"
Meta Candidates (Total=12; Excluded=3; Pruned=0; Remaining=9)
   770   C0332294:Resulting in [Functional Concept]
   750   C0459422:Normal result [Finding]
   744   C0205307:Normal [Qualitative Concept]
   744   C0392756:Decrease [Qualitative Concept]
   744   C0439166:% normal [Quantitative Concept]
   744   C0547047:Decrease [Quantitative Concept]
   744   C0599946:Attenuation [Activity]
   744   C0678226:resulting [Functional Concept]
   744   C2347086:% Normal [Quantitative Concept]
   711 E C1274040:Result [Functional Concept]
   711 E C1546471:Result [Idea or Concept]
   711 E C2825142:Result [Finding]

Phrase: "in renal blood flow"
Meta Candidates (Total=15; Excluded=7; Pruned=0; Remaining=8)
  1000   C0035070:renal blood flow [Organ or Tissue Function]
  1000   C1527409:Renal blood flow [Organ or Tissue Function]
   901   C0232338:Blood flow [Organism Function]
   827   C0005767:Blood [Tissue]
   827   C0005768:blood [Body Substance]
   827   C0022646:Renal [Body Part, Organ, or Organ Component]
   827   C0229664:Blood [Body Substance]
   827   C0806140:Flow [Natural Phenomenon or Process]
   755 E C0333275:Bloody [Qualitative Concept]
   743 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   743 E C0392895:Bloods [Population Group]
   743 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   743 E C1511228:VESSEL, BLOOD [Tissue]
   727 E C1558950:VASCULAR [Finding]
   727 E C1801960:Vascular [Qualitative Concept]

Phrase: "in response to"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0871261:Response [Organism Attribute]
   861   C1704632:Response [Finding]
   861   C1706817:Response [Intellectual Product]
   861   C2911692:Response [Mental Process]

Phrase: "exercise"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0015259:Exercise [Daily or Recreational Activity]
  1000   C1522704:Exercise [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "reduced renin output of juxtaglomerular cells of the kidney."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C1709366:Output [Conceptual Entity]
Processing 00000000.tx.236: Lower ANG II levels may then account for the observed blunting of AVP responses to exercise. 

Phrase: "Lower ANG II levels"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   844   C0441926:ii level [Intellectual Product]
   812   C0441889:Levels [Qualitative Concept]
   779 E C0456079:Level [Classification]
   779 E C1547707:Level [Geographic Area]
   779 E C2946261:Level [Pharmacologic Substance]

Phrase: "may"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "account for the observed blunting of AVP responses to"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   742   C0871261:responses [Organism Attribute]
   742   C1441672:Observed [Functional Concept]
   742   C1551359:account [Idea or Concept]
   742   C2741673:Account # [Clinical Attribute]
   742   C2981730:Account [Classification]
   708 E C1704632:Response [Finding]
   708 E C1706817:Response [Intellectual Product]
   708 E C2911692:Response [Mental Process]

Phrase: "exercise."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0015259:Exercise [Daily or Recreational Activity]
  1000   C1522704:Exercise [Therapeutic or Preventive Procedure]
Processing 00000000.tx.237: In contrast, the ANP response to exercise above VT were similar to the CG. 

Phrase: "In contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "the ANP response to"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   804   C0871261:Response [Organism Attribute]
   804   C1704632:Response [Finding]
   804   C1706817:Response [Intellectual Product]
   804   C2911692:Response [Mental Process]
   717   C0027481:Atrial natriuretic peptide [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "exercise"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0015259:Exercise [Daily or Recreational Activity]
  1000   C1522704:Exercise [Therapeutic or Preventive Procedure]

Phrase: "above VT"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   913   C0443129:Above threshold [Qualitative Concept]
   827   C0449864:Threshold [Qualitative Concept]

Phrase: "were"

Phrase: "similar to the CG."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C2348205:Similar [Qualitative Concept]
Processing 00000000.tx.238: Despite the differences in the ANG II and AVP responses to exercise, the two groups exhibited similar changes in osmolality and TP and albumin concentrations, suggesting similar overall water balance adjustments during the exercise bouts. 

Phrase: "Despite the differences"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   966   C1705241:*Difference [Quantitative Concept]
   966   C1705242:Difference [Qualitative Concept]
   916 E C0443199:Differential [Qualitative Concept]

Phrase: "in the ANG II"

Phrase: "and"

Phrase: "AVP responses to"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   827   C0871261:responses [Organism Attribute]
   793 E C1704632:Response [Finding]
   793 E C1706817:Response [Intellectual Product]
   793 E C2911692:Response [Mental Process]

Phrase: "exercise"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0015259:Exercise [Daily or Recreational Activity]
  1000   C1522704:Exercise [Therapeutic or Preventive Procedure]

Phrase: ","

Phrase: "the two groups"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   861   C0441833:Group [Idea or Concept]
   861   C0687744:group [Population Group]
   861   C1257890:Group [Population Group]
   861   C1552516:Group [Health Care Related Organization]
   861   C1552839:groups [Idea or Concept]
   861   C1705428:Group [Conceptual Entity]
   861   C1705429:Group [Population Group]

Phrase: "exhibited"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0015272:Exhibit [Intellectual Product]

Phrase: "similar changes in osmolality"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0392747:changes [Functional Concept]
   770   C0443172:changes [Quantitative Concept]
   737 E C1705241:Change [Quantitative Concept]

Phrase: "and"

Phrase: "TP"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0555903:Total protein [Laboratory Procedure]
  1000   C1261360:total protein [Laboratory or Test Result]
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0439175:% total [Quantitative Concept]
   861   C0439810:Total [Qualitative Concept]

Phrase: "and"

Phrase: "albumin concentrations,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0486291:albumin concentrations [Laboratory or Test Result]
   861   C0086045:Concentrations [Mental Process]
   827 E C1446561:Concentration [Quantitative Concept]
   777 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "similar overall water balance adjustments during the exercise bouts."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   742   C0376209:Adjustments [Individual Behavior]
   742   C0456081:Adjustments [Functional Concept]
   742   C2945673:adjustments [Therapeutic or Preventive Procedure]
   708 E C0683269:adjustment [Individual Behavior]
Processing 00000000.tx.239: Because this study examined the effects of human pregnancy responses to short-term exercise, future studies should be conducted to determine the effects of pregnancy on responses to prolonged exercise (>40-min duration). 

Phrase: "Because"

Phrase: "this study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "examined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]

Phrase: "the effects of human pregnancy responses"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C1280500:effects [Qualitative Concept]
   719 E C2348382:Effect [Qualitative Concept]

Phrase: "to short-term exercise,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0015259:Exercise [Daily or Recreational Activity]
   827   C1522704:Exercise [Therapeutic or Preventive Procedure]
   734   C0443303:Short-term [Temporal Concept]

Phrase: "future studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "should"

Phrase: "be"

Phrase: "conducted"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0004927:Conduct [Individual Behavior]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "determine"

Phrase: "the effects of pregnancy"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C1280500:effects [Qualitative Concept]
   737 E C2348382:Effect [Qualitative Concept]

Phrase: "on responses"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0871261:responses [Organism Attribute]
   966 E C1704632:Response [Finding]
   966 E C1706817:Response [Intellectual Product]
   966 E C2911692:Response [Mental Process]

Phrase: "to prolonged exercise"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0015259:Exercise [Daily or Recreational Activity]
   861   C1522704:Exercise [Therapeutic or Preventive Procedure]

Phrase: "("

Phrase: ">40-min duration"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0449238:Duration [Temporal Concept]
   827   C2926735:Duration [Pharmacologic Substance]

Phrase: ")."
Processing 00000000.tx.240: The study of renal blood flow during exercise in pregnancy would also be useful to understand the mechanisms responsible for possible discrepancies in hormonal responses.  

Phrase: "The study of renal blood flow"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   783   C0846101:renal study [Diagnostic Procedure]
   753   C0557651:Study [Manufactured Object]
   753   C2603343:Study [Research Activity]

Phrase: "during exercise"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0015259:Exercise [Daily or Recreational Activity]
  1000   C1522704:Exercise [Therapeutic or Preventive Procedure]

Phrase: "in pregnancy"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
  1000   C0032961:Pregnancy [Organism Function]
  1000   C3484365:Pregnancy [Clinical Attribute]
   928 E C0549206:Pregnant [Finding]
   928 E C0553641:Pregnant [Functional Concept]
   928 E C0600457:PREGNANT [Finding]
   916 E C0552112:Pregnancies [Clinical Attribute]

Phrase: "would"

Phrase: "also"

Phrase: "be"

Phrase: "useful to"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   789   C0042153:use [Functional Concept]
   789   C0457083:Use [Functional Concept]
   789   C1947944:Use [Intellectual Product]

Phrase: "understand"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0162340:Understand [Mental Process]

Phrase: "the mechanisms"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0441712:Mechanisms [Functional Concept]
   966 E C1706376:Mechanism [Manufactured Object]

Phrase: "responsible for possible discrepancies"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1273518:Responsible [Finding]

Phrase: "in hormonal responses."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0871261:responses [Organism Attribute]
   827 E C1704632:Response [Finding]
   827 E C1706817:Response [Intellectual Product]
   827 E C2911692:Response [Mental Process]
Processing 00000000.tx.241: DISCLOSURES TOP ABSTRACT METHODS RESULTS DISCUSSION DISCLOSURES REFERENCES  This study was supported by US Army Medical Research and Materiel Command Contract no. 

Phrase: "DISCLOSURES TOP ABSTRACT METHODS RESULTS DISCUSSION DISCLOSURES"

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "This study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "was"

Phrase: "supported by US Army Medical Research"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   790   C0079816:Medical Research [Research Activity]
   790   C1549454:US Army [Professional or Occupational Group]
   790   C1556038:Medical Research [Professional or Occupational Group]
   783   C0035176:research supported [Quantitative Concept]
   753   C0035168:research [Research Activity]
   753   C0205476:Medical [Functional Concept]
   753   C0242481:Research [Research Activity]
   753   C0680778:army [Organization]
   753   C1521721:Supported [Conceptual Entity]
   719 E C0183683:Support [Medical Device]

Phrase: "and"

Phrase: "Materiel Command"

Phrase: "Contract"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332522:Contract [Intellectual Product]
  1000   C1705564:Contract [Conceptual Entity]

Phrase: "no."
Processing 00000000.tx.242: DAMD17-96-C-6112, Ontario Thoracic Society, Ontario Respiratory Disease Foundation (Block-Term Grant Funding), and Natural Sciences and Engineering Research Council of Canada. 

Phrase: "DAMD17-96-C-6112,"

Phrase: "Ontario Thoracic Society,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0037455:society [Organization]

Phrase: "Ontario Respiratory Disease Foundation"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   812   C0016617:Foundation [Organization]
   729 E C0002055:base [Inorganic Chemical]
   729 E C0178499:Base [Chemical Viewed Functionally]
   729 E C1626935:Bases [Quantitative Concept]
   729 E C1880279:Base [Biomedical or Dental Material]
   706 E C0205112:Basal [Spatial Concept]

Phrase: "(Block-Term Grant Funding"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   902   C1555466:block funding [Idea or Concept]
   812   C0243098:Funding [Quantitative Concept]
   812   C0376244:funding [Quantitative Concept]
   708   C0680848:block grant [Regulation or Law]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "Natural Sciences and Engineering Research Council of Canada."
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   770   C0678530:Natural Sciences [Occupation or Discipline]
   744   C0014279:Engineering [Occupation or Discipline]
   744   C0035168:research [Research Activity]
   744   C0036397:Sciences [Occupation or Discipline]
   744   C0205296:Natural [Functional Concept]
   744   C0242481:Research [Research Activity]
   744   C1551807:Council [Population Group]
   711 E C0878517:Engineer [Professional or Occupational Group]
Processing 00000000.tx.243: A. 

Phrase: "A."
Processing 00000000.tx.244: P. 

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.245: Heenan was supported by an Ontario Graduate Scholarship for Science and Technology and an Ontario Thoracic Society training award.  

Phrase: "Heenan"

Phrase: "was"

Phrase: "supported by an Ontario Graduate Scholarship"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   753   C0029040:Ontario [Geographic Area]
   753   C0036365:scholarship [Idea or Concept]
   753   C0588053:Graduate [Population Group]
   753   C1521721:Supported [Conceptual Entity]
   753   C1547183:Graduate [Idea or Concept]
   719 E C0183683:Support [Medical Device]

Phrase: "for Science"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0036397:Science [Occupation or Discipline]

Phrase: "and"

Phrase: "Technology"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0039421:Technology [Occupation or Discipline]

Phrase: "and"

Phrase: "an Ontario Thoracic Society training award."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0004446:Award [Manufactured Object]
Processing 00000000.tx.246: FOOTNOTES  Address for reprint requests and other correspondence: L. 

Phrase: "FOOTNOTES  Address for reprint requests"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0376649:Address [Intellectual Product]
   760   C1442065:Address [Spatial Concept]

Phrase: "and"

Phrase: "other correspondence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0282413:Correspondence [Intellectual Product]

Phrase: ":"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.247: A. 

Phrase: "A."
Processing 00000000.tx.248: Wolfe, School of Physical and Health Education, Queen's Univ., Kingston, Ontario, Canada K7L 3N6 (E-mail: wolfel{at}post.queensu.ca ). 

Phrase: "Wolfe,"

Phrase: "School of Physical"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   858   C0262624:SCHOOL PHYSICAL [Diagnostic Procedure]
   790   C0036375:School [Manufactured Object,Organization]

Phrase: "and"

Phrase: "Health Education,"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0018701:Health education [Educational Activity]
   861   C0013621:Education [Educational Activity]
   861   C0013622:education [Classification]
   861   C0013658:Education, NOS [Finding]
   861   C0039401:Education [Educational Activity]
   789 E C1555905:Educational [Intellectual Product]

Phrase: "Queen's Univ.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0041740:UNIV [Manufactured Object,Organization]

Phrase: "Kingston,"

Phrase: "Ontario,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0029040:Ontario [Geographic Area]

Phrase: "Canada K7L 3N6"

Phrase: "(E-mail"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0013849:E-Mail [Intellectual Product]
  1000   C1705961:E-mail [Intellectual Product]
   861   C0024492:Mail [Manufactured Object]
   861   C1538057:MAIL [Gene or Genome]
   861   C1547565:Mail [Idea or Concept]

Phrase: ":"

Phrase: "wolfel{at}post.queensu.ca )."
Processing 00000000.tx.249: The costs of publication of this article were defrayed in part by the payment of page charges. 

Phrase: "The costs of publication of this article"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0010186:Costs [Quantitative Concept]
   748   C0220812:Costs [Quantitative Concept]

Phrase: "were"

Phrase: "defrayed in part"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0449719:Part [Spatial Concept]
   790   C1709471:Part [Quantitative Concept]

Phrase: "by the payment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0220808:payment [Quantitative Concept]
  1000   C0680264:payment [Quantitative Concept]

Phrase: "of page charges."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0007961:Charges [Quantitative Concept]
   827 E C1706211:Charge [Organism Attribute]
Processing 00000000.tx.250: The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. 

Phrase: "The article"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1706852:Article [Intellectual Product]

Phrase: "must"

Phrase: "therefore"

Phrase: "be"

Phrase: "hereby"

Phrase: "marked"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0522501:Marked [Qualitative Concept]
  1000   C1706089:Marked [Qualitative Concept]

Phrase: """advertisement"""
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0949214:advertisement [Intellectual Product]

Phrase: "in accordance with 18 U.S.C."
Processing 00000000.tx.251: Section 1734 solely to indicate this fact.  

Phrase: "Section 1734 solely to"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   812   C0205155:Section [Spatial Concept]
   812   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   812   C1522472:Section [Substance]
   812   C1552923:Section [Quantitative Concept]
   812   C1705191:Section [Physical Object]

Phrase: "indicate"

Phrase: "this fact."
Processing 00000000.tx.252: REFERENCES TOP ABSTRACT METHODS RESULTS DISCUSSION DISCLOSURES REFERENCES  Avery ND, Wolfe LA, Amara CE, Davies GAL, and McGrath MJ. 

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "TOP ABSTRACT METHODS RESULTS DISCUSSION DISCLOSURES"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0012625:disclosures [Individual Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Avery ND,"

Phrase: "Wolfe LA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0023031:La [Element, Ion, or Isotope]

Phrase: "Amara CE,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2827664:CE [Idea or Concept]

Phrase: "Davies GAL,"

Phrase: "and"

Phrase: "McGrath MJ."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439254:MJ [Medical Device]
Processing 00000000.tx.253: Effects of human pregnancy on cardiac autonomic function above and below the ventilatory threshold. 

Phrase: "Effects of human pregnancy"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C1280500:effects [Qualitative Concept]
   737 E C2348382:Effect [Qualitative Concept]

Phrase: "on cardiac autonomic function"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   913   C0232164:Cardiac function [Organ or Tissue Function]
   901   C0518003:autonomic function [Finding]
   827   C0004388:Autonomic [Body System]
   827   C0018787:Cardiac [Body Part, Organ, or Organ Component]
   827   C0031843:function [Physiologic Function]
   827   C0542341:Function [Functional Concept]
   827   C0700205:FUNCTION [Classification]
   827   C1522601:Cardiac [Spatial Concept]
   827   C1705273:Function [Intellectual Product]
   755 E C0205245:Functional [Functional Concept]
   755 E C2700217:Functional [Conceptual Entity]

Phrase: "above"

Phrase: "and below the ventilatory threshold."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0449864:Threshold [Qualitative Concept]
   760   C1515981:And [Idea or Concept]
Processing 00000000.tx.254: J Appl Physiol 90: 321328, 2001.[Abstract/Free FullText] Beaver WL, Wasserman K, and Whipp BJ. 

Phrase: "J Appl Physiol 90"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0439083:>90 [Quantitative Concept]
   812   C0439087:<90 [Quantitative Concept]
   812   C1858559:APPL [Gene or Genome]

Phrase: ":"

Phrase: "321328,"

Phrase: "2001."

Phrase: "[Abstract/Free FullText"

Phrase: "] Beaver WL,"

Phrase: "Wasserman K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "Whipp BJ."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0005005:BJ [Geographic Area]
Processing 00000000.tx.255: A new method for detecting anaerobic threshold by gas exchange. 

Phrase: "A new method for detecting anaerobic threshold"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0025663:Method [Intellectual Product]
   748   C0449851:Method [Functional Concept]
   748   C0871511:METHOD [Intellectual Product]

Phrase: "by gas exchange."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0678640:exchange [Social Behavior]
Processing 00000000.tx.256: J Appl Physiol 60: 20202027, 1986.[Abstract/Free FullText] Bonen A, Campagna P, Gilchrist L, Young DC, and Beresford P. 

Phrase: "J Appl Physiol 60"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1858559:APPL [Gene or Genome]

Phrase: ":"

Phrase: "20202027,"

Phrase: "1986."

Phrase: "[Abstract/Free FullText"

Phrase: "] Bonen A,"

Phrase: "Campagna P,"

Phrase: "Gilchrist L,"

Phrase: "Young DC,"

Phrase: "and"

Phrase: "Beresford P."
Processing 00000000.tx.257: Substrate and endocrine responses during exercise at selected stage of pregnancy. 

Phrase: "Substrate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1710236:Substrate [Manufactured Object]

Phrase: "and"

Phrase: "endocrine responses during exercise"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   770   C0871261:responses [Organism Attribute]
   737 E C1704632:Response [Finding]
   737 E C1706817:Response [Intellectual Product]
   737 E C2911692:Response [Mental Process]

Phrase: "at selected stage"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205390:Stage [Temporal Concept]
   861   C1300072:Stage [Clinical Attribute]
   861   C1306673:Stage [Qualitative Concept]

Phrase: "of pregnancy."
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
  1000   C0032961:Pregnancy [Organism Function]
  1000   C3484365:Pregnancy [Clinical Attribute]
   928 E C0549206:Pregnant [Finding]
   928 E C0553641:Pregnant [Functional Concept]
   928 E C0600457:PREGNANT [Finding]
   916 E C0552112:Pregnancies [Clinical Attribute]
Processing 00000000.tx.258: J Appl Physiol 73: 134142, 1992.[Abstract/Free FullText] Bonen A, Haynes FJ, Watson-Wright W, Sopper MM, Pierce GN, Low MP, and Graham TE. 

Phrase: "J Appl Physiol 73"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1858559:APPL [Gene or Genome]

Phrase: ":"

Phrase: "134142,"

Phrase: "1992."

Phrase: "[Abstract/Free FullText"

Phrase: "] Bonen A,"

Phrase: "Haynes FJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0016080:FJ [Geographic Area]

Phrase: "Watson-Wright W,"

Phrase: "Sopper MM,"

Phrase: "Pierce GN,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0018381:GN [Geographic Area]

Phrase: "Low MP,"

Phrase: "and"

Phrase: "Graham TE."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0039462:Te [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   861   C1705540:TE [Conceptual Entity]
Processing 00000000.tx.259: Effects of menstrual cycle on metabolic responses to exercise. 

Phrase: "Effects of menstrual cycle"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C1280500:effects [Qualitative Concept]
   737 E C2348382:Effect [Qualitative Concept]

Phrase: "on metabolic responses to"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   827   C0871261:responses [Organism Attribute]
   793 E C1704632:Response [Finding]
   793 E C1706817:Response [Intellectual Product]
   793 E C2911692:Response [Mental Process]

Phrase: "exercise."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0015259:Exercise [Daily or Recreational Activity]
  1000   C1522704:Exercise [Therapeutic or Preventive Procedure]
Processing 00000000.tx.260: J Appl Physiol 55: 15061513, 1983.[Abstract/Free FullText] Chiodera P, Volpi R, Caiazza A, Giuliani N, Magotti MG, and Coiro V. 

Phrase: "J Appl Physiol 55"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0450382:55 [Intellectual Product]
   812   C1858559:APPL [Gene or Genome]

Phrase: ":"

Phrase: "15061513,"

Phrase: "1983."

Phrase: "[Abstract/Free FullText"

Phrase: "] Chiodera P,"

Phrase: "Volpi R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Caiazza A,"

Phrase: "Giuliani N,"

Phrase: "Magotti MG,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0439269:mg% [Quantitative Concept]
   861   C1960952:mg % [Quantitative Concept]
   861   C2346927:Mg++ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "and"

Phrase: "Coiro V."
Processing 00000000.tx.261: Arginine vasopressin and oxytocin responses to angiotensin II are mediated by AT1 receptor subtype in normal men. 

Phrase: "Arginine vasopressin"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0003779:Arginine Vasopressin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
           Vasopressin
  1000   C1527128:Arginine Vasopressin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0003765:Arginine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   861   C0042413:vasopressin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1705480:Vasopressin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "and"

Phrase: "oxytocin responses to angiotensin II"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   760   C0871261:responses [Organism Attribute]
   726 E C1704632:Response [Finding]
   726 E C1706817:Response [Intellectual Product]
   726 E C2911692:Response [Mental Process]

Phrase: "are"

Phrase: "mediated by AT1 receptor subtype"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0086597:mediated [Social Behavior]
   760   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
   760   C0449560:Subtype [Classification]
   760   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   760   C1412113:AT-1 [Gene or Genome]

Phrase: "in normal men."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0025266:Men [Population Group]
   827 E C0024554:MAN [Finding]
   827 E C0086418:Man [Human]
Processing 00000000.tx.262: Metabolism 47: 893896, 1998.[ISI][Medline] Convertino VA, Keil LC, Bernauer EM, and Greenleaf JE. 

Phrase: "Metabolism 47"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0025519:Metabolism [Organism Function]
   861   C0025520:metabolism [Functional Concept]

Phrase: ":"

Phrase: "893896,"

Phrase: "1998."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Convertino VA,"

Phrase: "Keil LC,"

Phrase: "Bernauer EM,"

Phrase: "and"

Phrase: "Greenleaf JE."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0454673:JE [Geographic Area]
   861   C1550752:JE [Temporal Concept]
Processing 00000000.tx.263: Plasma volume, osmolality, vasopressin, and renin activity during graded exercise in man. 

Phrase: "Plasma volume,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0032127:Plasma Volume [Clinical Attribute]
   861   C0032105:Plasma [Body Substance]
   861   C0449468:*Volume [Quantitative Concept]
   861   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   861   C1690016:% volume [Qualitative Concept]
   861   C1705102:Volume [Intellectual Product]
   861   C2700258:Volume [Laboratory Procedure]

Phrase: "osmolality,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0086741:Osmolality [Clinical Attribute]
  1000   C0201803:Osmolality [Laboratory Procedure]
  1000   C1547034:*Osmolality [Quantitative Concept]
   900 E C0439186:osmol [Quantitative Concept]

Phrase: "vasopressin,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0003779:Vasopressin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C0042413:vasopressin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1705480:Vasopressin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "and"

Phrase: "renin activity during graded exercise"
Meta Candidates (Total=13; Excluded=4; Pruned=0; Remaining=9)
   806   C1150120:renin activity [Molecular Function]
   797   C0695406:activity exercise [Therapeutic or Preventive Procedure]
   778 E C1150116:chymosin activity [Molecular Function]
   762 E C0419117:Active exercise [Therapeutic or Preventive Procedure]
   760   C0035094:Renin [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0035100:Rennin [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   760   C0205177:Activity [Functional Concept]
   760   C0439167:% activity [Quantitative Concept]
   760   C0441655:Activity [Activity]
   760   C1419338:RENIN [Gene or Genome]
   760   C1561536:*Activity [Idea or Concept]
   704 E C0022877:Lab [Manufactured Object,Organization]
   704 E C0587081:Labs [Finding]

Phrase: "in man."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0024554:MAN [Finding]
  1000   C0025266:Man [Population Group]
  1000   C0086418:Man [Human]
Processing 00000000.tx.264: J Appl Physiol 50: 123128, 1981.[Abstract/Free FullText] Convertino VA, Keil LC, and Greenleaf JE. 

Phrase: "J Appl Physiol 50"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1858559:APPL [Gene or Genome]

Phrase: ":"

Phrase: "123128,"

Phrase: "1981."

Phrase: "[Abstract/Free FullText"

Phrase: "] Convertino VA,"

Phrase: "Keil LC,"

Phrase: "and"

Phrase: "Greenleaf JE."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0454673:JE [Geographic Area]
   861   C1550752:JE [Temporal Concept]
Processing 00000000.tx.265: Plasma volume, renin and vasopressin responses to graded exercise after training. 

Phrase: "Plasma volume,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0032127:Plasma Volume [Clinical Attribute]
   861   C0032105:Plasma [Body Substance]
   861   C0449468:*Volume [Quantitative Concept]
   861   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   861   C1690016:% volume [Qualitative Concept]
   861   C1705102:Volume [Intellectual Product]
   861   C2700258:Volume [Laboratory Procedure]

Phrase: "renin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0035094:Renin [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C0035100:Rennin [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
  1000   C1419338:RENIN [Gene or Genome]
   944 E C0022877:Lab [Manufactured Object,Organization]
   944 E C0587081:Labs [Finding]

Phrase: "and"

Phrase: "vasopressin responses to graded exercise"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   833   C2265833:response to exercise [Organism Function]
   760   C0871261:responses [Organism Attribute]
   726 E C1704632:Response [Finding]
   726 E C1706817:Response [Intellectual Product]
   726 E C2911692:Response [Mental Process]

Phrase: "after training."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0040607:Training [Educational Activity]
  1000   C0220931:Training [Educational Activity]
  1000   C2673163:training [Qualitative Concept]
Processing 00000000.tx.266: J Appl Physiol 54: 508514, 1983.[Free FullText] De Souza MJ, Maresh CM, Maguire MS, Kraemer WJ, Flora-Ginter G, and Goetz KL. 

Phrase: "J Appl Physiol 54"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1858559:APPL [Gene or Genome]

Phrase: ":"

Phrase: "508514,"

Phrase: "1983."

Phrase: "[Free FullText"

Phrase: "] De Souza MJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0439254:MJ [Medical Device]

Phrase: "Maresh CM,"

Phrase: "Maguire MS,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039676:MS [Amino Acid, Peptide, or Protein,Enzyme]
   861   C2349943:Ms. [Conceptual Entity]
   861   C3539704:MS [Gene or Genome]

Phrase: "Kraemer WJ,"

Phrase: "Flora-Ginter G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "Goetz KL."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1366480:KL [Gene or Genome]
   861   C1416656:KL [Gene or Genome]
Processing 00000000.tx.267: Menstrual status and plasma vasopressin, renin activity, and aldosterone exercise responses. 

Phrase: "Menstrual status"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0365291:Menstrual status [Clinical Attribute]
  1000   C0369663:Menstrual status [Finding]
   861   C0449438:Status [Qualitative Concept]

Phrase: "and"

Phrase: "plasma vasopressin,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0003779:Vasopressin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0032105:Plasma [Body Substance]
   861   C0042413:vasopressin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   861   C1705480:Vasopressin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "renin activity,"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
  1000   C1150120:renin activity [Molecular Function]
   972 E C1150116:chymosin activity [Molecular Function]
   861   C0035094:Renin [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0035100:Rennin [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1419338:RENIN [Gene or Genome]
   861   C1561536:*Activity [Idea or Concept]
   805 E C0022877:Lab [Manufactured Object,Organization]
   805 E C0587081:Labs [Finding]

Phrase: "and"

Phrase: "aldosterone exercise responses."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   827   C0871261:responses [Organism Attribute]
   793 E C1704632:Response [Finding]
   793 E C1706817:Response [Intellectual Product]
   793 E C2911692:Response [Mental Process]
Processing 00000000.tx.268: J Appl Physiol 67: 736743, 1989.[Abstract/Free FullText] Duvekot JJ, Cheriex EC, Pieters FAA, Menheere PPCA, and Peters LLH. 

Phrase: "J Appl Physiol 67"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1858559:APPL [Gene or Genome]

Phrase: ":"

Phrase: "736743,"

Phrase: "1989."

Phrase: "[Abstract/Free FullText"

Phrase: "] Duvekot JJ,"

Phrase: "Cheriex EC,"

Phrase: "Pieters FAA,"

Phrase: "Menheere PPCA,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0246138:ppcA [Nucleic Acid, Nucleoside, or Nucleotide]
   861   C1824812:PPCA [Gene or Genome]

Phrase: "and"

Phrase: "Peters LLH."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1538681:LLH [Gene or Genome]
Processing 00000000.tx.269: Early pregnancy changes in hemodynamics and volume homeostasis are consecutive adjustments triggered by a primary fall in systemic vascular tone. 

Phrase: "Early pregnancy"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
  1000   C0747845:early pregnancy [Disease or Syndrome]
   861   C0032961:Pregnancy [Organism Function]
   861   C3484365:Pregnancy [Clinical Attribute]
   789 E C0549206:Pregnant [Finding]
   789 E C0553641:Pregnant [Functional Concept]
   789 E C0600457:PREGNANT [Finding]
   777 E C0552112:Pregnancies [Clinical Attribute]

Phrase: "changes in hemodynamics"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0019010:Hemodynamics [Organ or Tissue Function]
   790   C0392747:Change [Functional Concept]
   790   C0443172:change [Quantitative Concept]
   790   C1705241:Change [Quantitative Concept]

Phrase: "and"

Phrase: "volume homeostasis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0019868:Homeostasis [Biologic Function]

Phrase: "are"

Phrase: "consecutive adjustments"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0376209:Adjustments [Individual Behavior]
   861   C0456081:Adjustments [Functional Concept]
   861   C2945673:adjustments [Therapeutic or Preventive Procedure]
   827 E C0683269:adjustment [Individual Behavior]

Phrase: "triggered by a primary fall"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   806   C1444748:Triggered by [Qualitative Concept]
           Trigger
   760   C0085639:Fall [Finding]
   760   C0205225:Primary [Qualitative Concept]
   760   C0238715:Fall [Temporal Concept]
   760   C0439631:Primary [Therapeutic or Preventive Procedure]
   726   C0032930:Trigger [Clinical Attribute]

Phrase: "in systemic vascular tone."
Processing 00000000.tx.270: Am J Obstet Gynecol 169: 13821392, 1993.[ISI][Medline] Freund BJ, Claybaugh JR, Dice MS, and Hashiro GM. 

Phrase: "Am"

Phrase: "J Obstet Gynecol 169"

Phrase: ":"

Phrase: "13821392,"

Phrase: "1993."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Freund BJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0005005:BJ [Geographic Area]

Phrase: "Claybaugh JR,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1708595:Jr [Idea or Concept]
   861   C3280986:JR [Disease or Syndrome]

Phrase: "Dice MS,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039676:MS [Amino Acid, Peptide, or Protein,Enzyme]
   861   C2349943:Ms. [Conceptual Entity]
   861   C3539704:MS [Gene or Genome]

Phrase: "and"

Phrase: "Hashiro GM."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0546866:GM [Antibiotic,Carbohydrate]
Processing 00000000.tx.271: Hormonal and vascular fluid responses to maximal exercise in trained and untrained males. 

Phrase: "Hormonal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0458083:Hormonal [Qualitative Concept]

Phrase: "and"

Phrase: "vascular fluid responses to maximal exercise"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   809   C2265833:response to exercise [Organism Function]
   753   C0871261:responses [Organism Attribute]
   719 E C1704632:Response [Finding]
   719 E C1706817:Response [Intellectual Product]
   719 E C2911692:Response [Mental Process]

Phrase: "in trained"
Meta Candidates (Total=9; Excluded=7; Pruned=0; Remaining=2)
   966   C0336809:Train [Manufactured Object]
   966   C1552514:Train [Manufactured Object]
   928 E C0009647:Conditioned [Mental Process]
   928 E C0012634:condition [Disease or Syndrome]
   928 E C0348080:Condition [Qualitative Concept]
   928 E C1705253:Condition [Conceptual Entity]
   907 E C0040607:Training [Educational Activity]
   907 E C0220931:Training [Educational Activity]
   907 E C2673163:training [Qualitative Concept]

Phrase: "and"

Phrase: "untrained males."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0024554:Males [Finding]
   861   C0086582:Males [Population Group]
   827 E C1706180:Male [Qualitative Concept]
   827 E C1706428:Male [Qualitative Concept]
   827 E C1706429:Male [Organism Attribute]
Processing 00000000.tx.272: J Appl Physiol 63: 669675, 1987.[Abstract/Free FullText] Freund BJ, Shizuru EM, Hashiro GM, and Claybaugh JR. 

Phrase: "J Appl Physiol 63"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1858559:APPL [Gene or Genome]

Phrase: ":"

Phrase: "669675,"

Phrase: "1987."

Phrase: "[Abstract/Free FullText"

Phrase: "] Freund BJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0005005:BJ [Geographic Area]

Phrase: "Shizuru EM,"

Phrase: "Hashiro GM,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0546866:GM [Antibiotic,Carbohydrate]

Phrase: "and"

Phrase: "Claybaugh JR."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1708595:Jr [Idea or Concept]
   861   C3280986:JR [Disease or Syndrome]
Processing 00000000.tx.273: Hormonal, electrolyte, and renal responses to exercise are intensity dependent. 

Phrase: "Hormonal, electrolyte,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0013832:Electrolyte [Inorganic Chemical,Pharmacologic Substance]
   861   C3536863:Electrolyte [Pharmacologic Substance]

Phrase: "and"

Phrase: "renal responses to"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   827   C0871261:responses [Organism Attribute]
   793 E C1704632:Response [Finding]
   793 E C1706817:Response [Intellectual Product]
   793 E C2911692:Response [Mental Process]

Phrase: "exercise"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0015259:Exercise [Daily or Recreational Activity]
  1000   C1522704:Exercise [Therapeutic or Preventive Procedure]

Phrase: "are"

Phrase: "intensity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0522510:Intensity [Qualitative Concept]

Phrase: "dependent."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0851827:Dependent [Qualitative Concept]
  1000   C1701901:Dependent [Qualitative Concept]
  1000   C3244310:dependent [Functional Concept]
Processing 00000000.tx.274: J Appl Physiol 70: 900906, 1991.[Abstract/Free FullText] Galliven EA, Singh A, Michelson D, Bina S, Gold PW, and Deuster PA. 

Phrase: "J Appl Physiol 70"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1858559:APPL [Gene or Genome]

Phrase: ":"

Phrase: "900906,"

Phrase: "1991."

Phrase: "[Abstract/Free FullText"

Phrase: "] Galliven EA,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0014963:EA [Organic Chemical,Pharmacologic Substance]
   861   C1457900:EA [Quantitative Concept]

Phrase: "Singh A,"

Phrase: "Michelson D,"

Phrase: "Bina S,"

Phrase: "Gold PW,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0242397:PW [Geographic Area]

Phrase: "and"

Phrase: "Deuster PA."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3541314:PA [Idea or Concept]
Processing 00000000.tx.275: Hormonal and metabolic responses to exercise across time of day and menstrual cycle phase. 

Phrase: "Hormonal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0458083:Hormonal [Qualitative Concept]

Phrase: "and"

Phrase: "metabolic responses to"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   827   C0871261:responses [Organism Attribute]
   793 E C1704632:Response [Finding]
   793 E C1706817:Response [Intellectual Product]
   793 E C2911692:Response [Mental Process]

Phrase: "exercise across time of day"
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
   862   C0439548:time of day [Temporal Concept]
   797   C0439587:Exercise time [Temporal Concept]
   760   C0015259:Exercise [Daily or Recreational Activity]
   760   C0040223:Time [Temporal Concept]
   760   C0332173:/day [Temporal Concept]
   760   C0439228:day [Temporal Concept]
   760   C0439505:/day [Temporal Concept]
   760   C1522704:Exercise [Therapeutic or Preventive Procedure]
   760   C3541383:Time [Temporal Concept]
   756   C0439511:day times [Quantitative Concept]
   704 E C0442043:Temporal [Spatial Concept]
   704 E C2362314:Temporal [Temporal Concept]

Phrase: "and"

Phrase: "menstrual cycle phase."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1818633:menstrual cycle phase [Organism Function]
   827   C0205390:Phase [Temporal Concept]
   734   C0025329:Menstrual cycle [Organism Function]
Processing 00000000.tx.276: J Appl Physiol 83: 18221831, 1997.[Abstract/Free FullText] Grant SM, Green HJ, Phillips SM, Enns DL, and Sutton JR. 

Phrase: "J Appl Physiol 83"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1858559:APPL [Gene or Genome]

Phrase: ":"

Phrase: "18221831,"

Phrase: "1997."

Phrase: "[Abstract/Free FullText"

Phrase: "] Grant SM,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036154:SM [Geographic Area]

Phrase: "Green HJ,"

Phrase: "Phillips SM,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036154:SM [Geographic Area]

Phrase: "Enns DL,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3642216:/dL [Quantitative Concept]

Phrase: "and"

Phrase: "Sutton JR."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1708595:Jr [Idea or Concept]
   861   C3280986:JR [Disease or Syndrome]
Processing 00000000.tx.277: Fluid and electrolyte hormonal responses to exercise and acute plasma volume expansion. 

Phrase: "Fluid"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0005889:FLUID [Body Substance]
  1000   C0302908:fluid [Substance]
  1000   C0444611:Fluid [Qualitative Concept]
  1000   C1704353:Fluid [Substance]

Phrase: "and"

Phrase: "electrolyte hormonal responses to"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   812   C0871261:responses [Organism Attribute]
   779 E C1704632:Response [Finding]
   779 E C1706817:Response [Intellectual Product]
   779 E C2911692:Response [Mental Process]

Phrase: "exercise"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0015259:Exercise [Daily or Recreational Activity]
  1000   C1522704:Exercise [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "acute plasma volume expansion."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   861   C0032127:Plasma Volume [Clinical Attribute]
   812   C0032105:Plasma [Body Substance]
   812   C0449468:*Volume [Quantitative Concept]
   812   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   812   C1690016:% volume [Qualitative Concept]
   812   C1705102:Volume [Intellectual Product]
   812   C2700258:Volume [Laboratory Procedure]
Processing 00000000.tx.278: J Appl Physiol 81: 23862392, 1996.[Abstract/Free FullText] Heenan AP and Wolfe LA. 

Phrase: "J Appl Physiol 81"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1858559:APPL [Gene or Genome]

Phrase: ":"

Phrase: "23862392,"

Phrase: "1996."

Phrase: "[Abstract/Free FullText"

Phrase: "] Heenan AP"

Phrase: "and"

Phrase: "Wolfe LA."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0023031:La [Element, Ion, or Isotope]
Processing 00000000.tx.279: Plasma acid-base regulation above and below ventilatory threshold in late gestation. 

Phrase: "Plasma acid-base regulation above"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0851285:Regulation [Governmental or Regulatory Activity]
   760   C1327622:Regulation [Biologic Function]

Phrase: "and below ventilatory threshold"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0449864:Threshold [Qualitative Concept]
   770   C1515981:And [Idea or Concept]

Phrase: "in late gestation."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0032961:Gestation [Organism Function]
   789 E C0439671:Gestational [Temporal Concept]
Processing 00000000.tx.280: J Appl Physiol 88: 149157, 2000.[Abstract/Free FullText] Kinugawa T, Ogino K, Miyakoda H, Saitoh M, Hisatome I, Fujimoto Y, Yoshida A, Shigemasa C, and Sato R. 

Phrase: "J Appl Physiol 88"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1858559:APPL [Gene or Genome]

Phrase: ":"

Phrase: "149157,"

Phrase: "2000."

Phrase: "[Abstract/Free FullText"

Phrase: "] Kinugawa T,"

Phrase: "Ogino K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Miyakoda H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Saitoh M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Hisatome I,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Fujimoto Y,"

Phrase: "Yoshida A,"

Phrase: "Shigemasa C,"

Phrase: "and"

Phrase: "Sato R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.281: Responses of catecholamines, renin-angiotensin system, and atrial natriuretic peptide to exercise in untrained men and women. 

Phrase: "Responses of catecholamines,"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   790   C0871261:responses [Organism Attribute]
   756 E C1704632:Response [Finding]
   756 E C1706817:Response [Intellectual Product]
   756 E C2911692:Response [Mental Process]

Phrase: "renin-angiotensin system,"
Meta Candidates (Total=12; Excluded=3; Pruned=0; Remaining=9)
  1000   C0035096:Renin-angiotensin system [Body System]
  1000   C2984247:Renin-angiotensin system [Functional Concept]
   827   C0003018:Angiotensin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   827   C0035094:Renin [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0035100:Rennin [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   827   C0449913:System [Functional Concept]
   827   C1419338:RENIN [Gene or Genome]
   827   C1553451:System [Manufactured Object]
   827   C1704459:System [Medical Device]
   771 E C0022877:Lab [Manufactured Object,Organization]
   771 E C0587081:Labs [Finding]
   755 E C0205373:Systemic [Functional Concept]

Phrase: "and"

Phrase: "atrial natriuretic peptide to"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   923   C0027481:Atrial natriuretic peptide [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   875   C0051989:atrial peptide [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   861   C1144709:natriuretic peptide [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C2709270:Natriuretic peptide [Amino Acid, Peptide, or Protein,Hormone]
   861   C3537020:Natriuretic Peptide [Pharmacologic Substance]
   812   C0018792:Atrial [Body Part, Organ, or Organ Component]
   812   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   812   C0597421:natriuretic [Pharmacologic Substance]
   741 E C0524422:atria [Body Part, Organ, or Organ Component]
   741 E C1280619:Atrium [Body Part, Organ, or Organ Component]

Phrase: "exercise in untrained men"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   770   C0015259:Exercise [Daily or Recreational Activity]
   770   C0025266:Men [Population Group]
   770   C1522704:Exercise [Therapeutic or Preventive Procedure]
   737 E C0024554:MAN [Finding]
   737 E C0086418:Man [Human]

Phrase: "and"

Phrase: "women."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043210:Women [Population Group]
Processing 00000000.tx.282: Gen Pharmacol 28: 225228, 1997.[Medline] Lindheimer MD, Barron WM, and Davison JM. 

Phrase: "Gen Pharmacol 28"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1704351:GEN [Quantitative Concept]
   827   C2239486:Gen [Gene or Genome]

Phrase: ":"

Phrase: "225228,"

Phrase: "1997."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Lindheimer MD,"

Phrase: "Barron WM,"

Phrase: "and"

Phrase: "Davison JM."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0022337:JM [Geographic Area]
Processing 00000000.tx.283: Osmotic and volume control of vasopressin release in pregnancy. 

Phrase: "Osmotic"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0029391:osmotic [Natural Phenomenon or Process]
  1000   C0311417:Osmotic [Functional Concept]

Phrase: "and"

Phrase: "volume control of vasopressin release"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C0449972:Volume control [Therapeutic or Preventive Procedure]
   760   C0243148:control [Qualitative Concept]
   760   C1550141:Control [Substance]
   760   C1882979:Control [Conceptual Entity]
   760   C2587213:Control [Functional Concept]
   760   C3274648:Control [Qualitative Concept]

Phrase: "in pregnancy."
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
  1000   C0032961:Pregnancy [Organism Function]
  1000   C3484365:Pregnancy [Clinical Attribute]
   928 E C0549206:Pregnant [Finding]
   928 E C0553641:Pregnant [Functional Concept]
   928 E C0600457:PREGNANT [Finding]
   916 E C0552112:Pregnancies [Clinical Attribute]
Processing 00000000.tx.284: Am J Kidney Dis 17: 105111, 1991.[ISI][Medline] Lindheimer MD and Davison JM. 

Phrase: "Am"

Phrase: "J Kidney Dis 17"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   812   C0022646:Kidney [Body Part, Organ, or Organ Component]
   812   C0227665:kidney [Body Part, Organ, or Organ Component]
   812   C0451119:DIS [Intellectual Product]
   812   C1278978:Kidney [Body Part, Organ, or Organ Component]
   812   C1444662:DIS [Finding]
   812   C1514845:KIDNEY [Tissue]
   719 E C0027697:Nephritides [Disease or Syndrome]

Phrase: ":"

Phrase: "105111,"

Phrase: "1991."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Lindheimer MD"

Phrase: "and"

Phrase: "Davison JM."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0022337:JM [Geographic Area]
Processing 00000000.tx.285: Osmoregulation, the secretion of arginine vasopressin and its metabolism during pregnancy. 

Phrase: "Osmoregulation,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0043064:osmoregulation [Organism Function]
  1000   C1510659:Osmoregulation [Cell Function]

Phrase: "the secretion of arginine vasopressin"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   797   C1154419:vasopressin secretion [Cell Function]
   760   C0036536:secretion [Biologic Function]
   760   C0036537:Secretion [Body Substance]

Phrase: "and"

Phrase: "its metabolism during pregnancy."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0025519:Metabolism [Organism Function]
   770   C0025520:metabolism [Functional Concept]
Processing 00000000.tx.286: Eur J Endocrinol 132: 133143, 1995.[ISI][Medline] Longo LD. 

Phrase: "Eur J Endocrinol 132"

Phrase: ":"

Phrase: "133143,"

Phrase: "1995."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Longo LD."
Processing 00000000.tx.287: Maternal blood volume and cardiac output during pregnancy: a hypothesis of endocrinologic control. 

Phrase: "Maternal blood volume"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0005850:Blood Volume [Organism Attribute]
   827   C0449468:*Volume [Quantitative Concept]
   827   C1690016:% volume [Qualitative Concept]
   827   C1705102:Volume [Intellectual Product]
   827   C2700258:Volume [Laboratory Procedure]

Phrase: "and"

Phrase: "cardiac output during pregnancy"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0007165:Cardiac Output [Clinical Attribute]
   770   C0018787:Cardiac [Body Part, Organ, or Organ Component]
   770   C1522601:Cardiac [Spatial Concept]
   770   C1709366:Output [Conceptual Entity]

Phrase: ":"

Phrase: "a hypothesis of endocrinologic control."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1512571:Hypothesis [Idea or Concept]
Processing 00000000.tx.288: Am J Physiol Regul Integr Comp Physiol 245: R720R729, 1983.[Abstract/Free FullText] Mannix ET, Palange P, Aronoff GR, Manfredi F, and Farber MO. 

Phrase: "Am"

Phrase: "J Physiol Regul Integr Comp Physiol 245"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   795   C0056167:COMP [Therapeutic or Preventive Procedure]
   795   C1456376:COMP [Gene or Genome]

Phrase: ":"

Phrase: "R720R729,"

Phrase: "1983."

Phrase: "[Abstract/Free FullText"

Phrase: "] Mannix ET, Palange P,"

Phrase: "Aronoff GR,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1552950:[gr] [Quantitative Concept]

Phrase: "Manfredi F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "and"

Phrase: "Farber MO."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3538743:MO [Idea or Concept]
Processing 00000000.tx.289: Atrial natriuretic peptide and the renin-aldosterone axis during exercise in man. 

Phrase: "Atrial natriuretic peptide"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
  1000   C0027481:Atrial natriuretic peptide [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   913   C0051989:atrial peptide [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   901   C1144709:natriuretic peptide [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   901   C2709270:Natriuretic peptide [Amino Acid, Peptide, or Protein,Hormone]
   901   C3537020:Natriuretic Peptide [Pharmacologic Substance]
   827   C0018792:Atrial [Body Part, Organ, or Organ Component]
   827   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   827   C0597421:natriuretic [Pharmacologic Substance]
   755 E C0524422:atria [Body Part, Organ, or Organ Component]
   755 E C1280619:Atrium [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "the renin-aldosterone axis during exercise"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0004457:Axis [Body Part, Organ, or Organ Component]
   753   C0999597:Axis [Mammal]
   753   C1522496:Axis [Spatial Concept]

Phrase: "in man."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0024554:MAN [Finding]
  1000   C0025266:Man [Population Group]
  1000   C0086418:Man [Human]
Processing 00000000.tx.290: Med Sci Sports Exerc 22: 785789, 1990.[ISI][Medline] Morton MJ, Paul MS, and Metcalfe J. 

Phrase: "Med Sci Sports Exerc 22"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0038039:Sports [Daily or Recreational Activity]
   804   C1552306:Sports [Professional or Occupational Group]
   804   C3642273:SCI [Professional or Occupational Group]

Phrase: ":"

Phrase: "785789,"

Phrase: "1990."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Morton MJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439254:MJ [Medical Device]

Phrase: "Paul MS,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039676:MS [Amino Acid, Peptide, or Protein,Enzyme]
   861   C2349943:Ms. [Conceptual Entity]
   861   C3539704:MS [Gene or Genome]

Phrase: "and"

Phrase: "Metcalfe J."
Processing 00000000.tx.291: Exercise during pregnancy. 

Phrase: "Exercise during pregnancy."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0015259:Exercise [Daily or Recreational Activity]
   790   C1522704:Exercise [Therapeutic or Preventive Procedure]
Processing 00000000.tx.292: Med Clin North Am 69: 97108, 1985.[ISI][Medline] Pedersen EB, Johannesen P, Rasmussen AB, and Danielsen H. 

Phrase: "Med Clin North"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1709269:North [Spatial Concept]

Phrase: "Am"

Phrase: "69"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450388:69 [Intellectual Product]

Phrase: ":"

Phrase: "97108,"

Phrase: "1985."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Pedersen EB,"

Phrase: "Johannesen P,"

Phrase: "Rasmussen AB,"

Phrase: "and"

Phrase: "Danielsen H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.293: The osmoregulatory system and the renin-angiotensin-aldosterone system in pre-eclampsia and normotensive pregnancy. 

Phrase: "The osmoregulatory system"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0449913:System [Functional Concept]
   861   C1553451:System [Manufactured Object]
   861   C1704459:System [Medical Device]
   789 E C0205373:Systemic [Functional Concept]

Phrase: "and"

Phrase: "the renin-angiotensin-aldosterone system in pre-eclampsia"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   833   C0086907:Renin-Angiotensin-Aldosterone System [Body System]
   793   C0035096:Renin-angiotensin system [Body System]
   793   C2984247:Renin-angiotensin system [Functional Concept]
   767   C1115104:Aldosterone/Renin [Laboratory Procedure]
   744   C0002006:Aldosterone [Hormone,Pharmacologic Substance,Steroid]
   744   C0003018:Angiotensin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   744   C0035094:Renin [Amino Acid, Peptide, or Protein,Enzyme]
   744   C0035100:Rennin [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   744   C0449913:System [Functional Concept]
   744   C1419338:RENIN [Gene or Genome]
   744   C1553451:System [Manufactured Object]
   744   C1704459:System [Medical Device]

Phrase: "and"

Phrase: "normotensive pregnancy."
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
   861   C0032961:Pregnancy [Organism Function]
   861   C3484365:Pregnancy [Clinical Attribute]
   789 E C0549206:Pregnant [Finding]
   789 E C0553641:Pregnant [Functional Concept]
   789 E C0600457:PREGNANT [Finding]
   777 E C0552112:Pregnancies [Clinical Attribute]
Processing 00000000.tx.294: Scand J Lab Invest 45: 627633, 1985.[ISI] Pivarnik JM, Lee W, Clark SL, Cotton DB, Spillman HT, and Miller JF. 

Phrase: "Scand J Lab"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0022877:Lab [Manufactured Object,Organization]
   771 E C0035100:Rennin [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   743 E C0587081:Labs [Finding]

Phrase: "Invest"

Phrase: "45"

Phrase: ":"

Phrase: "627633,"

Phrase: "1985."

Phrase: "[ISI] Pivarnik JM,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0022337:JM [Geographic Area]

Phrase: "Lee W,"

Phrase: "Clark SL,"

Phrase: "Cotton DB,"

Phrase: "Spillman HT,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0018510:HT [Geographic Area]
   861   C0677607:HT [Disease or Syndrome]

Phrase: "and"

Phrase: "Miller JF."
Processing 00000000.tx.295: Cardiac output responses of primigravid women during exercise determined by the direct Fick technique. 

Phrase: "Cardiac output responses of primigravid women"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   753   C0871261:responses [Organism Attribute]
   719 E C1704632:Response [Finding]
   719 E C1706817:Response [Intellectual Product]
   719 E C2911692:Response [Mental Process]

Phrase: "during exercise"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0015259:Exercise [Daily or Recreational Activity]
  1000   C1522704:Exercise [Therapeutic or Preventive Procedure]

Phrase: "determined by the direct Fick technique."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   783   C1704536:Direct Technique [Therapeutic or Preventive Procedure]
   753   C0439851:Direct [Qualitative Concept]
   753   C0449851:Technique [Functional Concept]
   753   C1441586:Fick [Diagnostic Procedure]
   753   C1947931:Direct [Qualitative Concept]
Processing 00000000.tx.296: Obstet Gynecol 75: 954959, 1990.[Abstract] Pivarnik JM, Lee W, Miller JF, and Werch J. 

Phrase: "Obstet Gynecol 75"

Phrase: ":"

Phrase: "954959,"

Phrase: "1990."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Pivarnik JM,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0022337:JM [Geographic Area]

Phrase: "Lee W,"

Phrase: "Miller JF,"

Phrase: "and"

Phrase: "Werch J."
Processing 00000000.tx.297: Alterations in plasma volume and protein during cycle exercise throughout pregnancy. 

Phrase: "Alterations in plasma volume"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C1515926:Alteration [Idea or Concept]

Phrase: "and"

Phrase: "protein during cycle exercise"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "throughout pregnancy."
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
  1000   C0032961:Pregnancy [Organism Function]
  1000   C3484365:Pregnancy [Clinical Attribute]
   928 E C0549206:Pregnant [Finding]
   928 E C0553641:Pregnant [Functional Concept]
   928 E C0600457:PREGNANT [Finding]
   916 E C0552112:Pregnancies [Clinical Attribute]
Processing 00000000.tx.298: Med Sci Sports Exerc 22: 751755, 1990.[ISI][Medline] Roy BD, Green HJ, Grant SM, and Tarnopolsky MA. 

Phrase: "Med Sci Sports Exerc 22"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0038039:Sports [Daily or Recreational Activity]
   804   C1552306:Sports [Professional or Occupational Group]
   804   C3642273:SCI [Professional or Occupational Group]

Phrase: ":"

Phrase: "751755,"

Phrase: "1990."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Roy BD,"

Phrase: "Green HJ,"

Phrase: "Grant SM,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036154:SM [Geographic Area]

Phrase: "and"

Phrase: "Tarnopolsky MA."
Processing 00000000.tx.299: Acute plasma volume expansion in the untrained alters the hormonal response to prolonged moderate-intensity exercise. 

Phrase: "Acute plasma volume expansion in the untrained"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   778   C0032127:Plasma Volume [Clinical Attribute]
   748   C0032105:Plasma [Body Substance]
   748   C0449468:*Volume [Quantitative Concept]
   748   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   748   C1690016:% volume [Qualitative Concept]
   748   C1705102:Volume [Intellectual Product]
   748   C2700258:Volume [Laboratory Procedure]

Phrase: "alters"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   916   C0392747:Altered [Functional Concept]

Phrase: "the hormonal response to prolonged moderate-intensity exercise."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   793   C2265833:response to exercise [Organism Function]
   744   C0871261:Response [Organism Attribute]
   744   C1704632:Response [Finding]
   744   C1706817:Response [Intellectual Product]
   744   C2911692:Response [Mental Process]
Processing 00000000.tx.300: Horm Metab Res 33: 238245, 2001.[ISI][Medline] Sala C, Campise M, Ambroso G, Motta T, Zanchetti A, and Morganti A. 

Phrase: "Horm Metab Res 33"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C2347379:RES [Finding]

Phrase: ":"

Phrase: "238245,"

Phrase: "2001."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Sala C,"

Phrase: "Campise M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Ambroso G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Motta T,"

Phrase: "Zanchetti A,"

Phrase: "and"

Phrase: "Morganti A."
Processing 00000000.tx.301: Atrial natriuretic peptide and hemodynamic changes during normal human pregnancy. 

Phrase: "Atrial natriuretic peptide"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
  1000   C0027481:Atrial natriuretic peptide [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   913   C0051989:atrial peptide [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   901   C1144709:natriuretic peptide [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   901   C2709270:Natriuretic peptide [Amino Acid, Peptide, or Protein,Hormone]
   901   C3537020:Natriuretic Peptide [Pharmacologic Substance]
   827   C0018792:Atrial [Body Part, Organ, or Organ Component]
   827   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   827   C0597421:natriuretic [Pharmacologic Substance]
   755 E C0524422:atria [Body Part, Organ, or Organ Component]
   755 E C1280619:Atrium [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "hemodynamic changes during normal human pregnancy."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   753   C0392747:changes [Functional Concept]
   753   C0443172:changes [Quantitative Concept]
   719 E C1705241:Change [Quantitative Concept]
Processing 00000000.tx.302: Hypertension 25: 631636, 1995.[Abstract/Free FullText] Sarda RI, De Bold ML, and De Bold AJ. 

Phrase: "Hypertension 25"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0020538:Hypertension [Disease or Syndrome]
   861   C1963138:Hypertension [Finding]

Phrase: ":"

Phrase: "631636,"

Phrase: "1995."

Phrase: "[Abstract/Free FullText"

Phrase: "] Sarda RI,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0035487:RI [Geographic Area]

Phrase: "De Bold ML,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0439526:/mL [Quantitative Concept]

Phrase: "and"

Phrase: "De Bold AJ."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0230613:AJ [Cell Component]
Processing 00000000.tx.303: Optimization of atrial natriuretic factor radioimmunoassay. 

Phrase: "Optimization of atrial natriuretic factor radioimmunoassay."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C2698650:Optimization [Activity]
Processing 00000000.tx.304: Clin Biochem 22: 1115, 1989.[ISI][Medline] Stachenfeld NS, Silva C, Keefe DL, Kokoszka CA, and Nadel ER. 

Phrase: "Clin Biochem 22"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1315013:CLIN [Intellectual Product]

Phrase: ":"

Phrase: "1115,"

Phrase: "1989."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Stachenfeld NS,"

Phrase: "Silva C,"

Phrase: "Keefe DL,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3642216:/dL [Quantitative Concept]

Phrase: "Kokoszka CA,"

Phrase: "and"

Phrase: "Nadel ER."
Processing 00000000.tx.305: Effects of oral contraceptives on body fluid regulation. 

Phrase: "Effects of oral contraceptives"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   819   C2945677:oral effects [Physiologic Function]
   802   C3179447:Contraceptive Effects [Physiologic Function]
   770   C1280500:effects [Qualitative Concept]
   737 E C2348382:Effect [Qualitative Concept]

Phrase: "on body fluid regulation."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0851285:Regulation [Governmental or Regulatory Activity]
   827   C1327622:Regulation [Biologic Function]
   734   C0005889:Body fluid [Body Substance]
Processing 00000000.tx.306: J Appl Physiol 87: 10161025, 1999.[Abstract/Free FullText] Stephenson LA, Kolka MA, Francesconi R, and Gonzalez RR. 

Phrase: "J Appl Physiol 87"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1858559:APPL [Gene or Genome]

Phrase: ":"

Phrase: "10161025,"

Phrase: "1999."

Phrase: "[Abstract/Free FullText"

Phrase: "] Stephenson LA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0023031:La [Element, Ion, or Isotope]

Phrase: "Kolka MA,"

Phrase: "Francesconi R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Gonzalez RR."
Processing 00000000.tx.307: Circadian variations in plasma renin activity, catecholamines and aldosterone during exercise in women. 

Phrase: "Circadian variations in plasma renin activity,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0205419:variations [Qualitative Concept]

Phrase: "catecholamines"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0007412:Catecholamines [Neuroreactive Substance or Biogenic Amine,Pharmacologic Substance]
   966 E C3536742:Catecholamine [Pharmacologic Substance]

Phrase: "and"

Phrase: "aldosterone during exercise"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0002006:Aldosterone [Hormone,Pharmacologic Substance,Steroid]

Phrase: "in women."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043210:Women [Population Group]
Processing 00000000.tx.308: Eur J Appl Physiol 58: 756764, 1989. 

Phrase: "Eur J Appl Physiol 58"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C1858559:APPL [Gene or Genome]

Phrase: ":"

Phrase: "756764,"

Phrase: "1989."
Processing 00000000.tx.309: Thomsen JK, Fogh-Anderson N, Jaszczak P, and Giese J. 

Phrase: "Thomsen JK,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1420098:JK [Gene or Genome]

Phrase: "Fogh-Anderson N,"

Phrase: "Jaszczak P,"

Phrase: "and"

Phrase: "Giese J."
Processing 00000000.tx.310: Atrial natriuretic peptide (ANP) decrease during normal pregnancy as related to hemodynamic changes and volume regulation. 

Phrase: "Atrial natriuretic peptide"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
  1000   C0027481:Atrial natriuretic peptide [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   913   C0051989:atrial peptide [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   901   C1144709:natriuretic peptide [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   901   C2709270:Natriuretic peptide [Amino Acid, Peptide, or Protein,Hormone]
   901   C3537020:Natriuretic Peptide [Pharmacologic Substance]
   827   C0018792:Atrial [Body Part, Organ, or Organ Component]
   827   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   827   C0597421:natriuretic [Pharmacologic Substance]
   755 E C0524422:atria [Body Part, Organ, or Organ Component]
   755 E C1280619:Atrium [Body Part, Organ, or Organ Component]

Phrase: "(ANP"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
  1000   C0027481:Atrial natriuretic peptide [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   913   C0051989:atrial peptide [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   901   C1144709:natriuretic peptide [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   901   C2709270:Natriuretic peptide [Amino Acid, Peptide, or Protein,Hormone]
   901   C3537020:Natriuretic Peptide [Pharmacologic Substance]
   827   C0018792:Atrial [Body Part, Organ, or Organ Component]
   827   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   827   C0597421:natriuretic [Pharmacologic Substance]
   755 E C0524422:atria [Body Part, Organ, or Organ Component]
   755 E C1280619:Atrium [Body Part, Organ, or Organ Component]

Phrase: ")"

Phrase: "decrease during normal pregnancy"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   833   C0232989:Normal pregnancy [Finding]
   791 E C0700573:normal pregnancies [Finding]
   770   C0032961:Pregnancy [Organism Function]
   770   C0205307:Normal [Qualitative Concept]
   770   C0392756:Decrease [Qualitative Concept]
   770   C0439166:% normal [Quantitative Concept]
   770   C0547047:Decrease [Quantitative Concept]
   770   C2347086:% Normal [Quantitative Concept]
   770   C3484365:Pregnancy [Clinical Attribute]

Phrase: "as"

Phrase: "related to hemodynamic changes"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   770   C0019010:Hemodynamic [Organ or Tissue Function]
   770   C0392747:changes [Functional Concept]
   770   C0439849:Related [Qualitative Concept]
   770   C0443172:changes [Quantitative Concept]
   770   C0445223:Related [Finding]
   737 E C0163712:Relate [Organic Chemical]
   737 E C1705241:Change [Quantitative Concept]

Phrase: "and"

Phrase: "volume regulation."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0449468:*Volume [Quantitative Concept]
   861   C0851285:Regulation [Governmental or Regulatory Activity]
   861   C1327622:Regulation [Biologic Function]
   861   C1690016:% volume [Qualitative Concept]
   861   C1705102:Volume [Intellectual Product]
   861   C2700258:Volume [Laboratory Procedure]
Processing 00000000.tx.311: Acta Obstet Gynecol Scand 72: 103110, 1993.[ISI][Medline] Walker JL and Jennings DB. 

Phrase: "Acta Obstet Gynecol Scand 72"

Phrase: ":"

Phrase: "103110,"

Phrase: "1993."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Walker JL"

Phrase: "and"

Phrase: "Jennings DB."
Processing 00000000.tx.312: Angiotensin mediates stimulation of ventilation after vasopressin V1 receptor blockade. 

Phrase: "Angiotensin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0003018:Angiotensin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "mediates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086597:Mediate [Social Behavior]

Phrase: "stimulation of ventilation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1292856:Stimulation [Therapeutic or Preventive Procedure]
   790   C1948023:Stimulation [Natural Phenomenon or Process]

Phrase: "after vasopressin V1 receptor blockade."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0332206:Blockade [Functional Concept]
   812   C3540676:Blockade [Pharmacologic Substance]
   708   C0078077:Vasopressin Receptor [Amino Acid, Peptide, or Protein,Receptor]
Processing 00000000.tx.313: J Appl Physiol 76: 25172526, 1994.[Abstract/Free FullText] Watanabe H, Lau DCW, Guyn HL, and Wong NLM. 

Phrase: "J Appl Physiol 76"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1858559:APPL [Gene or Genome]

Phrase: ":"

Phrase: "25172526,"

Phrase: "1994."

Phrase: "[Abstract/Free FullText"

Phrase: "] Watanabe H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Lau DCW,"

Phrase: "Guyn HL,"

Phrase: "and"

Phrase: "Wong NLM."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0027470:NLM [Health Care Related Organization]
Processing 00000000.tx.314: Effect of progesterone therapy on arginine vasopressin and atrial natriuretic factor in premenstrual syndrome. 

Phrase: "Effect of progesterone therapy"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   819   C1518681:Therapy Effect [Finding]
   770   C1280500:Effect [Qualitative Concept]
   770   C2348382:Effect [Qualitative Concept]

Phrase: "on arginine vasopressin"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0003779:Arginine Vasopressin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
           Vasopressin
  1000   C1527128:Arginine Vasopressin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0003765:Arginine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   861   C0042413:vasopressin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1705480:Vasopressin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "and"

Phrase: "atrial natriuretic factor in premenstrual syndrome."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   833   C0027481:Atrial Natriuretic Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   833   C1417807:ATRIAL NATRIURETIC FACTOR [Gene or Genome]
   790   C0027479:Natriuretic factor [Hormone,Organic Chemical]
   753   C0018792:Atrial [Body Part, Organ, or Organ Component]
   753   C0597421:natriuretic [Pharmacologic Substance]
   753   C1521761:Factor [Functional Concept]
   753   C2827422:Factor [Conceptual Entity]
Processing 00000000.tx.315: Clin Invest Med 20: 211223, 1997.[ISI][Medline] Wilson M, Morganti AA, Zervoudakis I, Letcher RL, Romney BM, Von Oeyon P, Papera S, Sealey JE, and Laragh JH. 

Phrase: "Clin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1315013:CLIN [Intellectual Product]

Phrase: "Invest"

Phrase: "Med 20"

Phrase: ":"

Phrase: "211223,"

Phrase: "1997."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Wilson M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Morganti AA,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1235746:Aa [Plant]
   861   C1882141:aa [Qualitative Concept]

Phrase: "Zervoudakis I,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Letcher RL,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1419337:RL [Gene or Genome]
   861   C3539667:RL [Gene or Genome]

Phrase: "Romney BM,"

Phrase: "Von Oeyon P,"

Phrase: "Papera S,"

Phrase: "Sealey JE,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0454673:JE [Geographic Area]
   861   C1550752:JE [Temporal Concept]

Phrase: "and"

Phrase: "Laragh JH."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0268060:JH [Disease or Syndrome]
   861   C1415529:JH [Gene or Genome]
Processing 00000000.tx.316: Blood pressure, the renin-aldosterone system and sex steroids throughout normal pregnancy. 

Phrase: "Blood pressure,"
Meta Candidates (Total=16; Excluded=7; Pruned=0; Remaining=9)
  1000   C0005823:Blood Pressure [Organism Function]
  1000   C1271104:Blood Pressure [Finding]
  1000   C1272641:Blood pressure [Finding]
   861   C0005767:Blood [Tissue]
   861   C0005768:blood [Body Substance]
   861   C0033095:Pressure [Phenomenon or Process]
   861   C0229664:Blood [Body Substance]
   861   C0460139:Pressure [Finding]
   861   C1306345:Pressure [Functional Concept]
   789 E C0333275:Bloody [Qualitative Concept]
   777 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   777 E C0392895:Bloods [Population Group]
   777 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   777 E C1511228:VESSEL, BLOOD [Tissue]
   761 E C1558950:VASCULAR [Finding]
   761 E C1801960:Vascular [Qualitative Concept]

Phrase: "the renin-aldosterone system"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   827   C0449913:System [Functional Concept]
   827   C1553451:System [Manufactured Object]
   827   C1704459:System [Medical Device]
   755 E C0205373:Systemic [Functional Concept]
   734   C1115104:renin aldosterone [Laboratory Procedure]

Phrase: "and"

Phrase: "sex steroids throughout normal pregnancy."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0009253:Sex [Organism Function]
   760   C0036864:Sex [Behavior]
   760   C0038317:Steroids [Steroid]
   760   C0079399:sex [Organism Attribute]
   760   C1314687:Sex [Finding]
   760   C1522384:sex [Organism Attribute]
Processing 00000000.tx.317: Am J Med 68: 97104, 1980.[ISI][Medline] Wolfe LA, Preston RJ, Burggraf GW, and McGrath MJ. 

Phrase: "Am"

Phrase: "J Med 68"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0450387:68 [Intellectual Product]

Phrase: ":"

Phrase: "97104,"

Phrase: "1980."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Wolfe LA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0023031:La [Element, Ion, or Isotope]

Phrase: "Preston RJ,"

Phrase: "Burggraf GW,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0018387:GW [Geographic Area]

Phrase: "and"

Phrase: "McGrath MJ."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439254:MJ [Medical Device]
Processing 00000000.tx.318: Effects of pregnancy and chronic exercise on maternal cardiac structure and function. 

Phrase: "Effects of pregnancy"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C1280500:effects [Qualitative Concept]
   756 E C2348382:Effect [Qualitative Concept]

Phrase: "and"

Phrase: "chronic exercise on maternal cardiac structure"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0015259:Exercise [Daily or Recreational Activity]
   753   C1522704:Exercise [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "function."
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C0031843:function [Physiologic Function]
  1000   C0542341:Function [Functional Concept]
  1000   C0700205:FUNCTION [Classification]
  1000   C1705273:Function [Intellectual Product]
   928 E C0205245:Functional [Functional Concept]
   928 E C2700217:Functional [Conceptual Entity]
Processing 00000000.tx.319: Can J Physiol Pharmacol 77: 909917, 1999.[ISI][Medline] This Article Abstract Full Text (PDF) All Versions of this Article: 95/6/2321 most recent 00984.2002v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Google Scholar Articles by Heenan, A. 

Phrase: "Can"

Phrase: "J Physiol Pharmacol 77"

Phrase: ":"

Phrase: "909917,"

Phrase: "1999."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "This Article Abstract Full Text"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C1527021:Text [Intellectual Product]
   812   C1554111:Text [Idea or Concept]
   812   C1705606:Text [Intellectual Product]
   812   C3541382:Text [Intellectual Product]

Phrase: "(PDF)"

Phrase: "All Versions of this Article"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0333052:versions [Functional Concept]
   726 E C2607870:Version [Spatial Concept]

Phrase: ":"

Phrase: "95/6/2321 most recent 00984.2002v1"

Phrase: "Alert"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0239110:ALERT [Finding]

Phrase: "me"

Phrase: "when"

Phrase: "this article"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1706852:Article [Intellectual Product]

Phrase: "is"

Phrase: "cited"

Phrase: "Alert"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0239110:ALERT [Finding]

Phrase: "me"

Phrase: "if"

Phrase: "a correction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1705565:CORRECTION [Intellectual Product]
  1000   C1947976:Correction [Functional Concept]

Phrase: "is"

Phrase: "posted"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0687676:Post [Temporal Concept]
   966   C1704687:Post [Manufactured Object]

Phrase: "Citation Map Services"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0557854:Services [Occupational Activity]
   793 E C2825316:Service [Manufactured Object]
   793 E C3245478:service [Idea or Concept]

Phrase: "Email"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0013849:E-Mail [Intellectual Product]
  1000   C1705961:E-mail [Intellectual Product]

Phrase: "this article to a friend Similar articles"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1706852:Article [Intellectual Product]

Phrase: "in this journal Similar articles"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   896   C0282420:Journal Article [Intellectual Product]
   793   C1706852:Article [Intellectual Product]

Phrase: "in ISI Web"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0282111:Web [Manufactured Object]

Phrase: "of Science Similar articles"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1706852:Article [Intellectual Product]

Phrase: "in PubMed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1138432:PubMed [Intellectual Product]

Phrase: "Alert"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0239110:ALERT [Finding]

Phrase: "me to new issues of the journal Download"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   744   C0162443:Journal [Intellectual Product,Manufactured Object]
   744   C0205314:New [Temporal Concept]
   711   C0033213:Issue [Finding]
   711   C1706387:Issue [Intellectual Product]

Phrase: "to citation manager Google Scholar Articles"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   771   C1706852:Article [Intellectual Product]

Phrase: "by Heenan,"

Phrase: "A."
Processing 00000000.tx.320: P. 

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.321: Articles by McGrath, M. 

Phrase: "Articles by McGrath,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C1706852:Article [Intellectual Product]

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.322: J. 

Phrase: "J."
Processing 00000000.tx.323: Articles citing this Article PubMed PubMed Citation Articles by Heenan, A. 

Phrase: "Articles"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1706852:Article [Intellectual Product]

Phrase: "citing"

Phrase: "this Article PubMed PubMed Citation Articles by Heenan,"

Phrase: "A."
Processing 00000000.tx.324: P. 

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.325: Articles by McGrath, M. 

Phrase: "Articles by McGrath,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C1706852:Article [Intellectual Product]

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.326: J. 

Phrase: "J."
Processing 00000000.tx.327: HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS Visit Other APS Journals Online Copyright  2003 by the American Physiological Society.

Phrase: "HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   742   C0039224:Table [Manufactured Object]
   742   C1706073:Table [Medical Device]
   742   C1706074:Table [Intellectual Product]

Phrase: "Visit"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0545082:Visit [Behavior]
  1000   C1512346:visit [Health Care Activity]
  1000   C2826704:VISIT [Intellectual Product]

Phrase: "Other APS Journals Online Copyright  2003 by the American Physiological Society."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   738   C0009993:Copyright [Intellectual Product]
   738   C0037455:society [Organization]
   738   C0162443:journals [Intellectual Product,Manufactured Object]
   738   C0205394:Other [Qualitative Concept]
   738   C0205463:Physiological [Functional Concept]
   738   C0596070:American [Population Group]
   738   C1552856:copyright [Idea or Concept]

